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ABSTRACT 
Ubiquitylation is an indispensable post-translational modification system in 
eukaryotic cells that leads to the covalent attachment of a small ubiquitin (Ub) protein 
onto a target.  The traditional and best-characterized role for ubiquitylation is a 
fundamental regulatory mechanism whereby target proteins are tagged with a 
characteristic Lys48-linked Ub chain that signals for their elimination through 
proteasomal degradation.  Challenging this conventional wisdom is the finding that some 
ubiquitylated proteins are modified by Ub chains linked through Lys63, providing a 
molecular signal that is thought to be structurally and functionally distinct from Lys48-
linked Ub chains.  Of further interest and significance is that the Lys63-linked Ub chains 
are apparently synthesized through a novel biochemical mechanism employing a unique 
complex formed between a true Ub conjugating enzyme (E2), Ubc13, and an E2-variant 
(Uev), Mms2 (or Uev1A).  The goal of this thesis was to employ structural and functional 
approaches in order to better characterize the Ubc13-Mms2 Lys63-linked Ub conjugation 
complex. 
Error-free DNA damage tolerance (DDT) in the budding yeast is dependent on 
Lys63-linked Ub chains synthesized by Ubc13-Mms2 and thus provided the opportunity 
to experimentally test the function of the human UBC13 and MMS2 genes in a simple 
model organism.  Human UBC13 and MMS2 were each shown to function in place of 
their yeast counterparts and in accordance, human Ubc13 was shown to physically 
interact with yeast Mms2, and vice versa.  Two human MMS2 homologs were also tested 
and it was determined that UEV1A but not UEV1B can function in place of mms2 in yeast 
DDT.  Physical interactions were observed between Ubc13 and Uev1A, but not between 
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 Ubc13 and Uev1B, suggesting that Ubc13-Uev complex formation is required for 
function.  
In collaboration with a research group at the University of Alberta, crystal 
structure and NMR data were used to develop a mechanistic model for the conjugation of 
Lys63-linked Ub chains by the Ubc13-Mms2 heterodimer, whereby the special 
orientation of two Ub molecules facilitates a specific Ub-Ub linkage via Lys63.  In order 
to help support the in vitro model and to determine how the Ubc13-Mms2 structure 
relates to biological function, I used a structure-based approach to direct the creation of 
point mutations within four key regions of the Ubc13-Mms2 heterodimer; the Ubc13 
active-site, the Ubc13-E3 (Ub ligating enzyme) interface, the Mms2-Ub interface, and the 
Ubc13-Mms2 interface.  
Underscoring the importance of the Ub conjugation by Ubc13-Mms2, a Ubc13-
C87S active-site mutation was created that could bind to Mms2 but was unable to 
function in DDT.  Regarding the Ubc13-E3 interface, a single Ubc13-M64A point 
mutation had a potent effect on disrupting Ubc13 function in DDT, as well as its physical 
interaction with Rad5, TRAF6, and CHFR.  The results suggest that different RING 
finger E3s use the same Ubc13 surface to sequester the Ub conjugation activity of 
Ubc13-Mms2.  Two human Mms2 mutations at Ser32 and Ile62, which are contained 
within the Mms2-Ub interface, were found to reduce the ability of Mms2 to bind Ub.  
When the corresponding yeast mutations are combined, a synergistic loss in DDT 
function is observed.  The relative orientation of Ser32 and Ile62 suggests that the Mms2 
and Tsg101 Uev families use different Uev surfaces to physically interact with Ub.  A 
200 µM dissociation constant for the wild-type Mms2-Ub interaction was also 
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 determined.  The systematic mutagenesis and testing of 14 Ubc13-Mms2 interface 
residues led to mutants with partial or complete disruption of binding and function.  
Using this data, a model involving the insertion of a specific Mms2-Phe residue into a 
unique Ubc13 hydrophobic pocket was created to explain the specificity of Mms2 for 
Ubc13, and not other E2s.  In addition, the dissociation constant for the wild-type Ubc13-
Mms2 heterodimer was determined to be approximately 50 nM.  
The structural and functional studies strongly support the notion that Ubc13-
Mms2 complex has the unique ability to conjugate Lys63-linked Ub chains.  However, 
several reported instances of Lys63-linked Ub chains in vivo have not yet been attributed 
to Ubc13 or Mms2.  To address the disparity I was able to demonstrate and map a 
physical interaction between Mms2 and Rsp5, an E3 implicated in Lys63-linked Ub 
conjugation.  Surprisingly, it was found that MMS2 is not responsible for the RSP5-
dependent Lys63-linked Ub conjugation of a plasma membrane protein.  A possible 
explanation for the apparent paradox is presented. 
iv 
  
ACKNOWLEDGEMENTS 
I would first like to acknowledge three important people who, in my mind, have 
had the greatest influence on my budding scientific career.  Thank you Dr. Sean 
Hemmingsen for helping me to realize that the minute details which can consume some 
scientists must ultimately fit within a grander scheme.  You have taught me to think 
differently, and more effectively, about scientific problems.  Parker Andersen, I sincerely 
thank you for the countless enthusiastic scientific arguments over the years.  You have 
taught me that criticism should not be met with offense, but embraced as a privilege that 
encourages better science.  Most importantly, thank you Dr. Wei Xiao for providing 
supervision that strikes a perfect balance between scientific direction and scientific 
freedom.  I appreciate the many opportunities and challenges that you bestow upon your 
students in order to help them reach their potential; our ability to grow and improve as 
scientists truly rests on us alone.  Finally, your mastery of scientific execution is to be 
idolized, and I will be forever conscious of your example. 
I want to thank my advisory committee; Dr. Hughes Goldie, Dr. Troy Harkness, 
Dr. Dwayne Hegedus, Dr. Lambert Loh, and Dr. Peter Howard, for their selfless acts of 
guidance.  I am impressed by and grateful for the time and energy you sacrificed to 
ensure my success. 
I sincerely thank my fellow lab-mates, past and present, for creating a most 
pleasant and productive work environment.  A special thank you is reserved for the 
brilliant Michelle Hanna, who in addition to fulfilling an outlet for interesting intellectual 
discussion, has also provided me with unconditional scientific assistance and support.  
v 
 Thank you also to the support staff in the department, especially Mary Woodsworth, 
Sherry Olauson, and Shirley Cooke. 
I thank my Uncle Rick Holwinko, Grandfather John Holwinko, and Mother-in-
law Colleen Teague for their unconditional love and support, and the lowest monthly rent 
in Saskatoon.  Thank you to my Mom and Dad for instilling in me the desire to achieve, 
and my sister for her undying praise and encouragement.  Last, I am eternally thankful to 
my lovely wife Danielle, who was a necessary and fulfilling distraction from my studies.  
Thank you for keeping my eyes open to the “real world” while I was focused on science. 
Funding was provided by: John Larson Cancer Research Trust Fund; College of 
Medicine Graduate Teaching Fellowship; Natural Sciences and Engineering Research 
Council Scholarship; Arthur Smyth Graduate Scholarship; University of Saskatchewan 
Graduate Scholarship. 
vi 
  
TABLE OF CONTENTS 
page 
 
PERMISSION TO USE..................................................................................................... i 
ABSTRACT....................................................................................................................... ii 
ACKNOWLEDGMENTS .................................................................................................v 
LIST OF TABLES .............................................................................................................x 
LIST OF FIGURES ......................................................................................................... xi 
LIST OF ABBREVIATIONS ....................................................................................... xiv 
CHAPTER ONE - LYS63-LINKED UBIQUITYLATION ...........................................1 
1.1        Ubiquitylation and ubiquitylation enzymology ................................................. 2 
1.2        The ubiquitin-proteasome system...................................................................... 6 
1.3        Mono-ubiquitylation .......................................................................................... 8 
1.4        Alternative ubiquitin linkages.......................................................................... 10 
1.5        Discovery of Lys63-linked ubiquitin chains in vivo ........................................ 11 
1.6        DNA damage tolerance in Saccharomyces cerevisiae..................................... 14 
1.7        Lys63-linked ubiquitin chains signal for error-free DNA damage tolerance .. 20 
1.8        Structure and proposed mechanism of Ubc13-Mms2 ubiquitin conjugation .. 22 
1.9        Structure of Lys63-linked ubiquitin chains...................................................... 31 
1.10      Cellular roles for Lys63-linked ubiquitin chains ............................................. 33 
        1.10.1     Cellular roles for Lys63-linked ubiquitin chains generated by Ubc13-
Uev................................................................................................................................ 33 
        1.10.2     Cellular roles implicated with Lys63-linked ubiquitin chains............... 37 
1.11      Summary and significance............................................................................... 39 
 
CHAPTER TWO - MATERIALS AND METHODS ..................................................41 
2.1        Strains, cell culture, transformation, and storage............................................. 41 
        2.1.1     Yeast ........................................................................................................ 41 
        2.1.2     Bacteria .................................................................................................... 41 
2.2        Plasmids and DNA........................................................................................... 45 
        2.2.1     UBC13 and MMS2 ................................................................................... 45 
        2.2.2     UEV1A and UEV1B ................................................................................. 47 
        2.2.3     RSP5......................................................................................................... 47 
        2.2.4     CHFR, TRAF6, and FUR4 ....................................................................... 48 
        2.2.5     DNA cloning and analysis ....................................................................... 49 
2.3        Polymerase chain reaction ............................................................................... 50 
2.4        Site-directed mutagenesis ................................................................................ 50 
2.5        Recombinant protein expression and purification ........................................... 54 
2.6        Protein analysis ................................................................................................ 55 
vii 
 2.7        GST pull-down assays ..................................................................................... 56 
2.8        Co-immunoprecipitation .................................................................................. 58 
2.9        Yeast two-hybrid assay .................................................................................... 58 
2.10      Functional complementation assays ................................................................ 59 
2.11      Yeast membrane protein enrichment ............................................................... 60 
2.12      Antibody generation and antibodies used........................................................ 61 
2.13      Ubiquitylation assays ....................................................................................... 62 
2.14      Surface plasmon resonance.............................................................................. 63 
 
CHAPTER THREE - FUNCTION OF HUMAN UBC13-UEV COMPLEXES IN 
YEAST DNA DAMAGE TOLERANCE.......................................................................67 
3.1        Rationale .......................................................................................................... 67 
3.2        Results.............................................................................................................. 72 
        3.2.1     Human UBC13 and MMS2 are able to function in Saccharomyces 
cerevisiae ...................................................................................................................... 72 
        3.2.2     Human UBC13 and MMS2 complement their corresponding genes in S. 
cerevisiae ...................................................................................................................... 74 
        3.2.3     Functional complementation by human MMS2 homologs in S. cerevisiae
....................................................................................................................................... 77 
        3.2.4     Physical interactions between Ubc13-Uev proteins ................................ 80 
3.3        Discussion........................................................................................................ 85 
 
CHAPTER FOUR - STRUCTURAL AND FUNCTIONAL 
CHARACTERIZATION OF UBC13-MMS2 ...............................................................91 
4.1        Introduction...................................................................................................... 91 
4.2        Ubc13 active-site results .................................................................................. 93 
        4.2.1     The Ubc13 active-site is required for its function in DDT ...................... 95 
4.3        Ubc13-E3 interface results............................................................................... 97 
        4.3.1     Design of a Ubc13-M64A mutant............................................................ 98 
        4.3.2     The UBC13-M64A mutant does not function in DDT........................... 101 
        4.3.3     Ubc13-M64A disrupts a physical interaction with RING finger E3s.... 103 
        4.3.4     Discussion of the Ubc13-E3 interface ................................................... 109 
4.4        Mms2-Ub interface results............................................................................. 111 
        4.4.1     NMR-directed design of Mms2 surface mutations................................ 111 
        4.4.2     Mutagenesis of a putative Mms2 phosphorylation site.......................... 113 
        4.4.3     Identification of Mms2 surface mutants defective in binding Ub in vitro
..................................................................................................................................... 115 
        4.4.4     Functional complementation in DDT is impaired by Mms2-Ub interface 
mutations..................................................................................................................... 119 
        4.4.5     Discussion of the Mms2-Ub interface ................................................... 122 
4.5        Ubc13-Mms2 interface results....................................................................... 129 
        4.5.1     Structure of the Ubc13-Mms2 interface ................................................ 129 
        4.5.2     Design of Ubc13 mutants and their interaction in the yeast two-hybrid 
assay............................................................................................................................ 134 
viii 
         4.5.3     Design of Mms2 Mutants and their interaction in the yeast two-hybrid 
assay............................................................................................................................ 138 
        4.5.4     The in vivo function of MMS2 and UBC13 mutants correlates with their 
in vivo interaction........................................................................................................ 139 
        4.5.5     Binding ability of interface mutants by in vitro pull-down ................... 142 
        4.5.6     Binding ability of interface mutants by surface plasmon resonance ..... 145 
        4.5.7     Catalytic activity of interface mutants in ubiquitylation assays ............ 150 
        4.5.8     Interactions between Ubc13-Arg70 and Mms2-Phe13.......................... 152 
        4.5.9     Discussion of the Ubc13-Mms2 interface.............................................. 156 
 
CHAPTER FIVE - A PHYSICAL RELATIONSHIP BETWEEN MMS2 AND RSP5 
5.1          Rationale ...................................................................................................... 162 
5.2          Results.......................................................................................................... 165 
        5.2.1     Stable physical interactions are observed for Mms2 and Rsp5 ............. 165 
        5.2.2     A physical interaction is observed for Mms2 and Rsp5 in the yeast two-
hybrid assay ................................................................................................................ 168 
        5.2.3     A physical interaction between Ubc13 and Rsp5 is not observed ......... 170 
        5.2.4     Deletion mapping of the Mms2-Rsp5 physical interaction ................... 172 
        5.2.5     Rsp5 does not likely function in error-free DDT................................... 176 
        5.2.6     Rsp5 is involved in the Lys63-dependent Ub conjugation of plasma 
membrane permeases .................................................................................................. 177 
        5.2.7     MMS2 is not required for the Lys63-dependent Ub conjugation of the 
uracil permease ........................................................................................................... 179 
5.3          Discussion.................................................................................................... 182 
 
CHAPTER SIX - CONCLUSIONS AND FUTURE DIRECTIONS ........................187 
6.1           Conclusions................................................................................................. 187 
         6.1.1    Major conclusions from chapter three ................................................... 187 
         6.1.2    Major conclusions from chapter four..................................................... 187 
         6.1.3    Major conclusions from chapter five ..................................................... 188 
6.2          Future directions .......................................................................................... 189 
         6.2.1    Can an E2 be engineered to create a new physical interaction with Mms2?
..................................................................................................................................... 189 
         6.2.2    What is the mechanism of Lys63-linked Ub conjugation in vivo? ........ 190 
         6.2.3    Possible misinterpretation of Lys63-dependent Ub conjugation in vivo 192 
 
 
REFERENCES...............................................................................................................195 
 
 
  
LIST OF TABLES 
Table page 
 
2-1.  Oligonucleotides used for site-directed mutagenesis and PCR amplification...............53 
3-1.  Sequence conservation of eukaryotic DDT proteins .....................................................71 
4-1.  SPR binding data of Ubc13-Mms2 and their mutants...................................................149 
x 
  
LIST OF FIGURES 
Figure  page 
 
1-1.  Overview of DNA damage tolerance genes. .................................................................15 
1-2.  Overall structure of the human Ubc13-Mms2 heterodimer...........................................25 
1-3.  Channels created by the Ubc13-Mms2 heterodimer provide the framework for 
Lys63-linked Ub conjugation. .............................................................................27 
1-4.  Model for the mechanism of Lys63-linked Ub conjugation by Ubc13-Mms2 .............29 
2-1.  Site-directed mutagenesis strategy ................................................................................52 
2-2.  Example of binding curves used for computer-generated binding constant 
determination .......................................................................................................65 
2-3.  Example of plots used in the manual calculation of dissociation constants..................66 
3-1.  Functional complementation of yeast ubc13 mms2 double deletions by their 
corresponding human genes.................................................................................73 
3-2.  Functional complementation of yeast ubc13 and mms2 single deletions by their 
corresponding human genes.................................................................................75 
3-3.  Dilution plate analysis of the functional complementation of yeast ubc13 and mms2 
single deletions by their corresponding human genes .........................................76 
3-4.  Heterologous functional complementation of human UEV genes in yeast...................79 
3-5.  Ubc13–Uev physical interactions..................................................................................81-82 
3-6.  Heterologous Ubc13–Mms2 complex formation ..........................................................84 
4-1.  Residues mutated in Ubc13-Mms2 structure-function studies......................................92 
4-2.  Protein sequence alignment of the E2 homologs in S. cerevisiae and human Ubc13...94 
4-3.  The Ubc13-C87S substitution abrogates its function in yeast DDT but not its 
physical interaction with Mms2...........................................................................96 
4-4.  Identification of a Ubc13 residue of putative importance in binding RING finger 
domains ................................................................................................................100 
4-5.  The Ubc13-M64A substitution abrogates its function in yeast DDT but not its 
physical interaction with Mms2...........................................................................102 
xi 
 4-6.  The Ubc13-M64A substitution abolishes its physical interaction with Rad5 ...............104 
4-7.  The Ubc13-M64A substitution abolishes its physical interaction with TRAF6 ...........106 
4-8.  The Ubc13-M64A substitution abolishes its physical interaction with CHFR .............108 
4-9.  The mutation of the Mms2-Ub interface disrupts its binding with Ub in vitro.............118 
4-10.  The mutation of the Mms2-Ub interface disrupts the in vivo function of MMS2 .......120 
4-11.  The MMS2-S27A/I57A double-mutant causes an additive MMS sensitive 
phenotype.............................................................................................................121 
4-12.  The Uev domains of human Mms2 and Tsg101 use different surfaces to physically 
interact with Ub....................................................................................................127 
4-13.  Protein sequence alignment of Mms2 proteins from various model organisms..........128 
4-14.  Secondary and tertiary structures of Ubc13 and Mms2 ..............................................131-133 
4-15.  In vivo interaction of mutated Ubc13 and Mms2 with wild-type partners by a yeast 
two-hybrid assay ..................................................................................................137 
4-16.  Functional complementation of yeast ubc13 and mms2 mutants by corresponding 
human genes and their derivatives.......................................................................141 
4-17.  Binding of Ubc13 and Mms2 mutants in vitro ............................................................144 
4-18.  Relative in vitro binding of Ubc13 and Mms2 mutants measured by surface 
plasmon resonance ...............................................................................................148 
4-19.  Catalytic activity of Ubc13 and Mms2 mutants in vitro .............................................151 
4-20.  Physical and functional relationships between Ubc13-Arg70 and Mms2-Phe13 .......154-155 
4-21.  The Mms2-Phe insertion into a Ubc13 hydrophobic pocket is important for Ubc13-
Mms2 affinity.......................................................................................................160 
4-22.  A hydrophobic pocket is conserved in Ubc13 but not other Ubcs ..............................161 
5-1.  An Mms2-Rsp5 physical interaction is detected in vitro ..............................................167 
5-2.  An Mms2-Rsp5 physical interaction is detected in the yeast two-hybrid assay ...........169 
5-3.  A Ubc13-Rsp5 physical interaction is not observed .....................................................171 
5-4.  Mapping the Mms2-Rsp5 physical interaction..............................................................174-175 
5-5.  MMS2 is not required for the polyubiquitylation of the uracil permease......................181 
xii 
 6-1.  Proposed mechanisms for the Lys63-linked Ub conjugation of a target in vivo ...........191 
6-2.  Possibilities for Ub4 chain formation involving Ub-Lys48 and -Lys63........................194 
 
 
 
xiii 
 LIST OF ABBREVIATIONS 
 
3-AT   3-aminotriazole 
A   alanine 
Ala   alanine 
AD   activation domain 
Ade   adenine 
amp   ampicillin 
Arg   arginine 
Asp   aspartate 
β-gal   β-galactosidase 
BD   binding domain 
BLAST  basic local alignment search tool 
bp   base pair 
C   cysteine, carboxy 
CDART  conserved domain architecture research tool 
Cys   cysteine 
D   aspartate 
Da   Dalton 
dd   double-distilled 
DDT   DNA damage tolerance 
DMSO   dimethyl sulfoxide 
E   glutamate 
E1    ubiquitin activating enzyme 
E2    ubiquitin conjugating enzyme 
E3   ubiquitin ligating enzyme 
E-tube   Eppendorf-tube 
F   phenylalanine 
Gln   glutamine 
Glu   glutamate 
Gly   glycine 
GST   glutathione-S-transferase 
h   human 
HECT   homology to the E6-AP carboxyl terminus 
His   histidine 
I   isoleucine 
Ile   isoleucine 
IPTG   isopropyl-β-D-thiogalactopyranoside 
K   lysine 
Kd   dissociation constant 
L   leucine 
LB   Luria broth 
Leu   leucine 
M   methionine 
Met   methionine 
xiv 
 MMS   methylmethane sulfonate 
N   amino, asparagine 
NMR   nuclear magnetic resonance 
nt   nucleotide   
OD   optical density 
ORF   open reading frame 
P   proline 
PBS   phosphate-buffered saline 
PCNA   proliferating cell nuclear antigen 
PCR   polymerase chain reaction 
Phe   phenylalanine 
Pro   proline 
PRR   postreplication repair 
Q   glutamine 
R   arginine 
RING   really interesting new gene 
rpm   revolutions per minute 
RU   response units 
S   serine 
SD   synthetic dextrose 
SDS-PAGE  sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Ser   serine 
SPR   surface plasmon resonance 
ss   single strand 
TLS   translesion synthesis 
Trp   tryptophan 
ts   temperature sensitive 
Tyr   tyrosine 
Ub, Ub2, Ub4  ubiquitin, di-ubiquitin, tetra-ubiquitin 
Uev   ubiquitin conjugating enzyme variant 
UPS   ubiquitin proteasome system 
UV   ultraviolet 
Wt   wild-type 
X-Gal   5-bromo-4-chloro-3-indolyl-β-D-galactoside 
y   yeast (budding) 
Y   tyrosine 
YPD   yeast extract-peptone-dextrose 
xv 
 CHAPTER ONE 
LYS63-LINKED UBIQUITYLATION 
 
 Originating from the discovery of Ubiquitin (Ub) (Schlesinger et al., 1975) over 
30 years ago, ubiquitylation (Hershko et al., 1983) has become one of the cornerstones of 
covalent protein modification in eukaryotic cells.  For perspective, an incredible surge in 
Ub-related research in the last decade has revealed an astonishing number of 
ubiquitylation targets with a breadth and diversity that may very well rival 
phosphorylation.  Underscoring this significance, the scientists who pioneered the 
ubiquitylation field were awarded the 2004 Nobel Prize in Chemistry.  The traditional 
and best characterized role for ubiquitylation is targeted protein turnover through 
proteasome-dependent degradation.  The targeted removal of proteins is a simple yet 
powerful strategy that can be envisioned to influence essentially any given cellular 
pathway.  However, drawing some of the great interest in the field are recent discoveries 
that have revealed unexpected complexity and versatility regarding ubiquitylation.  The 
findings have challenged our way of thinking about the biochemical mechanisms and 
cellular roles traditionally attributed to this important type of covalent modification.  In 
the best and arguably most intriguing example to date, a unique Ub conjugating enzyme 
heterodimer comprised of Ubc13 and Mms2 generates atypical Ub linkages.  Most 
interestingly, these specialized Ub chains seem to provide a molecular signal that is 
distinct from proteasome-dependent degradation.  During my graduate studies, I have 
thus undertaken a research program to determine how the novel molecular structure of 
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 the Ubc13-Mms2 complex relates to its biological function.  Through the effective use of 
genetic and biochemical approaches, I was able to substantiate, challenge, and provide 
greater insight into the conventional wisdom regarding the molecular mechanisms and 
cellular roles of Ubc13-Mms2.  This introductory chapter aims to provide a sufficient 
overview of ubiquitylation in general, with particular emphasis on Ubc13-Mms2 and 
Lys63-linked Ub chains.  
  
1.1  Ubiquitylation and ubiquitylation enzymology 
In the simplest sense, ubiquitylation is a three-step biochemical reaction that uses 
ubiquitin, a small globular 76 amino acid protein, to covalently modify target proteins.  
As the name implies, Ub is found throughout eukaryotic cells.  With a mere three amino 
acid sequence difference between lower and higher eukaryotes, it is one of the most 
conserved proteins in nature (Ozkaynak et al., 1984).  The biochemical reaction is 
initiated when an ATP-dependent ubiquitin-activating enzyme (Uba or E1) forms a high-
energy thioester bond between the carboxy-terminal (C-terminal) Gly76 residue of Ub, 
and an internal Cys residue of the E1.  Ub is next transferred from the E1 to form another 
thioester bond, this time with the active-site Cys residue of a ubiquitin-conjugating 
enzyme (Ubc or E2).  The final step in the covalent modification links the C-terminal 
residue of Ub to a Lys ε-amino group on the target, forming an isopeptide bond in a 
process that usually requires a ubiquitin-ligating enzyme (Ubl or E3).  For review, please 
see (Hershko and Ciechanover, 1998; Hochstrasser, 1996; Jentsch, 1992; Pickart, 2001). 
 Whereas the E1 is encoded by a single or very few genes in the cell and performs 
a general role in activating the Ub molecule, E2s and E3s are responsible for the 
versatility and target specificity of ubiquitylation.  E2s comprise a family of proteins with 
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 a highly conserved core domain of approximately 150 amino acids.  Based on 3-
dimensional structure comparisons, the core domain forms a globular α/β fold with a 
central β-sheet and surrounding α-helices (Moraes et al., 2001; Pickart, 2001).  Within 
this region lies an active-site with the aforementioned Cys residue that is absolutely 
conserved among all E2s, and is housed in a shallow cleft in the center of the protein 
(VanDemark and Hill, 2002).  Based on data generated from multiple E2 crystal 
structures (for example see Cook et al., 1993; Moraes et al., 2001; Worthylake et al., 
1998) this characteristic 3-dimensional organization has been termed the Ubc- or E2-fold.  
Although confined to these general similarities, E2 enzymes are found to participate in 
very different and numerous cellular roles.  Because S. cerevisiae contains only eleven 
E2s that can covalently attach Ub to various target proteins, it is at first surprising that 
they can specifically select between hundreds (if not thousands) of potential 
ubiquitylation targets.  This diversity and specificity is achieved in several ways.  First, 
many E2s are longer than the ~150 amino-acid core domain itself, and instead contain 
non-conserved carboxy- or amino-terminal extensions, leading them to be characterized 
as Class II and Class III E2s, respectively (Jentsch, 1992).  It is believed that such 
extensions impart additional functions on the particular E2s, such as the mediation of 
specific downstream interactions with E3(s) or the eventual ubiquitylation target itself 
(Pickart, 2001).  Second, at least one E2, Ubc13, requires a specialized accessory factor 
protein in order to carry out ubiquitylation.  The requirement of an E2-variant in this case 
is a large focus of this thesis.  Last, a single E2 may independently associate with 
multiple E3s.  Because the E3s represent the most abundant family of ubiquitylation 
proteins, the E2-E3 affiliation is likely the most significant factor in creating target 
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 diversity for the E2s.  The E3s are thus often responsible for specifying the biological 
process or cellular role in which a particular ubiquitylation event is performed.   
 The remarkable variability of the E3 family of proteins is attributed to several 
factors.  First, they are generally very large and contain multiple different protein 
domains, many of which do not function in the ubiquitylation process itself.  This leads to 
large structural diversity, with inter-domain regions that often bear no significant 
homology to other proteins.  Another level of complexity is added because E3s may act 
independently with the cognate E2 or with other proteins as a part of a multi-subunit E3 
complex.  Furthermore, from a mechanistic standpoint, E3s may actively participate in 
ubiquitylation reactions (by forming covalent bonds with Ub) or act as passive adapters 
that physically bridge a given E2 to its target. 
 Aside from a small variable subset, E3s normally contain one of two well-defined 
and characteristic domains.  One of these is the HECT (homology to the E6-AP carboxyl 
terminus) domain which can bind Ub in a thioester-dependent manner, similar to E1 and 
E2 enzymes (Scheffner et al., 1995).  Several documented examples suggest that the 
covalent bonds generated between the HECT domain E3s and Ub are absolutely required 
for their role in the ubiquitylation process.  The HECT domain normally binds directly to 
the E2, as seen in an E2-E3 crystal structure (Huang et al., 1999), while other regions or 
domains are available to bind the target. 
 The other predominant E3 domain is signified by the RING (really interesting 
new gene) finger motif (Freemont, 1993).  The RING finger generally does not 
participate in Ub conjugation reactions directly, but instead acts as physical adaptor 
between E2s and their substrates (reviewed in Joazeiro and Weissman, 2000).  The 
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 discovery of the RING finger was based on its similarity to the DNA-binding zinc finger 
motif (Freemont et al., 1991; Lovering et al., 1993).  Like the zinc finger, the RING 
finger requires a Zn2+ ion to stabilize and create a scaffold for an otherwise unstructured 
loop region.  Compared to the well-known zinc finger motif, the RING finger has a long 
consensus sequence designated Cys-X2-Cys(9-39)-Cys-X(1-3)-His-X(2-3)-Cys/His-X2-Cys-
X(4-48)-Cys-X2-Cys, where X is any amino acid (Saurin et al., 1996).  The flexibility of 
the consensus sequence is likely one of the complicating factors in identifying novel 
RING finger E3s based on sequence alignments.  Unlike the zinc finger, the RING finger 
motif binds other proteins, especially E2s, instead of DNA.  Several crystal structures of 
proteins containing RING finger motifs have been solved, the most significant of which 
is the structure of the E2-RING finger heterodimer formed by UbcH7 and c-Cbl (Zheng 
et al., 2000).  The structure reveals that the E2-E3 physical interaction is directly 
mediated by the RING finger motif.  The functional importance of this specific 
interaction is evidenced by point mutations that prevent the formation of the Zn2+ cross-
bridge or in deletions that remove the RING finger all-together.  The E2-E3 physical 
interaction is thus destroyed and the ubiquitylation of the target is prevented. 
 In the last few years, a third family of E3s has emerged with a characteristic U-
box domain that is highly similar to the RING finger (Aravind and Koonin, 2000; 
Hatakeyama and Nakayama, 2003).  Based on sequence analysis and structural data, the 
position of key residues and the 3-dimensional conformation adopted is remarkably 
similar to the RING finger (Ohi et al., 2003).  The distinction is that the stabilization of 
the U-box domain is achieved through a cross-bridge comprised of intra-peptide 
hydrogen bonds and salt-bridges, instead of the metal chelation necessary for the RING 
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 finger domain.  In accordance, the mutation of key residues in the U-box domain leads to 
the severe destabilization of the U-box tertiary structure (Ohi et al., 2003).  Like the 
HECT and RING finger E3s, proteins containing a U-box work with E1 and E2 enzymes 
in order to promote ubiquitylation (Hatakeyama et al., 2001).  However, with the small 
number of U-box E3s identified to date, including only two in S. cerevisiae, it is 
suggested that they may not ubiquitylate a range of targets as substantial as the HECT 
and RING finger E3s. 
 
1.2  The Ubiquitin-Proteasome System 
 From a biochemical standpoint, a single round of ubiquitylation causes the 
conjugation of a single Ub (mono-Ub) moeity onto the target.  In some cases, this is the 
desired end product.  Alternatively, poly-Ub chains can be formed if, through mostly 
unknown mechanisms, successive conjugation reactions take place and a lysine residue of 
another Ub molecule is used as the subsequent site of attachment.  Poly-Ub chains linked 
through Lys48 participate in the Ub-proteasome system (UPS; also called the Ub-
proteasome pathway), which is the best understood cellular role for ubiquitylation.  
Lys48 Ub-conjugates of at least four Ub molecules in length act as characteristic 
molecular signals that allow the proteasome to specifically recognize the conjugated 
target (Thrower et al., 2000).  The proteasome is a large, barrel-like multi-subunit 
complex (~2.1 MDa) with ATP-dependent protein unfolding and cleavage activity.  The 
successful passage of the target protein through the lumen of the proteasome causes its 
irreversible cleavage into short polypeptides.  The Ub chain itself is also cleaved during 
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 proteasome-mediated degradation, but is done so by Ub-specific proteases in a particular 
manner that allows the eventual generation of re-usable Ub molecules. 
 Because the targeted degradation of proteins is a straightforward means for their 
regulation, it is reasonable to imagine that the UPS is likely to exert its effects on 
essentially any cellular pathway or function.  The type of proteins targeted by the UPS 
run the gamut of possibilities, from transcription activators, DNA binding proteins, signal 
transducers, and structural proteins, to name but a few.  There are generally no spatial or 
temporal limitations for the UPS, as it occurs throughout the cell and over the various 
cell-cycle stages.  For example, the UPS is responsible for terminating the activity of 
cytosolic signaling pathways (Chen et al., 1995; Tanaka et al., 2001) and degrading 
nuclear transcription factors (Salghetti et al., 2001).  Also, the UPS has an integral role in 
regulating cell-cycle control through the timely degradation of key regulatory proteins 
such as cyclins, which govern the transition from one cell cycle stage to another (Glotzer 
et al., 1991).  Several large review articles have done well to address many of the major 
roles of the UPS (Devoy et al., 2005; Hershko and Ciechanover, 1998; Hochstrasser, 
1996; Smith et al., 1996; Ulrich, 2002) 
 The cell’s devotion to the UPS is also observed from the standpoint of the Ub-
conjugating enzymes themselves.  The budding yeast dedicates almost all of its 11 E2s to 
the UPS.  Given the ability of multiple E2-E3 combinations and the potential for multi-
subunit E3s, it is apparent that the cell contributes a large arsenal toward protein 
degradation.  Furthermore, in higher eukaryotes, the encoding of the same E2 by several 
different genes helps to ensure the availability of particular E2s involved in the UPS.  In 
some cases, the functional complementation of completely different E2s provides yet 
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 another level of safeguarding.  For example, Ubc4 and Ubc5 in S. cerevisiae are both 
involved in the response to various cellular stresses and in many cases have been shown 
to functionally complement for one another.  An even more striking example is seen in 
cases where ubc4ubc5 double-knockout strains are complemented by a divergent E2, 
UBC1 (Seufert and Jentsch, 1990).  The redundancy and interchangeability of E2s likely 
provides a necessary backup for important cellular functions that require the UPS.  From 
another perspective, these properties can complicate experimental testing and make it 
difficult to attribute particular functions to specific E2s. 
 
1.3  Mono-ubiquitylation 
 The conjugation of a single Ub moeity to the target is a necessary step toward 
poly-Ub chains, and in some cases is the desired modification.  In other words, what may 
be considered as an intermediate en route to the poly-Ub chain is actually a bona fide 
modification with a possibly distinct purpose and function.  It could be suggested that 
cellular roles involving mono-ubiquitylation may have very well preceded those for poly-
ubiquitylation.  The conjugation of mono-Ub to target proteins was observed more than 
20 years ago (Busch and Goldknopf, 1981).  The nucleosome histone proteins were the 
first discovered to be mono-ubiquitylated, but it was not until quite recently that a 
function for the modification was attributed.  Yeast cells that are unable to conjugate 
mono-Ub to the histones H2A and H2B because of mutations in the E2 Rad6 (Ubc2) 
exhibit a slow-growth phenotype and are defective in sporulation (Robzyk et al., 2000).  
This apparent defect in meiosis extends to higher eukaryotic systems because rad6 
knockout mice (mHR6B−/−) have a defect in spermatogenesis leading to male sterility 
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 (Roest et al., 1996).  Other predominant roles involving the mono-ubiquitylation of target 
proteins are in viral budding (Morita and Sundquist, 2004; Patnaik et al., 2000), the 
endocytosis and transport of membrane permeases (Shih et al., 2003; Urbe, 2005), and 
translesion DNA synthesis (Hoege et al., 2002; Kannouche et al., 2004). 
 In contrast to the numerous E2s used for the UPS, only a small subset has been 
implicated in mono-ubiquitylation to date.  Interestingly, two of these E2s, Rad6 and 
Ubc5, are also involved in the poly-ubiquitylation of target proteins.  It is presumably the 
association with a particular E3 or substrate that specifies the nature of the Ub 
conjugation to be performed in each case.  For example, the association of Rad6 with the 
E3 Ubr1 leads to Lys48-linked Ub conjugation for N-end rule protein degradation by the 
26S proteasome (Sung et al., 1991a).  On the other hand, complexes formed by Rad6 and 
the RING finger E3s Rad18 and Bre1 lead to the mono-ubiquitylation of PCNA (Hoege 
et al., 2002) and histone proteins (Hwang et al., 2003; Wood et al., 2003), respectively.  
The physical association of Ubc5 and the HECT domain E3s Nedd4 and Rsp5 lead to the 
mono-ubiquitylation of the viral Gag protein (Ott et al., 1998; Strack et al., 2000) and 
several yeast plasma-membrane proteins (Rotin et al., 2000), respectively. 
 Regardless of the specific ubiquitylation proteins or particular cellular pathway, 
the common factor in all cases of mono-ubiquitylation described so far is that the 
modification does not lead to proteasome-mediated degradation.  Physical studies of Ub 
recognition support such findings, because mono-Ub is an insufficient modification to be 
effectively recognized by the proteasome (Thrower et al., 2000).  At least one particular 
fate of mono-ubiquitylated proteins does in fact lead to degradation; however, the notable 
difference is that the protein degradation is unrelated to the UPS.  The covalent 
9 
 modification by mono-Ub in these cases directs protein traffic into and through the 
multivesicular sorting pathway, which often leads to proteasome-independent protein 
degradation within the lysosome.  
 Because mono-ubiquitylation is a functional molecular signal as well as an 
unavoidable step in building poly-Ub chains, an interesting regulatory opportunity is 
inherently possible during the process of poly-ubiquitylation.  In a hypothetical scenario, 
the linkage of a single Ub could turn on a particular protein function and subsequently, 
the simple addition of Ub molecules linked through Lys48 would turn off the function by 
causing the degradation of the modified target.  Exciting possibilities for this kind of 
dynamic regulatory mechanism through Ub chain building are beginning to emerge 
(Hoege et al., 2002; Li et al., 2003). 
 
1.4  Alternative ubiquitin linkages 
 The sections above outline some of the ways that ubiquitylation exerts its 
versatility and variability.  On one level, the various E2s offer a number of conjugation 
factors that can act upon many different, albeit generalized cellular roles throughout the 
cell.  Then, a given E2 may often separately associate with many different E3s to impinge 
on a specific biological target.  Because the E3s are such a plentiful group of proteins, the 
sheer number of possible E2-E3 combinations is immense.  Another level of complexity 
in ubiquitylation is added because targets may be modified by mono-Ub or poly-Ub 
chains.  Furthermore, while the prototypical Ub chain is synthesized via Lys48 linkages, 
poly-Ub chains can be linked through other Lys residues as well.  In this way, 
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 ubiquitylation proves to be an even more functionally powerful and versatile signal than 
was first imagined. 
 There are a total of seven surface-exposed Lys residues on Ub which allow the 
possibility that Ub can be conjugated through many different non-Lys48 linkages.  
Indeed, poly-Ub chains made via Lys63 (Arnason and Ellison, 1994; Spence et al., 1995), 
Lys-11 (Baboshina and Haas, 1996), Lys29 (Arnason and Ellison, 1994; Johnson et al., 
1995), and Lys6 (Baboshina and Haas, 1996; Wu-Baer et al., 2003) have been 
demonstrated in vitro or in vivo (Peng et al., 2003).  Because the lysines are well 
dispersed on the Ub surface, it is expected that the linkage specificity may be governed 
by different Ub conjugation mechanisms.  Thus, given the high degree of structural 
conservation between all E2s, the ability to conjugate different Ub chains is an important 
mechanistic question in the field.  Distinct Ub conjugation activities presumably arise 
from intrinsic E2 differences, such as small sequence variations that may alter the linkage 
specificity, or through the association with specialized accessory factor(s).  An intriguing 
case for the latter was recently discovered through studies of a very unique Ub 
conjugating complex comprised of Ubc13 and Mms2 (Hofmann and Pickart, 1999; 
McKenna et al., 2001). 
 
1.5  Discovery of Lys63-linked ubiquitin chains in vivo 
 While a few earlier studies suggested that Ub conjugation may occur via non-
Lys48 linkages (Haas et al., 1991; Hochstrasser et al., 1991; Johnson, 1992; Johnson et 
al., 1995), a systematic approach in budding yeast was the first to clearly demonstrate the 
existence of atypical Ub conjugates in vivo (Arnason and Ellison, 1994).  The authors of 
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 the landmark study created a complete panel of Myc-Ub constructs (seven in total) that 
were each mutated Lys to Arg at all but a single Lys residue.  Western Blots against the 
myc epitope of total-cell lysates then revealed whether poly-ubiquitylation was dependent 
on any of the seven lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, or 
Lys63).  The results showed that Ub conjugates are formed in vivo via Lys29, Lys48, and 
Lys63.  The authors also observed an increase in Lys63-dependent ubiquitylation under 
stress-inducing conditions.  Ubiquitylation through Lys63 was required for cell survival 
after canavanine treatment and heat stress (Arnason and Ellison, 1994).  The finding was 
the first evidence that Lys63-linked Ub conjugates are physiologically relevant.  Due to 
the nature of the Myc-Ub fusions used, they were not able to address the possible 
substrate(s) of the atypical Ub modifications.  Only “free” poly-Ub conjugates were 
monitored. 
 Shortly after these findings, a similar approach in yeast was undertaken by a 
separate research group in order to shed more light on Lys63 Ub chains in vivo (Spence et 
al., 1995).  A yeast strain was generated with all of its four Ub-encoding genes deleted 
from the genome, with viability maintained by the introduction of single Ub gene of 
choice, ensuring it as the only source of Ub in the cell.  This approach circumvented the 
need for tagging Ub with an epitope in order to keep track of the Ub derivative of choice.  
As analysed by 2-D polyacrylamide gel electrophoresis, several protein spots were 
shifted in the ub-K63R mutant strain, indicating the dependence upon Ub conjugation via 
Lys63.  Although their identities were not determined, at least three different proteins 
were found to be conjugated in a Lys63-dependent manner.  Expanding on the affiliation 
between stress conditions and Lys63 Ub chains, the authors attributed the ub-K63R 
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 mutant phenotype to the RAD6 DNA damage tolerance pathway (also called 
postreplication repair) (Spence et al., 1995).  
 Taken together, these studies provided the foundation for a novel field of 
ubiquitylation research that deals with atypical poly-Ub chains.  Perhaps as exciting as 
the discovery of the novel chains themselves, these studies opened the door to several 
questions that are still of great significance in the ubiquitylation field today.  From a 
biological standpoint, the identification of the particular targets modified by the variant 
chains and their eventual fate within the cell became central questions.  From a 
biochemical standpoint, research was spurred to determine the precise E2(s) responsible 
and to decipher the molecular mechanisms that could lead to the conjugation of such 
atypical Ub chains. 
 A greater emphasis was placed upon the Ub linkages made via Ub Lys63 in the 
landmark studies above.  This was likely due in part to the abundance of Lys63-linked Ub 
conjugates observed in the experiments and the fact that Lys63-linked Ub conjugates 
were not previously demonstrated.  On the other hand, Ub-Lys29 chains had been shown 
in an artificial Ub-fusion degradation system (Johnson et al., 1995).  More significantly, 
however, each study demonstrated that the ub-K63R mutation causes a detectible 
phenotype after stress treatments such as DNA damage.  This phenotype was linked 
many years later to the budding yeast UBC13 and MMS2 genes of the DNA damage 
tolerance (DDT) pathway (Hofmann and Pickart, 1999).  Subsequent studies showed that 
Ubc13 and Mms2 form a specific E2 complex that generates atypical poly-Ub chains 
linked through Lys63.  Furthermore, these Lys63 Ub conjugates were found to be 
absolutely required for error-free DDT (Hofmann and Pickart, 1999).  Since that time, 
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 several breakthroughs in the field (several involving this thesis work) have revealed 
detailed insight into the molecular underpinnings and cellular function of Ubc13-Mms2 
(or Ubc13-Uev1A) and their unique Lys63 poly-Ub chains.   
 
1.6  DNA damage tolerance in Saccharomyces cerevisiae 
 My work involving Ubc13 and Mms2 began from genetics-based approaches that 
led to the discovery of the MMS2 gene in Saccharomyces cerevisiae.  Our subsequent 
studies led to the characterization of a novel error-free pathway of DNA postreplication 
repair (PRR) (Broomfield et al., 1998).  It is notable that the term “postreplication repair” 
is mainly used in a historical sense based upon the early methods used to characterize it 
in S. cerevisiae.  I currently favour the use of a more technically accurate term, 
replication-associated DNA damage tolerance (DDT).  DDT in this sense is a eukaryotic 
process that allows cells to evade replication-blocking DNA damage that would 
otherwise lead to cell death.  Because the replicative polymerases rely on a pristine DNA 
template, the DDT pathway is triggered by a wide range of DNA lesions that can be 
caused by various DNA damaging agents.   
 Classical genetic analyses has led to the convention that DDT consists of a 
branched pathway that includes at least one error-free and one translesion synthesis 
(mostly error-prone) pathway (Figure 1-1 and reviewed in (Broomfield et al., 2001).  The 
RAD6 and RAD18 genes are required for both sub-pathways and mutations that disrupt 
either gene result in the most severe DNA damage sensitivities of all DDT 
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 RAD6 (E2)
RAD18 (E3)
RAD5 (E3)
MMS2 (Uev)
UBC13 (E2)
REV1
REV3
REV7
RAD30*
error-free error-prone
Figure 1-1. Overview of DNA damage tolerance genes in S. cerevisiae. Epistatic
analysis has outlined a branched pathway for DDT originating from RAD6 and RAD18 and 
leading to at least one error-free and error-prone component as indicated.  Brackets 
indicate gene product function: E2 (Ub conjugating enzyme); E3 (Ub ligating enzyme); 
Uev (E2-variant). For clarity, the genes for polymerase δ and its subunits are not shown. 
*RAD30 is conditionally error-prone. 
(polymerase ζ)
(polymerase η)
(cytidyl transferase)
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 genes.  Yeast RAD6 encodes a multi-functional E2 (Jentsch et al., 1987) that in addition 
to DNA repair, functions in histone modification (Sung et al., 1988; Haas et al., 1991) 
and “N-end rule” protein degradation (Bachmair et al., 1986; Dohmen et al., 1991).  
Because the Ub-conjugating activity of Rad6 is required for all its known biological roles 
(Sung et al., 1991a; Sung et al., 1990), it stands to reason that Rad6 fulfills its distinct 
functions through interactions with different E3s or via different Ub conjugations, or 
both.  Indeed, Rad6 is able to form exclusive complexes with  Ubr1 or Rad18 (Bailly et 
al., 1994) for N-end rule protein degradation and DDT (Bailly et al., 1997b), respectively.      
 RAD18 encodes a RING finger E3 with ATPase and ssDNA-binding activities 
(Bailly et al., 1997a).  The rad18 mutant is completely defective in DDT and does not 
influence the other functions associated with RAD6.  The affinity of Rad18 for both 
ssDNA and Rad6 (and proliferating-cell nuclear antigen as will be discussed later) fits 
well with a working model whereby Rad18 brings Rad6 into close proximity with ssDNA 
gaps left by a stalled polymerase, so that the ubiquitylation of a target protein can initiate 
the DDT pathway.  The ssDNA-binding activity of Rad18 is consistent with observations 
that DDT mutants are sensitive to killing by a broad range of DNA damaging agents that 
may all potentially lead to a common replication-blocking end-product (Broomfield et al., 
2001; Prakash et al., 1993). 
 The translesion synthesis (TLS) branch of DDT consists of REV3 and REV7 
(encoding subunits of Polζ), RAD30 (Polη), and REV1.  These genes encode non-
essential DNA polymerases with very low processivity that are involved in translesion 
synthesis that is for the most part mutagenic (Prakash et al., 2005).  The majority of 
spontaneous and DNA-damage-induced mutagenesis in S. cerevisiae is attributed to the 
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 predominant TLS polymerase, Polζ.  Several properties lead to the mutagenic designation 
of the TLS polymerases.  First, they do not have the proofreading subunits or editing 
activity of the high-fidelity replicative polymerases.  Second, the active-site through 
which the DNA template passes is larger and less stringent and thus leads to “sloppy” 
nucleotide additions.  Last, some TLS polymerases have a bias for inserting particular 
nucleotides, which can be mutagenic when placed across an incorrect template 
nucleotide.  For example, Polη inserts adenine nucleotides that are appropriate when 
placed across thymine dimers, but are otherwise potentially mutagenic.  Mutants of the 
TLS pathway lead to relatively moderate DNA-damage sensitivities that vary somewhat 
with the particular DNA lesion encountered.   
 In a slight simplification, the error-free component of DDT consists of the RAD5, 
UBC13, and MMS2 genes, and an unknown mechanism for circumventing DNA damage.  
The MMS2 gene was isolated by functional complementation of an mms2-1 allele that is 
sensitive to the DNA damaging agent methylmethane sulfonate (MMS).  Subsequent 
genetic analysis revealed that MMS2 belongs to the RAD6 epistasis pathway (Broomfield 
et al., 1998).  However, unlike the rad6 and rad18 mutants which are severely sensitive 
to DNA damaging agents, the mms2 mutant displays only moderate DNA damage 
sensitivity, but significantly increased mutation rates.  The dramatic increase in mutation 
rates is attributed to the redirection of the pathway to the TLS side, because mutagenesis 
is abolished through the inactivation of REV3.  Another significant genetic relationship is 
that mms2 and rev3 mutations exhibit a remarkable synergism with respect to killing by 
DNA damaging agents.  Taken together, these observations placed MMS2 in an error-free 
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 branch of DDT that is parallel to the Polζ-mediated mutagenesis pathway (Broomfield et 
al., 1998; Xiao et al., 1999). 
 The first study to isolate the MMS2 gene also reported that it encodes an E2-like 
or Ubc-variant (Uev) domain (Broomfield et al., 1998).  The Uev domain shares a high 
degree of protein sequence and tertiary structure similarity to the Ubc domain, but lacks 
the obligatory active-site Cys residue required for Ub conjugation.  Due to this fact, it 
was originally hypothesized that Uevs would function as dominant-negative regulators of 
Ub conjugation (Koonin and Abagyan, 1997).  Homologs containing Uev domains have 
been found in all eukaryotic organisms examined to date, including humans (Sancho et 
al., 1998; Xiao et al., 1998).  Phylogenetic analysis indicates that Uevs evolved from 
Ubcs as a distinct class of proteins, early on in eukaryotic evolution (Villalobo et al., 
2002).  There are two Uev-containing proteins in the budding yeast, Mms2 and Vps23, 
and they are representative of the two predominant Uev-containing protein families.  The 
Mms2/Uev1 family is marked by proteins that contain the Uev domain alone and are 
occasionally accompanied by short variable N- or C-terminal extensions.  The 
Vps23/Tsg101 family contains proteins with a Uev domain as one of several identifiable 
protein domains.  The Uev domain in the Vps23/Tsg101 proteins functions as a Ub-
interacting module for protein-protein interactions, whereas the Mms2/Uev1 family of 
proteins function to promote Ub conjugation.   
Given the epistatic relationship between rad6 and mms2 in DNA repair, it was 
originally suggested that Mms2 functions as an accessory protein that positively regulates 
the ubiquitylation activity of Rad6 (Broomfield et al., 1998).  However, rigorous in vivo 
and in vitro studies failed to demonstrate a physical link between Mms2 and Rad6 (Xiao 
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 et al., unpublished observations) and it turned out that Mms2 forms a stable complex with 
a different and novel E2 in DNA repair, named Ubc13. 
In contrast to the genetic approaches that placed many of the players within the 
DDT pathway, a relatively indirect biochemical approach led to the involvement of 
Ubc13 in DDT.  In the landmark study, a special Ub derivative was used to test the 
ability of seven partially purified E2s from mammalian cell extracts for the formation of 
Lys63 poly-Ub chains in vitro (Hofmann and Pickart, 1999).  Based on previous studies 
that found DNA damage sensitivity in ub-K63R mutant strains (Arnason and Ellison, 
1994; Spence et al., 1995), the experiment had some immediate relevance to DDT.  Of all 
the E2s tested, only Ubc13 was able to form Lys63-linked Ub conjugates; however, the 
conjugation activity could not be reproduced with purified Ubc13 from bacterial sources.  
The failure was due to a surprising dependence on a protein cofactor, Mms2 (Uev1), 
which was present in the original eukaryotic extracts.  The requirement for Mms2 was 
specifically demonstrated through a restoration-of-activity experiment using mammalian 
cell extract fractions.  Using a co-purification approach, they went on to demonstrate a 
physical interaction between the yeast Ubc13 and Mms2 proteins (Hofmann and Pickart, 
1999).  A preliminary genetic experiment was used to demonstrate an equivalent 
sensitivity to ultraviolet (UV) radiation in ubc13, mms2, and ub-K63R mutant yeast 
strains.  The definitive placement of UBC13 in the error-free branch of S. cerevisiae DDT 
was done in our laboratory.  We found that ubc13 exhibits the characteristic phenotypes 
of error-free DDT genes (Brusky et al., 2000).  With respect to DNA damage sensitivity, 
rad6 is epistatic to ubc13 and ubc13 is synergistic with rev3.  In addition, as with mms2∆, 
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 a mostly REV3-dependent increase in mutagenesis is seen in a ubc13∆ strain (Brusky et 
al., 2000). 
RAD5 was genetically placed within the DDT pathway with the epistatic grouping 
of radiation sensitive yeast mutants.  RAD5 was also isolated as rev2 in an early study 
due to a reversion (mutator) phenotype that is characteristic of error-prone DDT genes 
(Lawrence, 1982).  More recent studies have resolved the role of RAD5 within the error-
free DDT pathway (Johnson et al., 1992; Ulrich and Jentsch, 2000; Xiao et al., 2000).  
The Rad5 protein is a RING finger E3 with a ssDNA-dependent ATPase domain 
(Johnson et al., 1992) and Swi2/Snf2-like domains that are suggested for roles in 
chromatin remodeling (Richmond and Peterson, 1996).  The Swi2/Snf2-like and ATPase 
domains have not been linked to DDT to date, but the Rad5 RING finger binds to Ubc13 
in yeast two-hybrid and in vitro co-immunoprecipitation experiments (Ulrich and Jentsch, 
2000).  The functional significance of this interaction is a DNA-damage-dependent 
nuclear localization of Ubc13-Mms2, and the co-localization of Ubc13-Rad5 to 
chromatin (Ulrich and Jentsch, 2000).  It was also found that Rad5 physically interacts 
with Rad18 through a region that is independent of the RING finger that is responsible 
for binding to Ubc13.      
 
1.7  Lys63-linked ubiquitin chains signal for error-free DDT 
 The description of DDT above paints a picture of an interesting branched pathway 
with two distinct ways of dealing with DNA damage through error-free and TLS (error-
prone) processes.  In addition to the mystery surrounding the role of Lys63-linked Ub 
chains in DDT, a central question in the field is thus how the choice is made between the 
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 error-free and TLS pathways.  Perhaps not surprisingly, some answers came through 
studies that identified the proliferating-cell nuclear antigen (PCNA) as the target of 
ubiquitylation in DDT (Hoege et al., 2002).  Homotrimers of PCNA encircle DNA to 
function as the essential sliding-clamp subunits that garner processivity for the replicative 
polymerases (Waga and Stillman, 1998).  In addition, PCNA is involved in other forms 
of DNA metabolism such as nucleotide excision repair, base excision repair, mismatch 
repair, chromatin assembly, and post-replicative processing (Kelman and Hurwitz, 1998; 
Paunesku et al., 2001; Zhang et al., 2000).  The involvement of PCNA in DDT was 
originally implicated through the characterization of the gene encoding PCNA in S. 
cerevisiae, POL30.  The mutant allele pol30-46 conferred UV sensitivity (Ayyagari et al., 
1995) and genetic analysis of pol30-46 placed POL30 within the RAD6 epistasis pathway 
(Torres-Ramos et al., 1996).  In addition, pol30-46 appeared to be defective in the error-
free branch of  DDT (Xiao et al., 2000). 
 Given that PCNA was genetically linked to DDT (Torres-Ramos et al., 1996), the 
poly-ubiquitylation of PCNA after DNA damaging treatment (Hoege et al., 2002) 
suggested that one of the E2 complexes of the DDT pathway was responsible.  Indeed, 
the DNA-damage-induced ubiquitylation of PCNA was completely abolished in rad6∆ 
mutant strains.  Furthermore, mutants in the error-free genes ubc13, mms2, and rad5 also 
led to the disappearance of poly-Ub conjugates, however, a mono-ubiquitylated PCNA 
species was still present.  It was deduced that mono-ubiquitylation of PCNA is performed 
by the Rad6-Rad18 complex, while Ubc13-Mms2-Rad5 is responsible for the poly-
ubiquitylation of PCNA (Hoege et al., 2002).  Providing a further connection between 
Ubc13-Mms2 and the ubiquitylation of PCNA was the finding that the poly-Ub 
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 conjugates of PCNA were absent in yeast cells solely expressing Lys63-mutated Ub.  The 
poly-Ub conjugates were thus attributed to the Lys63-linked Ub conjugation activity of 
Ubc13-Mms2 (Hoege et al., 2002). 
 Another striking finding in the pivotal DDT study by Hoege et al. was that PCNA 
is predominantly ubiquitylated, by both mono- and poly-Ub, at a single Lys residue that 
is invariant among PCNA proteins throughout eukaryotes (Pastushok and Xiao, 2004).  
The single site for Ub conjugation enabled the creation of a regulatory model for DDT 
whereby the sequential addition of mono-Ub and Lys63-linked poly-Ub chains onto 
PCNA leads to the TLS and error-free DDT processes, respectively.  Indeed, the model is 
in accordance with various genetic data (Brusky et al., 2000; Hofmann and Pickart, 1999; 
Stelter and Ulrich, 2003). 
 To further describe the mechanisms behind PCNA modification by Ub, Hoege et 
al. (2002) demonstrated a physical molecular framework for the relevant DDT proteins.  
The authors identified novel interactions between PCNA and the two RING finger 
proteins, Rad18 and Rad5.  Considering their ssDNA-binding affinities, the interactions 
involving Rad18 and Rad5 can be seen as physical connections between the substrate 
(ssDNA), conjugation machinery (Rad6 and Ubc13-Mms2), and ubiquitylation target 
(PCNA) of the DDT pathway.  Taking into account the earlier report that Rad5 binds to 
Ubc13 and Rad18 (Ulrich and Jentsch, 2000), a large multi-subunit conjugation complex 
and its biological effects through the Ub modification of PCNA can be envisioned. 
    
1.8  3-dimensional structure and proposed mechanism of Ubc13-Mms2 Ub 
conjugation 
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 Shortly after the discovery which found that Ubc13 and Mms2 co-purify and 
generate Lys63-linked Ub chains, studies with the corresponding human Ubc13 and 
Mms2 proteins provided greater detail into their biochemical properties.  Using highly 
purified Ubc13 and Mms2 proteins, a 1:1 Ubc13:Mms2 heterodimer with an approximate 
Kd = 2 µM was demonstrated (McKenna et al., 2001; Moraes et al., 2001).  Performing 
ubiquitylation reactions in vitro with a reconstitution approach, it was revealed that the 
Ubc13-Ub thioester targets a free “acceptor” Ub for conjugation.  The thioester can be 
formed with or without Mms2; however, the Ubc13-Mms2 heterodimer thioester is more 
stable.  In light of more recent in vivo findings it is expected that heterodimer formation 
precedes thioester generation because the Ubc13-Mms2 complex is recruited to the site of 
DNA damage where it subsequently ubiquitylates PCNA (Hoege et al., 2002; Ulrich, 
2003).  The most groundbreaking finding from the in vitro studies came from nuclear 
magnetic resonance (NMR) data which helped to propose a mechanistic basis for Ubc13-
Mms2-mediated Ub conjugation through Ub-Lys63.  Two dimensional 1H-15N 
heteronuclear single nuclear quantum coherence was used in chemical-shift perturbation 
experiments to show that Mms2 binds to Ub in a non-covalent manner in vitro.  
Furthermore, the detailed data generated in the experiment allowed the creation of an 
elegant model to explain the Ub conjugation by Ubc13-Mms2.  It was suggested that 
Mms2 is responsible for the proper orientation of the acceptor Ub, such that Ub-Lys63 is 
made available to the donor Ub of the Ubc13 active-site thioester (McKenna et al., 2001).  
Shortly thereafter, the solving of the yeast (VanDemark et al., 2001) and human (Moraes 
et al., 2001) Ubc13-Mms2 heterodimer crystal structures provided a visual basis to 
support the model.  Additional NMR data generated through the careful analysis of each 
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 component (Ubc13, Mms2, donor Ub, acceptor Ub) involved in the Lys63 Ub-
conjugation reaction provided further refinement of the model (McKenna et al., 2003b). 
The overall structure of the human Ubc13-Mms2 heterodimer is shown in Figure 
1-2 and is highly super-imposable with the corresponding S. cerevisiae structure.  Owing 
to the high degree of protein sequence similarity in the core regions of the E2 and Uev 
protein families, it was not surprising that each molecule adopts the characteristic 
globular α/β E2 fold (for example see Cook et al., 1993; Worthylake et al., 1998).  The 
main exception is that Mms2 lacks two carboxy-terminal α-helices.  The most striking 
and exciting feature of the heterodimer is that it is asymmetrical, with Mms2 binding 
Ubc13 in an “end-on” or “T-shaped” manner.  Because the crystal structures of Ubc13 
and Mms2 were also solved on their own, it was observed that neither protein undergoes 
a large overall structural change upon heterodimer formation, except for a localized 
displacement of the most N-terminal residues of Mms2 up to its first α-helix (Moraes et 
al., 2001).  Further inspection reveals that the Mms2 N-terminus, α1 helix, and Loop 1 
portions apparently pack against Ubc13 to form the unique E2-Uev structure.  This 
physical interaction creates a long channel which buries ~1500 Å of solvent-accessible 
surface area (Moraes et al., 2001; VanDemark et al., 2001). 
 Perhaps the greatest contribution of the Ubc13-Mms2 crystal structures is the 
insight they gave into the possible mechanistic basis behind Lys63-mediated poly-Ub 
chain formation.  Visual inspection of the 3-dimensional structures reveals three 
predominant channels through which Ub could be envisioned to bind or pass along.
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 Figure 1-2. Overall structure of the human Ubc13-Mms2 heterodimer.  3-dimensional 
crystal structure co-ordinates were derived from the Protein Databank File “17JD” and 
RasTop 2.1 (www.geneinfinity.org) was used to create the molecular image.  The Ubc13 
active-site Cys is indicated in space-fill representation (yellow).
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 Each channel converges on the Ubc13 active-site, facilitating a multi-component scenario 
involving both a donor and acceptor Ub, and a putative exit path (Figure 1-3).  Channel 1 
corresponds to the typical E2 active-site where in this case, Ubc13 would bind the donor 
Ub through a covalent thioester bond.  Because the Ubc13 structure does not appreciably 
change upon binding Mms2, it has been inferred that channel 1 behaves relatively 
independent of Mms2.  In contrast, the remaining two channels are formed only after the 
asymmetrical heterodimer is created by the Ubc13-Mms2 interaction.  Channel 2 runs 
steeply along one side of Mms2 toward the Ubc13 active-site, and is postulated to 
comprise the necessary link between donor and acceptor Ub, thus providing the key 
molecular framework for Lys63-linked poly-Ub chain assembly.  In accordance, 
molecular docking programs lead to solutions whereby Mms2 specifically interacts with 
an acceptor Ub such that the Ub-Lys63 residue is made specifically available to the 
Ubc13 active-site through Channel 2.  The last identifiable channel to converge on the 
Ubc13 active-site is also only apparent after Ubc13-Mms2 heterodimer formation.  With 
the conjugation steps accounted for, Channel 3 has been speculated as an outgoing path 
for Lys63-linked Ub conjugates and follows in a relatively opposite direction to channel 
2. 
 The predictions concerning channels 1 and 2 that were based on visualization of 
the heterodimer crystal structures were later supported by detailed NMR analyses 
(McKenna et al., 2003b).  In these experiments, the chemical-shifts for every residue in 
Ubc13, Mms2, and Ub were monitored during all the possible binding combinations to 
create an elaborate interaction map for each of the individual protein surfaces.
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 Figure 1-3. Channels created by the Ubc13-Mms2 heterodimer provide the 
framework for Lys63-linked Ub conjugation. (A) van der Waals space-fill 
representation of the Ubc13-Mms2 surface.  Mms2 (green), Ubc13 (blue), Ubc13 active-
site Cys (yellow).  Residues undergoing chemical shift upon Ub-Ubc13 thiolester
formation and Mms2-Ub non-covalent interaction are shown in tan and rose, respectively.  
Arrows indicate channels through which Ub is proposed to pass during ubiquitylation. (B) 
Cartoon representation showing the steps involved in Ubc13-Mms2-mediated 
ubiquitylation from left to right.  Channel 1 involves thiolester formation with the donor 
Ub, Channel 2 orients the acceptor Ub for Lys63 conjugation, and Channel 3 aids in the 
delivery of the conjugate (direct or indirect) to the target.
A
B
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 The pooled data was then used to create an unbiased, data-driven, computer generated 
prediction of the Ub-Ubc13-Mms2-Ub tetrameric complex (Figure 1-4).  The solution 
alleviated any speculation surrounding the mechanistic hypothesis proposed from visual 
inspection of the crystal structures alone.  The results showed that the Mms2-bound Ub is 
oriented such that its Lys63 ε-amino nitrogen is placed within 4 Å of the carboxyl-
terminus of Ub-Gly76 at the Ubc13 active-site.  It is notable that in this model the surface 
of Ubc13 at the distal end of channel 3, which is proposed to bind E3s, remains 
completely available  (McKenna et al., 2003b). 
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 acceptor Ub
donor Ub
Ub C-terminus
Ub Lys63
Figure 1-4. Model for the mechanism of Lys63-linked Ub conjugation by Ubc13-
Mms2. The NMR-based structure on the left is adapted from McKenna et al., 2003 
showing the human Ubc13 (yellow and white) and Mms2 (blue-green) heterodimer
oriented similar to Figure 1-3, and bound to two molecules of ubiquitin (red).  Shown at 
right is a close-up view of the acceptor Ub bound by Mms2 such that its Lys63 ?-amino 
group is in close proximity to the C-terminus of a donor Ub bound at the Ubc13 active-site 
Cys (green).
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      The elegant and detailed model describing Lys63-linked Ub conjugation by the 
Ubc13-Mms2 (i.e. Ubc13-Uev) E2 complex is a unique case in the ubiquitylation field.  
Whereas the chemistry of ubiquitylation has been understood for quite some time (Haas 
and Rose, 1982; Hershko et al., 1983), the mechanistic basis behind the various steps 
remains somewhat unclear despite a wealth of structural data.  One of the greatest 
difficulties is that, unlike the case for Ubc13-Mms2, the conjugation of one Ub molecule 
to another is generally expected to take place on the E3 or the target protein.  Therefore, 
the variability of E3s (HECT, RING finger, U-box, multi-subunit, etc.), the sheer number 
of target proteins, and the lack of a ubiquitylation consensus sequence are a few of many 
features that make it difficult to present a unified model for Ub conjugation.  Indeed, the 
structure-based models of Ub chain assembly so far suggest two very different general 
strategies in order to overcome the same apparent problem; a very large distance between 
the C-terminus of the Ub bound at the E2 active-site and its eventual conjugation site on 
the target (VanDemark and Hill, 2002).  In the case of HECT-domain E3s, the problem is 
proposed to be overcome by mechanisms involving large  
conformational changes (Huang et al., 1999; Verdecia et al., 2003).  In contrast, the 
structural data of the RING finger E3 c-Cbl (Zheng et al., 2000) and the multi-subunit E3 
SCF (Hao et al., 2005; Zheng et al., 2002; Zheng et al., 2000) suggest that structural 
rigidity is important.  The passing of Ub from the E2 active-site in these cases is instead 
proposed to involve the specific placement of the target within large gaps created in the 
E2-E3 structure.  Most interestingly, neither of these current models explain how a 
particular Lys-specific Ub linkage is made.  The clarity and precision of the mechanistic 
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 model for Lys63-linked Ub-conjugation by Ubc13-Mms2 is likely to be a gold-standard 
in the ubiquitylation field for a long time to come. 
 
1.9  Structure of Lys63-linked ubiquitin chains 
 With an elegant mechanistic model to explain Lys63-linked Ub chain formation, 
another important question involves the consequence that the unique chains have on the 
target.  An obvious possibility is that Lys63-linked Ub chains result in a significantly 
different topology than Lys48 Ub chains, and are therefore presented to the cell as a 
distinct molecular signal.  Indeed, several lines of evidence to date suggest that Lys63-
linked Ub would signal for something other than proteasome-mediated degradation.  
First, cells expressing Ub-K63R as their sole source of Ub have no apparent deficiency in 
bulk protein turnover (Spence et al., 1995).  Second, several studies suggest that the half-
life of proteins conjugated by Lys63-linked Ub is not appreciably reduced (Arnason and 
Ellison, 1994; Fisk and Yaffe, 1999; Galan and Haguenauer-Tsapis, 1997; Spence et al., 
2000) and the current cellular roles involving Lys63-linked Ub chains so far do not seem 
to involve proteasome-mediated degradation.  For example, inhibition of the proteasome 
does not lead to a significant reduction in DNA damage tolerance activity (Hofmann and 
Pickart, 2001) or Ub-Lys63-dependent signaling (Deng et al., 2000).  Also, Ub4 is the 
minimum Ub-chain length recognized by the 26S proteasome (Thrower et al., 2000) and 
some in vitro evidence suggests that Ubc13-Mms2 predominantly synthesize Ub2 
(McKenna et al., 2001).  Third, Lys63-linked Ub chains are structurally distinct from 
those linked through Lys48. 
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  The 3-dimensional structures of Lys48-linked Ub2 and Ub4 have been solved by 
NMR (Varadan et al., 2003; Varadan et al., 2002) and X-ray crystallography (Cook et al., 
1992; Cook et al., 1994; Phillips et al., 2001).  Despite this wealth of data, the flexible 
nature of the Lys48-linked Ub-conjugates leaves some uncertainty surrounding the 
particular orientation to which the chain conforms.  For example, Lys48-linked chains 
appear to orient themselves in “open” and “closed” conformations in vitro.  The closed 
conformation is made possible through intermolecular Ub interactions mediated by 
hydrophobic patches.  The Lys48-linked open conformation does not have such non-
covalent contacts.  The most recent and detailed NMR data suggests that Lys48-linked 
Ub chains predominantly exist in the closed conformation under physiological 
conditions; however, a small degree of conformational flexibility when binding other 
proteins in vivo is not ruled-out (Varadan et al., 2004).  Nonetheless, the invariable 
feature of Lys48-linked Ub chains is that the connections between the C-terminal Gly 
residue of one Ub and the Lys48 residue of the next are at ~90° with respect to one 
another.   
In a marked contrast to Lys48, the Ub-Lys63 residue is approximately 180° 
relative to the C-terminal Gly residue.  As a result, these linkages can be envisioned to 
create a more linear or extended poly-Ub tertiary structure.  Structural studies of Lys63-
linked Ub2 in solution are in accordance with this prediction (Varadan et al., 2004).  In 
addition, the intermolecular binding of Lys48-linked poly-Ub chains is not observed for 
the Ub linkages via Lys63.  Yet another distinction between Lys48- and Lys63-linked Ub 
chains was demonstrated through protein interaction studies using a Ub-binding protein.  
In the experiment a promiscuous Ub-binding domain was shown to bind to Lys63-linked 
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 Ub chains in a manner similar to mono-Ub.  In contrast, the interaction with Lys48-linked 
Ub chains was made in a different, albeit undetermined, high-affinity manner (Varadan et 
al., 2004).  Future structural studies of Lys63-linked Ub chains, especially those for Ub4, 
are expected to provide more evidence supporting the notion that different Ub chains lead 
to distinct chain topology and behavior. 
 
1.10  Cellular roles of  Lys63-linked ubiquitin chains 
 It is in some ways helpful to group the cellular roles of Lys63-linked poly-Ub 
chains into two categories; 1) those that clearly involve Ubc13-Uev-mediated 
ubiquitylation and 2) those that do not appear to involve Ubc13-Uev-mediated 
ubiquitylation, or where the data is insufficient or merely suggestive.  Taken together, the 
number of cellular roles implicated with Lys63-linked Ub chains to date is still far fewer 
than those for Lys48-linked Ub chains. 
 
1.10.1  Cellular roles of Lys63-linked ubiquitin chains generated by Ubc13-Uev 
 As discussed above, one of the best-characterized roles for Ubc13-generated 
Lys63-linked Ub chains is error-free DNA damage tolerance in S. cerevisiae (Broomfield 
et al., 2001; Pastushok and Xiao, 2004).  Largely due to studies in our laboratory, there is 
strong evidence to suggest that the role of Ubc13-Mms2 and Lys63-linked Ub chains is 
conserved in error-free DDT throughout eukaryotes (Andersen et al., 2005; Ashley et al., 
2002; Brown et al., 2002; Li et al., 2002; Wen, et al., in press).  In addition, the cadmium 
sensitivity of a mouse neuroblastoma cell line induced by the expression of Ub-K63R is 
likely attributed to a deficiency in Ubc13-Mms2-mediated ubiquitylation in DDT 
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 (Tsirigotis et al., 2001).  A complicating factor in studying DNA repair in higher 
eukaryotes, however, is the occurrence of an additional Mms2 homolog called Uev1.  
Uev1A adopts a similar 3-dimensional structure to Mms2 (Zhang et al., 2005), binds with 
similar affinity to Ubc13 and Ub (McKenna et al., 2003a), and is able to function in place 
of MMS2 in yeast DDT (Chapter 3 of this thesis).  These similar features made it difficult 
to exclude the possibility that Uev1A could function like Mms2 with Ubc13 to generate 
Lys63-linked Ub chains in mammalian DDT.  A recent publication by our laboratory was 
able to rule out this option by showing that the Ubc13-Mms2 complex functions in DNA 
repair, while the Ubc13-Uev1A complex is responsible for the activation of the NF-κB 
signaling pathway (Andersen et al., 2005). 
 The activation of the NF-κB pathway through Lys63-linked Ub chains is the other 
well-characterized role involving Ubc13 (Finley, 2001).  NF-κB is a vertebrate 
transcription factor that is responsible for the expression of numerous genes that govern 
various important biological processes such as cell differentiation and apoptosis, 
inflammation, and immunity (Baldwin, 1996; Chen et al., 1999; Chen, 2005; Krappmann 
and Scheidereit, 2005).  Under non-stimulating conditions, an IκB protein prevents the 
transcription function of NF-κB by sequestering it in the cytosol.  NF-κB can be activated 
through a number of elaborate signal-transduction pathways that respond to various 
stimuli that are most often, but not always, detected by plasma-membrane receptors 
(Krappmann and Scheidereit, 2005).  Transduction of the signal requires the action of 
various cytosolic proteins that eventually lead to the phosphorylation of IκB by an 
activated IκB kinase (IKK).  Phophorylated IκB is ubiquitylated via Lys48-linked poly-
Ub chains and subsequently degraded by the proteasome, leaving NF-κB free to enter the 
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 nucleus and elicit the appropriate transcriptional response (Chen et al., 1995; Scherer et 
al., 1995). 
 The connection between Ubc13-Uev1A and the NF-κB pathway was originally 
made through the establishment of a cell-free system to monitor IKK activation by 
TRAF6 (tumor necrosis factor receptor-associated factor 6; Deng et al., 2000).  TRAF6 is 
a RING finger E3 involved in the NF-κB signal transduction pathway responding to the 
stimulation of interleukin-1 and Toll-like receptors.  Using the in vitro cell-free assay, 
Deng et al. showed that TRAF6-dependent activation of IKK required a cell-extract 
fraction containing the Ubc13-Uev1A complex.  Further analysis specifically 
demonstrated that IKK activation is dependent on Lys63-linked ubiquitylation by Ubc13-
Uev1A, and that the ubiquitylation activity is promoted by TRAF6.  The lack of 
proteasomes in the assay also suggested that the Lys63-linked poly-Ub-mediated 
activation of IKK is proteasome independent.  In a follow-up study, it was reported that 
TRAF6 is actually a target of the Ubc13-Uev1A Lys63-linked Ub chains, in a step that is 
required for the activation of IKK (Wang et al., 2001). 
 Shortly after these novel findings, Ubc13-Uev1A and Lys63-linked Ub chains 
were demonstrated to be involved in the activation of several other signaling pathways 
employing the same general scheme; namely the transduction of a receptor-borne signal 
by TRAF-associated Lys63-linked poly-ubiquitylation by Ubc13-Uev1A.  These signal 
transduction pathways included those for tumor necrosis factor receptors (Shi and Kehrl, 
2003), endosome-associated Toll-like receptors (Luftig et al., 2003), and T-cell receptors 
(Sun et al., 2004; Zhou et al., 2004).  Intriguingly, in the latter case, the final target of the 
Lys63-linked Ub chains was the γ subunit of IKK (NEMO), indicating that TRAF6 might 
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 be a ubiquitylation intermediate instead of a bone fide target.  However, it cannot be ruled 
out that TRAF6 and NEMO are both biologically relevant targets of Ubc13-Uev1A-
mediated Ub conjugation.  
 In addition to DNA repair and cell signaling, a very recent discovery will likely 
uncover additional roles for Ubc13-Mms2/Uev1A-generated Lys63-linked Ub chains.  A 
crystal structure has been reported for a trimeric complex consisting of Ubc13, Uev1A, 
and CHIP (C-terminal of Hsp70 interacting protein; Zhang et al., 2005).  The physical 
interaction was confirmed through the co-purification of Ubc13-Uev1A and CHIP 
derived from human cell-extracts.  In the crystal structure, CHIP binds directly to Ubc13 
through a surface that is typical of E2-E3 interactions.  Based on the visual comparison 
with the Ubc13-Mms2 heterodimer structure, the Ubc13-Uev1A interaction is apparently 
uninhibited by binding to CHIP (Moraes et al., 2001; VanDemark et al., 2001).  
Importantly, the physical interaction of CHIP with Ubc13-Uev1A does not appear to 
obstruct the surfaces necessary for the Lys63-linked Ub-conjugation model.  In support 
of this fact, CHIP specifically facilitates Ubc13-Uev1A-mediated Lys63-linked Ub chain 
formation (Zhang et al., 2005). 
 CHIP normally exists as a dimeric U-box E3 that mediates interactions between 
E2s from the Ubc4/5 family and the molecular chaperones Hsp70 and Hsp90 (Ballinger 
et al., 1999).  The physical connection between ubiquitylation machinery and protein 
chaperones suggests that CHIP plays a general role in protein quality control.  Indeed, 
along with Ubc4/5, CHIP is responsible for the ubiquitylation of unfolded protein 
(Murata et al., 2001).  Given the novel finding that CHIP is also involved with Ubc13-
Uev1A-mediated Lys63-linked ubiquitylation, I propose a model whereby CHIP can 
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 have two distinctly opposite roles in governing protein folding.  In one role, a terminally 
unfolded protein could be marked for elimination through the CHIP-Ubc4/5 complex and 
modification by Lys48-linked Ub chains.  In another role, the CHIP-Ubc13-Uev1A 
complex could target an unfolded protein with Lys63-linked Ub chains which would not 
lead to proteasome-mediated degradation.  This could potentially allow for proper protein 
refolding through the affiliation of CHIP with Hsp70/90.   
 While the hypothesis involving Ubc13-Uev1A in protein folding is speculative, it 
is interesting to recall the discovery of Lys63-linked Ub chains in vivo.  In the study, the 
authors identified that the ub-K63R mutation caused yeast cells to be sensitive to 
treatments that can cause protein misfolding (heat-shock and canavanine) (Arnason and 
Ellison, 1994).  Other evidence that implicates Ubc13-Uev1A in protein folding is found 
via the physical association with CHIP.  CHIP has been connected to the Lys63-linked 
ubiquitylation of tau, and the tau protein and associated insoluble protein aggregates are 
typical in Alzheimer’s disease (Babu et al., 2005; Petrucelli et al., 2004; Shimura et al., 
2004).  CHIP is also found to physically interact with the RING finger E3 Parkin, which 
is involved with Lys63-linked Ub-conjugation by Ubc13-Uev1A (Doss-Pepe et al., 2005; 
Imai et al., 2002; Lim et al., 2005a).  The mutation of Parkin can lead to the misfolding 
and aggregation of proteins which are characteristically found in Parkinson’s Disease 
(Lim et al., 2005b).  Taken together, a potential role for Ubc13 in general protein folding 
is plausible and the implication in neurodegenerative diseases is exciting. 
 
1.10.2  Cellular roles implicated with Lys63-linked ubiquitin chains 
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  Spanning a wide range of biological processes in several different organisms, 
Lys63-linked Ub chains have been implicated in poxvirus function (Huang et al., 2004), 
cell motility (Didier et al., 2003), photomorphogenesis (Yanagawa et al., 2004), a mitotic 
checkpoint (Bothos et al., 2003), mitochondrial inheritance (Fisk and Yaffe, 1999), 
ribosome function (Spence et al., 2000), and membrane permease endocytosis (Galan and 
Haguenauer-Tsapis, 1997; Springael et al., 1999).  While these roles for Lys63-linked Ub 
chains are exciting, there is either insufficient or no evidence in these cases to support the 
involvement of Ubc13-Mms2/Uev1A.   
In several of these instances the involvement of a Ubc13-Uev complex is 
implicated but the data is not conclusive.  With poxvirus function (Huang et al., 2004), 
photomorphogenesis (Yanagawa et al., 2004), and the mitotic checkpoint (Bothos et al., 
2003), the affiliation of Lys63-linked Ub chains with Ubc13-Uev is based solely upon in 
vitro ubiquitylation assays.  It is notable that such experiments are sometimes prone to 
erratic behavior and possible false-positives.  For example, the E2 UbcH5 has 
promiscuous Ub conjugation activities in vitro and can promote ubiquitylation reactions 
with numerous E3s that may not be physiologically relevant (Bothos et al., 2003).  Also, 
in vitro ubiquitylation reactions involving Ubc13-Uev may be promoted by the simple 
addition of irrelevant peptide sequences (personal communication, T. Moraes, University 
of Alberta, Edmonton, AB).  While the ubiquitylation involved with cell motility was 
monitored in vivo, the experimentation did not distinguish between a direct or indirect 
relationship with Ubc13 (Didier et al., 2003). 
A second group of cellular roles attributed with Lys63-linked Ub chains has been 
discovered using the expression of ub-K63R to invoke various phenotypes.  While the 
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 Ub-Lys63 residue was shown to be important for mitochondrial inheritance (Fisk and 
Yaffe, 1999), ribosome function (Spence et al., 2000), and membrane permease 
endocytosis (Galan and Haguenauer-Tsapis, 1997; Springael et al., 1999), a connection 
between the ub-K63R phenotype and ubc13 has not been made.  In fact, there is evidence 
to suggest that Ub conjugation via Lys63 in at least two of these cases may be mediated 
by other ubiquitylation enzymes.  For example, the Lys63-dependent ubiquitylation of 
the large ribosomal subunit in vivo is abolished in a ubc4∆ strain (Spence et al., 2000; 
Spence et al., 1995).  Also, the modification of the uracil and general amino acid 
permeases requires Ub-Lys63 and the HECT domain E3, Rsp5 (Galan and Haguenauer-
Tsapis, 1997; Galan et al., 1996; Springael et al., 1999).  While neither Ubc4 or Rsp5 
have been shown to genetically or physically interact with Ubc13, they have been 
documented to interact with one another (Horak, 2003; Nuber and Scheffner, 1999).   
One of three possibilities is expected for the implicated roles for Lys63-linked Ub 
conjugation in this section; 1) they are experimental artifacts, 2) a definitive requirement 
for Ubc13-Uev will be demonstrated, or 3) an additional mechanism of Lys63-linked Ub 
conjugation will be discovered.  Given the clear data-derived model for Lys63-linked Ub 
chain formation by Ubc13-Uev, my feeling is that the second possibility is most likely.  I 
expect that phenotypes for ubc13, mms2, and/or uev1 will eventually be linked to the 
cellular roles where in vivo Lys63-linked Ub chains are well-demonstrated. 
 
1.11  Summary and significance 
 Ubiquitylation is a fundamental and indispensable covalent modification system 
found throughout eukaryotes.  Conventional wisdom has held that ubiquitylation leads to 
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 the conjugation of Lys48-linked Ub chains to various protein targets, which in turn 
signals for their specific degradation by the proteasome.  The discovery of Ub chains 
linked through alternative Lys residues, such as Lys63, has presented new and exciting 
challenges in the field.  Central questions concerning Lys63-linked Ub chains that arose 
were the identity of the E2(s) involved in creating them, the biochemical mechanism(s) 
employed, and in what cellular role(s) they function. 
 The revelation that a unique Ubc13-Uev heterodimer could provide the 
biochemical activity for Lys63-linked Ub chain formation came as a surprise.  Through 
close collaboration, I had the pleasure of being involved in the landmark studies that 
carved out an elegant model for the mechanism behind Lys63-linked Ub conjugation by 
Ubc13-Mms2.  Without an in vivo functional context, however, the proposal stands as a 
mere hypothetical in vitro model.  This thesis serves to provide many detailed structure-
function studies in order to help validate the Ubc13-Mms2 Ub conjugation model.  
Through the generation of additional hypotheses and careful experimentation, the 
molecular underpinnings behind the cellular functions of Ubc13-Mms2 were further 
uncovered. 
 Despite the proposed mechanism of Lys63-linked Ub conjugation by Ubc13-Uev, 
a connection between Lys63-linked Ub chains observed in vivo and Ubc13-Uev has not 
been found in some cases.  In the final chapter of this thesis, I attempted to clarify one of 
these occurrences through the investigation of a novel direct interaction between Mms2 
and a protein involved in a membrane-permease endocytosis pathway. 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1  Strains, cell culture, transformation, and storage 
2.1.1  Yeast 
The Saccharomyces cerevisiae two-hybrid strains used in this study include PJ69-
4A (MATa trp1-901 leu2-3, 112 ura3-52 his3-200 gal4∆ gal80∆ PGAL2-ADE2 
LYS2::PGAL1-HIS3 met2::PGAL7-lacZ), a gift from P. James (University of Wisconsin at 
Madison).  The other two-hybrid strain used was Y190 (MATa gal4 gal80 his3 trp1 ade2-
101 ura3 LEU2::URA3 GAL1-LAC7 LYS2::GAL1-HIS3), which was received from D. 
Gietz (University of Manitoba, Winnipeg, MB). 
Most of the functional tests were performed using the haploid S. cerevisiae strain 
HK580-10D (MATa ade-1 can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1) as the wild-
type reference strain.  The strain was received from H. Klein (New York University, New 
York, NY) and used as the recipient to delete the entire MMS2 open reading frame (ORF) 
by a one-step gene replacement method (Rothstein, 1983) using an mms2∆::HIS3 cassette 
generated through PCR (polymerase chain reaction) amplification as previously described 
(Xiao et al., 1999).  With the same approach, a ubc13∆ HK580-10D strain using a 
ubc13∆::HIS3 cassette (Brusky et al., 2000), a mms2∆ ubc13∆ HK580-10D strain using 
the mms2∆::HIS3 and ubc13::hisG-URA3-hisG cassettes, and a mms2∆ rev3∆ HK580-
10D strain using mms2∆::HIS3 and rev3::hisG-URA3-hisG cassettes were also created.  
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 The rev3::hisG-URA3-hisG was obtained using a KpnI restriction digestion of plasmid 
pDG347, received from D. Gietz (Roche et al., 1994). 
The rsp5 strain used in this study came from the allelic mut2 strains that were 
received as a tetrad from a backcross (HP148-2A, 2B, 2C, 2D).  The wild-type parental 
strain is XV185-14C (MATa ade2-1, arg4-17, his1-7, hom3-10, lys1-1, trp5-48) and all 
strains were provided as a gift from R.C. von Borstel (University of Alberta, Edmonton, 
AB). 
SUB280 (MATa, his3-∆200, leu2-3,112, ura3-52, lys2-801, trp1-1, [am] ubi-
∆1::TRP1, ubi2-∆2::ura3, ubi3-∆ub-2, ubi4-∆2::LEU2) (Finley et al., 1994) and 
SUB413 (isogenic to SUB280) are specially engineered yeast strains for the exclusive 
expression of wild-type and K63R mutated ubiquitin, respectively.  In SUB280, Ub is 
expressed from a gene on the multi-copy plasmid pUB39 which is under the control of a 
copper-inducible CUP1 promoter. In SUB413, the wild-type Ub of pUB39 is replaced 
with a K63R mutant.  SUB280 and SUB413 were received as gracious gifts from R. 
Haguenauer-Tsapis (Institut Jacques Monod, Université Paris, Paris). 
A BY4741 (MATa, his3∆, leu2∆, lys2∆, ura3∆) fur4∆ strain was purchased from 
Research Genetics as part of a homozygous deletion library in S. cerevisiae.  The strains 
were created using the protocol described at the Saccharomyces Genome Deletion Project 
(http://www-sequence.stanford.edu/group/yeast_deletion_project/deletions3.html).  An 
otherwise isogenic strain with trp1∆ was used as the wild-type control. 
Yeast cells were cultured at 30°C in a complete YPD medium (1% Bacto-yeast 
extract, 2% Bacto-peptone, 2% glucose) or in a synthetic dextrose (SD) medium (0.67% 
Bacto-yeast nitrogen base without amino acids, 2% glucose) supplemented with 
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 necessary nutrients as required (20 mg/l of adenine, uracil, tryptophan, histidine, arginine, 
and methionine; 30 mg/l of tyrosine, lysine; 50 mg/ml leucine; 200 mg/ml threonine; 
Adames, 1997).  To make solid plates, 2% agar was added to either YPD or SD medium 
prior to autoclaving and the molten agar was cooled in a 55°C water bath before being 
poured into Petri dishes.   
Yeast cells were transformed using a modified dimethyl sulfoxide (DMSO)-
enhanced protocol (Hill et al., 1991).  For each transformation, approximately 1.5 ml of 
early log-phase yeast cells were pelleted and washed with 500 µl lithium acetate solution 
(LiOAc, 0.1 M lithium acetate, 10 mM Tris-HCl, pH 8.0).  The suspension was pelleted 
once again and resuspended in 100 µl of LiOAc.  The transforming DNA was then added 
along with 4 µl of denatured and sheared salmon sperm DNA (10 mg/ml stock).  Prior to 
a 45 minute incubation at 30°C, 280 µl of 50% polyethelene glycol 4000 was added and 
each sample was mixed gently.  After this incubation, 39 µl dimethyl sulfoxide was added 
and the cells were heat-shocked at 42°C for 5 minutes.  Cells were pelleted, the 
supernatant was discarded, and 500 µl double-distilled water (ddH2O) was used to 
resuspend and wash the cells.  Cells were pelleted once again, the supernatant was 
discarded, and the cells were resuspended in 100 µl ddH2O and the entire volume was 
spread evenly on an agar plate.  Plates were incubated at 30°C for 72 hours to allow 
colony growth.  Prior to experimental use, putative transformants were streaked onto 
selective medium and allowed to grow up once again.  For short term storage, yeast cell 
plates were sealed and then placed at 4°C for up to two months.  For long term storage, 
actively growing yeast cells were suspended in 15% sterile glycerol and then frozen and 
stored at -70°C indefinitely. 
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 2.1.2  Bacteria 
The bacterial strain used in this study for protein expression was BL21-CodonPlus 
(DE3)-RIL [F- ompT hsdS(rB- mB-) dcm+ Tetr galλ (DE3) endA Hte (argU ileY leuW 
Camr)].  This strain carries extra copies of the argU, ileY and leuW tRNA genes to help 
overcome codon bias, and was purchased from Stratagene (#230245). For typical DNA 
plasmid propagation and isolation, Escherichia coli DH10B (F- mcrA (mrr-hsdRMS-
mcrBC) 80lacZ M15 lacX74 recA1 endA1 ara 139 (ara, leu)7697 galU galK - 
rpsL (StrR) nupG) or Escherichia coli DH5α (F- 80dlacZ M15 (lacZYA-argF) U169 
recA1 endA1 hsdR17(rk-, mk+) phoA supE44 - thi-1 gyrA96 relA1) purchased from 
GibcoBRL (now Invitrogen) was used.  With the exception of the incubation 
temperatures used for protein expression (see below), bacterial cells were incubated at 
37°C.  Bacteria cultures were grown in Luria Broth (LB) (1% Bacto-tryptone, 0.5% 
Bacto-yeast extract, 1% NaCl, pH 7.0).  LB agar plates were prepared by the addition of 
water to a ready-made stock powder (US Biological, #L1500) which was then autoclaved, 
cooled to 55°C, and poured into Petri plates.  When required for plasmid selection, media 
cooler than 55°C was supplemented with ampicillin (amp) to a final concentration of 50 
µg/ml. 
Transformation of competent bacterial cells was performed by chemical and 
electroporation methods.  For an electroporation, a 25 µl aliquot of competent DH10B 
cells was removed from -70°C and placed on ice to thaw.  Approximately 0.01 µg of 
plasmid DNA was added to the cells and incubated for 45 seconds on ice.  The plasmid 
and cell mixture was then transferred to a pre-chilled Gene Pulser Cuvette (Bio-Rad, 
#165-2089) that was then loaded into a Bio-Rad E. coli Gene Pulser and administered a 
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 1.80 kV electric pulse.  400 µl of liquid SOC media (2% Bactro-tryptone, 0.5% Bacto-
yeast extract, 0.05% NaCl, 20 mM glucose, 2.5 mM KCl, 10 mM MgCl2, pH 7.0) was 
added to the electrocuted cells which were subsequently incubated in a 37°C water bath 
for one hour.  100 µl of the cell suspension was then spread evenly onto an appropriate 
selectable agar plate for an overnight incubation at 37°C.  For a chemical transformation, 
a 50 µl aliquot of competent DH5α cells was removed from -70°C and placed on ice to 
thaw.  Approximately 0.1 µg of plasmid DNA was added to the cells and after a 30 
minute incubation on ice, the cells and DNA were heat-shocked at 42°C for 45 seconds, 
and 450 µl of room-temperature SOC media was added.  The tube was then incubated in 
a 37°C water bath for one hour after which 150 µl of the cell suspension was spread 
evenly onto an appropriate selectable agar plate for an over night incubation at 37°C.  All 
putative transformants were streaked onto selective medium prior to their experimental 
use.  For short term storage, the bacterial cell plates were sealed and then placed at 4°C 
for up to one month.  For long term storage, actively growing bacterial cultures were 
suspended in 10% DMSO and then frozen and stored at -70°C indefinitely. 
 
2.2  Plasmids and DNA 
2.2.1  UBC13 and MMS2 
The human UBC13 open-reading frame (ORF) was PCR amplified as an EcoRI-
SalI fragment and cloned into pGBT9 (Bartel and Fields, 1995) to form pGBT-hUBC13, 
an N-terminal fusion to Gal4BD.  The same UBC13 fragment was similarly cloned into 
pGEX6 (GE Healthcare, #27-4597-01) to form an N-terminal gene fusion to glutathione-
S-transferase (GST) and named pGEX-hUBC13.  Human MMS2 cDNAs were isolated as 
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 previously reported (Xiao et al., 1998).  The ORF was PCR amplified as a BamHI-SalI 
fragment and cloned into pGAD424 (Bartel and Fields, 1995) to form an N-terminal 
fusion to Gal4AD, named pGAD-hMMS2.  The same MMS2 fragment was cloned into 
pGEX6 to form an N-terminal fusion to GST, named pGEX-hMMS2.  The pGEX6-
hUBC13-Y34A, -L83A, and pGEX6-hMMS2-F13A clones were provided as gracious 
gifts from M. Ellison (University of Alberta, Edmonton, AB).  pYEX-MMS2 and pYEX-
UBC13 are yeast GST-fusion constructs that were purchased from Research Genetics as 
part of a yeast GST-fusion library, and encode yeast GST-Mms2 and GST-Ubc13, 
respectively.  The pYEX constructs are under the control of the CUP1 inducible 
promoter.  The YCpL-MMS2 construct was cloned using a BglII restriction digest of 
yeast genomic DNA which releases a 1043 base pair (bp) fragment containing the entire 
yeast MMS2 gene, corresponding to 246 bps downstream and 797 bps upstream of the 
start site.  YCpL-MMS2-A and YCpL-MMS2-B represent the two orientations for the bi-
directional cloning of the BglII DNA fragment.  The human MMS2 ORF was PCR 
amplified to generate a BamHI-SalI fragment without a stop codon that was subsequently 
cloned into pG4BD-1 (received from R.B. Brazas, University of California San 
Francisco, San Francisco, CA) to create a C-terminal fusion to Gal4BD called pG4BD-
hMMS2.  pG4BD-yMMS2 was created in the same manner. 
Yeast two-hybrid, GST-fusion, and yeast centromeric plasmids containing site-
specific mutations within human UBC13, MMS2, or yeast MMS2 were constructed by the 
mega-primer site-directed mutagenesis approach described below. 
 
2.2.2  UEV1A and UEV1B 
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 The GST-Uev1A and GST-Uev1B proteins were derived from PCR amplification 
of cDNA clones for UEV1A (obtained from Z.J. Chen, University of Texas Southwestern 
Medical Center, Dallas, TX) and UEV1B (obtained from S. Lin, Robert Wood Johnson 
Medical School, Piscataway, NJ); the resulting fragments were cloned into pGEX6 (GE 
Healthcare, #27-4597-01).  For the yeast two-hybrid constructs, UEV1A and UEV1B 
coding regions without stop codons were amplified by PCR as BamHI–SalI fragments 
and cloned into pG4BD-1 as C-terminal fusions to Gal4BD. 
 
2.2.3  RSP5 
For yeast RSP5 protein expression, a yeast pES4 plasmid containing a C-terminal-
truncated BglII-XhoI PCR fragment of yeast RSP5 that retains the WW and HECT 
domains was received as a gift from T. Harkness (University of Saskatchewan, 
Saskatoon, SK).  This construct, pES4-RSP5∆C2, contains the TRP1 gene for selection 
and is under the inducible expression of the CUP1 promoter, which governs the 
expression of a Myc-tagged Rsp5 fragment that lacks the C2 domain.  It is noted that a 
BglII-XhoI digestion only releases the RSP5 fragment, and not the MYC portion.  
To determine the domain(s) sufficient for Rsp5 interaction with Mms2, N-
terminal and C-terminal deletion constructs were made as follows.  The RSP5 ORF was 
obtained by an EcoRI-XhoI digestion of pYES-RSP5 (as a gift from T. Harkness) which 
was then cloned into EcoRI-SalI fragments of pGBT9 and pGAD424 to form pGBT-
RSP5 and pGAD-RSP5, respectively.  Plasmid pGBT-RSP5 containing the entire coding 
sequence (for amino acids 1-809) or subsequent derivatives were used to create a panel of 
deletion constructs.  Double restriction digestion was carried out to generate the desired 
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 deletions, followed by filling of the cohesive ends by the Klenow fragment of DNA 
polymerase I where required.  The resulting DNA was then self-ligated and a small DNA 
linker was used to restore the proper reading frame when necessary.  pGBT-RSP5 
derivatives were made with the following restriction enzymes; Rsp5∆1-180 (EcoRI-
EcoNI); Rsp5∆1-325 (EcoRI-KpnI); Rsp5∆1-360 (EcoRI-BamHI); Rsp5∆1-468 (EcoRI-
BsaBI); Rsp5∆326-809 (KpnI-NotI); Rsp5∆468-809 (BsaBI-NotI); Rsp5∆183-809 
(EcoNI -NotI). 
 
2.2.4  CHFR, TRAF6, and FUR4 
A human CHFR gene construct, pGEX4T-1, was received from T.D. Halazonetis 
(University of Pennsylvania, Philadelphia, PA) encoding a GST-fusion to amino acids 
281-543 of CHFR, which contains the entire RING-finger domain. 
The full-length mouse TRAF6 ORF was obtained from Z.J. Chen. The mTRAF6 
ORF was cloned as an EcoRI–SalI fragment into pGBT9 and pGAD424 to form pGBT-
mTRAF6 and pGAD-mTRAF6, respectively. 
The multi-copy yeast plasmid YEp352fF (2µ LEU2) carries the FUR4 gene under 
its own promoter and encodes the yeast uracil permease (Galan et al., 1996).  YEp352fF 
was received as a gracious gift from R. Haguenauer-Tsapis. 
 
2.2.4  DNA cloning and analysis 
 Plasmid manipulations were performed using enzymes from Invitrogen and New 
England Biolabs as per manufacturer instructions.  Plasmid DNA was normally 
propagated using a small-scale boiling method (Maniatis et al., 1982).  Approximately 
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 1.5 ml of overnight bacterial culture was pelleted and subsequently resuspended in 350 µl 
of bacterial lysis solution (0.1M NaCl, 10mM Tris-HCl, 1mM EDTA, 5% Triton X-100, 
pH 8).  20 µl lysozyme (10 mg/ml in 10mM Tris-HCl, pH 8) was then added, the 
suspension was gently mixed, and the tubes were immediately placed in boiling water for 
45 seconds, and then spun in a bench-top centrifuge at high speed (~16,000 x g) for 10 
minutes.  The cell debris pellet was discarded and ethanol precipitation was carried out.  
Plasmids were resuspended in ddH2O and kept frozen at -20°C for storage at a working 
concentration of ~0.005 µg/µl.  Plasmid preparations requiring higher concentration, 
yield, and purity were created using a plasmid mini-prep kit (BioRad, #732-6100). 
Plasmid DNA and DNA fragments were separated by agarose gel electrophoresis 
[0.75% agarose in 1X TAE buffer (24% Tris base, 5.7% glacial acetic acid, 10% EDTA, 
pH 8.0)].  Gels were loaded into an electrophoresis apparatus filled with 1X TAE buffer, 
and a constant current of <100 mA was applied until the desired migration was reached.  
Gels were stained in 0.5 µg/ml ethidium bromide for 5-10 minutes and the DNA was 
viewed using a UV trans-illuminator.  DNA to be isolated was cut from the agarose gel as 
thin as possible, and placed at -70°C in a 1.5 ml Eppendorf tube (E-tube) for at least 30 
minutes.  A sieve for the DNA fragment was then made by introducing a pin-point hole 
in the bottom of a 0.5 ml E-tube, into which a small amount of cheesecloth 
(representative of ~50 µl volume) was packed.  The frozen gel piece was added into the 
0.5 ml E-tube, which was placed inside a 1.5 ml E-tube and spun in a table-top centrifuge 
for 10 minutes (~16,000 x g).  The flow-through was collected and subsequently treated 
with phenol/chloroform as required to remove contaminants from the DNA preparation, 
which was then precipitated in ethanol and resuspended in ddH2O. 
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2.3  Polymerase chain reaction 
Polymerase chain reaction was used to amplify DNA fragments for the purposes 
of cloning and mutagenesis.  PCR reaction mixtures were created using the recipe 
guidelines in the instruction manual for the Pfu Turbo DNA polymerase (Strategene, 
#600250), which was used in all reactions.  A PTC-100 programmable thermal controller 
(MJ Research, Inc., Watertown, MA) was used as the thermocycler to carry out the 
various amplifications.  As a program guideline, a denaturing temperature of 95°C for 
one minute was followed by an annealing temperature of 55°C for 45 seconds, and 
primer extension was carried out at 72°C for 1 minute per kilobase of DNA to be 
amplified.  These three steps were repeated 25 times per reaction.     
 
2.4  Site-directed mutagenesis 
The site-directed mutagenesis of human UBC13 and MMS2 was performed using 
a modified form of the megaprimer site-directed mutagenesis approach (Figure 2-1) 
based on (Barettino et al., 1994).  For the first round of PCR, the pGEX6-hUBC13 and -
hMMS2 constructs were used as the templates in a PCR using the upstream primer 
pGEX6-5’, and a relevant downstream mutagenic primer (see Table 2-1) to synthesize 
the mutagenic megaprimer.  The megaprimer fragment was then gel purified and used in 
the second round of PCR where the pGBT-hUBC13 and pGAD-hMMS2 constructs were 
used as templates in their respective reactions, pGEX6-5’ was re-added (to amplify the 
megaprimer), and hUBC13-3 and pGAD-3’ were used as downstream primers for pGBT-
hUBC13 and pGAD-hMMS2, respectively.  The resultant hUBC13 and hMMS2 
50 
 fragments were cloned into pGBT9 and pGAD424, respectively.  Point mutations were 
confirmed by automated DNA sequencing at the Plant Biotech Institute, Saskatoon, SK  
or by my own manual DNA sequencing using a T7 Sequencing Kit (USB Corporation, 
#27168201).  
The site-directed mutagenesis of yeast MMS2 was carried out using the original 
megaprimer site-directed mutagenesis approach (Landt et al., 1990).  In the first PCR, the 
YCpL-yMMS2 construct in the “A” orientation was used as the template DNA, and an 
upstream M13 universal reverse and a downstream mutagenic primer were used to 
generate the megaprimer.  In the second PCR, the same vector backbone was used but 
with yMMS2 in the opposite orientation (YCpL-yMMS2-B) and the M13 universal 
reverse primer was re-added along with the megaprimer. 
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 Figure 2-1. Site-directed mutagenesis strategy. A modified version of the megaprimer method of 
site-directed mutagenesis was employed. Of note is that two different vectors containing the same gene 
of interest is used.  In the second round of PCR, a single primer specific for each vector allows the 
exponential amplification of the mutated DNA only.
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 Table 2-1. Oligonucleotides used for site-directed mutagenesis and PCR 
amplification.   
Oligonucleotide* Sequence (5’-3’) 
ohMMS2-Q23A CGCCTACTCCTTTTGCTCCTTCTTCAAGTTC 
ohMMS2-K24A CGCCTACTCCTGCTTGTCCTTCTTCAAG 
ohMMS2-S32A CAAGGCCCCAGGCAACTGTACCGTC 
ohMMS2-M49A GGCCCAATAATCGCGCCTGTCCACC 
ohMMS2-N12D CCAACAAGCGAAAATCACGAGGAACTTT 
ohMMS2-N12A CCAACAAGCGAAACGAACGAGGAACT 
ohMMS2-P10A GCGAAAATTACGAGCAACTTTAACTC 
ohMMS2-F13Y CCAACAAGCGATAATTACGAGGAAC 
ohMMS2-F13E CCAACAAGCGCTCATTACGAGGAAC 
ohMMS2-S64A CTACTTTCAGGGCATATATTCTGTTTTC 
ohMMS2-S64E CTACTTTCAGCTCATATATTCTGTTTTC 
ohUBC13-E55Q GGAAGGAATAGTTGAAGTTTAAAAGTCCC 
ohUBC13-F57E TCTTCTGGAAGCTCTAGTTCAAGTTT 
ohUBC13-F57Y TCTTCTGGAAGGTATAGTTCAAGTTT 
ohUBC13-E60Q TGGGTATTCTTGTGGAAGGAATAG 
ohUBC13-R70A TTGGTCATGAAAGCTACTTTAGGTGC 
ohUBC13-R70L TTGGTCATGAAAAGTACTTTAGGTGC 
ohUBC13-R70F TTGGTCATGAAAAATACTTTAGGTGC 
ohUBC13-M64A TTTAGGTGCTGCTGCTGGGTATTCTTC 
ohMMS2-I62A ACTTTCAGGCTATATGCTCTGTTTTCATAATTT 
oyMMS2-S27A GCTAAACCATAAGCACATGATTCTGG 
oyMMS2-I57A GAAAGGGAATAGGCTCTGTTTTCATG 
M13 universal forward GTAAAACGACGGCCAGT 
M13 universal reverse GGA AAC AGC TAT GAC CAT G 
pGEX6-5’ CTG GCA AGC CAC GTT TG 
pGAD-3’ GAA CTT GCG GGG TTT TTC 
hUBC13-3 CCG TCG ACT TAA ATA TTA TTC ATG GC 
*All oligonucleotides were ordered from Integrated DNA Technologies. 
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 2.5  Recombinant protein expression and purification 
BL21(DE3)-RIL (Strategene, #230245) cells transformed with pGEX6-hMMS2, 
pGEX-hUBC13, or pGEX-CHFR were grown overnight at 37 ˚C in LB + amp media and 
then sub-cultured 1:10 into pre-warmed LB + amp the following day.  Cells continued to 
grow to an optical density (OD) at 600 nm of between 0.6 and 0.8, and were then induced 
with 0.5 nM isopropyl-β-D-thiogalactopyranoside (IPTG) and transferred to a 30°C 
incubator for a 2 hour induction.  Cells were harvested by centrifugation at 5000 x g and 
resuspended in phosphate-buffered saline (PBS, 140 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.3).  Crude extracts were generated by passing the cells 
through a French Press at 10,000 psi and the soluble fraction was retained after 
centrifugation at 39,800 x g for 30 minutes.  When needed, a bacterial protease inhibitor 
cocktail (Sigma, #P8465) was added as per the manufacturer guideline.  All subsequent 
steps were performed at 4 ˚C.  Soluble extracts were passed through a pre-packed 5 ml 
GSTrap column (GE Healthcare, #17-5131-01), which was then washed with at least 5 
column volumes of 1X PBS.  GST-fusion proteins were eluted with reduced glutathione 
elution buffer (10 mM glutathione in 50 mM Tris-HCl, pH 8.0) and dialyzed extensively 
against cleavage buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM 
dithiothreitol, pH 7.0).  If protein purity was not sufficient, the above purification steps 
were repeated.  When needed, cleavage was performed by the addition of 2 units of 
Prescission Protease (GE Healthcare, #27-0843-01) per mg of fusion protein, followed by 
16 hours incubation at 4°C with gentle rocking.  Cleaved proteins were then applied to a 
GSTrap column in order to remove the GST component from the cleaved protein of 
interest.  When necessary, proteins were concentrated using Amicon Ultra centrifugal 
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 filter devices (Millipore, #901024), and protein concentrations were determined using the 
BCA Protein Assay Kit (Pierce, #23227) as per the instruction manual.  Purified proteins 
were kept at 4°C for short term use, or placed into <500 µl aliquots and were frozen 
quickly and kept at -70°C for long term storage.  Purified Ub was purchased 
commercially (Sigma, #93950). 
 
2.6  Protein analysis 
Proteins were subject to sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) for visual analysis.  In general, samples for SDS-PAGE 
were made by the addition of 2X protein sample buffer (125 mM Tris pH 6.8, 4% SDS, 
10% glycerol, 0.006% bromophenol blue, 1.8% β-mercaptoethanol) to the protein 
solution.  The protein samples were then placed in boiling water for 5 minutes, cooled, 
and then loaded onto the protein gel.  Most commonly, 12% discontinuous (5% stacking, 
12% separating) Tris-glycine polyacrylamide (37:1 acrylamide:bisacrylamide) gels were 
used (recipe in Maniatis et. al, 1989), with the exception that 10% polyacrylamide gels 
were used for the Fur4 membrane-protein analysis.  Gels were stained with Coomassie 
Blue staining solution (0.025% Coomassie Brilliant Blue R250, 40% methanol, 7% acetic 
acid) for at least 30 minutes, followed by incubation in de-stain solution (40% methanol, 
10% acetic acid) until proper protein band visibility was observed (1 hour to over night).  
The Mini-Protean 3 (Bio-Rad, #165-3301) gel apparatus was used for all SDS-PAGE. 
In order to visualize proteins via Western blot, polyacrylamide gels from SDS-
PAGE were equilibriated for 20 minutes in transfer buffer (0.037% SDS, 5.8% Tris-base, 
3% (w/v) glycine, 10% methanol pH) along with equal-sized polyvinylidine fluoride 
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 transfer membranes (Perkin-Elmer, #NEF1002) and filter papers.  The components were 
assembled as described in manual for the Bio-Rad trans-blot semi-dry transfer cell, which 
was used for the blotting of proteins onto the PVDF membranes.  Transfers were carried 
out for 1 hour at a constant current of 1 mA/cm2.  Membranes were then incubated in a 
blocking solution of (PBS, 3% non-fat milk powder) overnight at 4°C.  The desired 
primary antibody was diluted in 10 ml PBST (PBS, 0.05% Tween-20, 1% non-fat milk 
powder) and the PBST solution was incubated with the membranes at room temperature 
for 1 hour with gentle rocking.  The membranes were washed 3 times for 5 minutes with 
PBST.  Subsequently, the desired secondary antibody was diluted in 10 ml PBST and 
incubated with the membranes as with the primary antibody.  The membranes were then 
washed 3 times for 5 minutes with PBST and then 2 times with PBS to prepare for 
detection.  The Western Lightning Chemiluminescence Reagent (Perkin-Elmer, 
#NEL101) was used as the substrate for the visualization of horseradish peroxidase-
conjugated secondary antibodies.  The detection of alkaline phosphatase-conjugated 
secondary antibodies was performed by a colourimetric reaction using the substrates 
nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate diluted in 
alkaline phosphatase buffer (100 mM Tris, 100 mM NaCl, 5 mM MgCl2, pH 8.5) to 330 
µg/ml and 165 µg/ml, respectively. 
 
2.7  GST pull-down assays 
 GST pull-downs were performed using MicroSpin GST Purification Modules (GE 
Healthcare, #27-4570-03).  For the assays testing the interaction between human Ubc13 
and Mms2, and Ubc13 and CHFR, 0.03 mg of purified GST fusion protein in 1X PBS 
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 was loaded and incubated in the purification module for 1 h at 4°C with gentle rocking. 
The module was then washed three times with 500 µl PBS.  Subsequently, 0.03 mg of 
purified, non-fused protein of interest in 1X PBS was added to the module and the 
incubation was continued for another hour at 4°C. The module was washed again three 
times with 500 µl PBS and 80 µl of reduced glutathione elution buffer was then added to 
elute the affinity-purified proteins. Eluted samples were subjected to SDS-PAGE and 
visualized by Coomassie Blue staining and/or Western Blot analysis. 
 The yeast protein GST pull-downs involving GST-Mms2, GST-Ubc13, and myc-
Rsp5 were performed similar to the above but with the following differences.  All 
proteins of interest were expressed from plasmids in S. cerevisiae cells and were 
harvested from total-cell extracts.  The pES4-RSP5∆C2 construct was co-transformed 
with pYEX-yMMS2 or pYEX-yUBC13 into mms2∆ or ubc13∆ yeast strains, 
respectively.  The co-transformed cells were grown in selective media at 30°C until an 
OD at 600 nm of approximately 0.8 was reached.  0.5 mM CuSO4 was then added to 
induce the expression of GST-MMS2, GST-UBC13, and MYC-RSP5 for 2 hours at 30°C.  
Cells were then pelleted and resuspended in 1.5 x volume PBS with yeast protease 
inhibitor cocktail (Sigma, #P8215) as suggested.  The suspension was then vortexed 
vigorously at 4°C in the presence 1 x volume of 0.5 mm glass beads for three 15 second 
bursts.  The extract was then centrifuged at 4°C for 20 minutes at ~16,000 x g.  500 µl of 
the supernatant was applied to the Microspin GST Purification Modules and rocked 
gently for 2 hours at 4°C.  The eluted proteins were visualized by Western Blots using α-
GST and α-Myc Western blots. 
  
57 
 2.8  Co-immunoprecipitation 
The pES4-RSP5∆C2 construct was transformed into yeast cells and prepared as 
above (GST pull-down assays) to generate yeast cell extracts containing myc-Rsp5.  In 
this case, N150 buffer (50 mM HEPES pH 7.8, 5 mM magnesium acetate, 10% glycerol, 
0.005% NP40, 60 mM potassium acetate with 1 mM DTT) was used in place of PBS.  
Myc-Rsp5 was immunoprecipitated after the addition of 15 µl of mouse α-Myc antibody 
to 1 ml of the yeast cell extract, followed by a 4 hour incubation at 4°C with gentle 
rocking.  100 µl of Protein A Sepharose (Sigma, #P9424) was then added with 50 µg of 
purified yeast Mms2 protein and the incubation was continued for another 4 hours at 4°C 
with gentle rocking.  The suspension was centrifuged at low speed (2000 x g), the 
supernatant was removed (and saved as the input control), and 1 ml of N150 buffer was 
added to wash the beads.  These wash steps were repeated 5 times except 200 µl of 
protein sample buffer was added instead of N150 in the final step.  The protein samples 
were then placed in boiling water for 5 minutes, cooled to room temperature, and the 
supernatant was loaded to a polyacrylamide gel.  The co-immunoprecipitation of yMms2 
was visualized by Western blot analysis using the cross-reacting mouse α-hMms2 
polyclonal antibody. 
 
2.9  Yeast two-hybrid assay 
The yeast two-hybrid strains PJ69-4A (James et al., 1996) or Y190 (Zheng et al., 
2002) were co-transformed with different combinations of Gal4BD and Gal4AD constructs.  
For each strain, the co-transformed colonies were initially selected on SD-Trp-Leu.  For 
the PJ69-4A strain, a cell growth assay was performed where at least four independent 
colonies were grown in SD-Trp-Leu media and then replica plated onto either SD-Trp-
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 Leu-His alone or SD-Trp-Leu-His + 3-aminotriazole (3-AT) to test the activation of the 
PGAL1-HIS3 reporter gene, or SD-Ade to test the activation of the PGAL1-ADE reporter 
gene.  Plates were incubated for 48 hours at 30°C unless otherwise indicated.  For the 
Y190 strain, a filter-lift assay was performed (Bartel and Fields, 1995) where at least four 
independent colonies were replica plated onto SD-Trp-Leu.  White filter paper (3 mm) 
was then carefully overlaid onto the agar plate and the adhered yeast cells were then 
submerged in liquid nitrogen for 10 seconds.  This filter paper was then overlaid, with the 
cells facing up, onto another filter paper pre-equilibriated in a Petri dish with a freshly 
mixed development buffer containing 1.8 ml of “buffer Z” (60 mM Na2HPO4, 40 mM 
NaH2PO4, 10 mM KCl, 1 mM MgSO4), 45 µl X-gal (40 mg/ml stock in 
dimethylformamide), and 5 µl β-mercaptoethanol.  The Petri dish was then sealed with 
parafilm and placed at 30°C until the desired signal was seen (4 hours to overnight).  
 
2.10  Functional complementation assays 
Gradient plate assays were performed for the semi-quantitative measurement of 
yeast cell sensitivity to MMS.  At least three independent colonies for each strain were 
individually inoculated into 1 ml of SD minimal media and grown overnight.  To prepare 
the gradient plates, molten YPD agar (30 ml) was mixed with the appropriate 
concentration of MMS to form a bottom layer.  The gradient was created by pouring this 
layer into tilted square Petri dishes. After solidification for one hour, the Petri dishes were 
laid flat and 30 ml of the same molten agar without MMS was poured to form the top 
layer which was allowed to solidify for one hour.  0.1 ml of cells were then taken from 
the overnight cultures, mixed with 0.4 ml sterile water and 0.5 ml of 2% molten YPD 
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 agar, and then immediately imprinted, using the edge of a microscope slide, onto the 
gradient plates that were made that day.  Plates were incubated at 30°C for 48 hours 
(unless otherwise noted) before taking the photograph. 
Dilution plate assays were performed for the semi-quantitative measure of yeast 
cell sensitivity to MMS and UV.  10 µl of overnight cell culture grown in selective 
minimal media was spotted as 10-fold dilutions in water, beginning with undiluted 
cultures, on selective minimal media agar plates containing MMS.  For UV treatment, the 
spots were left to dry prior to dose administration.  Plates were incubated at 30°C for 72 
hours before taking the photograph. 
 
2.11  Yeast membrane protein enrichment 
The enrichment of yeast membrane proteins for SDS-PAGE was closely based on 
the method outlined by Galan et al., 1996.  Yeast cells transformed with YEp352fF 
(encoding Fur4) were cultured in 100 ml of selective minimal media to an optical density 
at 600 nm of 0.8.   Cell cultures were then centrifuged at 4,700 x g and the wet cell pellets 
were weighed.  300 µl of lysis buffer (0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, 5 mM 
EDTA) containing yeast protease inhibitor cocktail (Sigma, #P8215) was added for every 
100 µg of wet cell pellet.  All subsequent steps were performed at 4°C.  A 1 x volume of 
glass beads was added and the tubes were vortexed vigorously in 1 minute intervals for a 
total of 3 minutes.  The crude extract was then diluted 3X in lysis buffer and centrifuged 
at 0.4 x g for 1 minute.  Leaving the pelleted cell debris and glass beads, the supernatant 
was removed and transferred to a separate tube, followed by centrifugation for 30 minutes 
at ~16,000 x g.  This supernatant, representing the non-membrane-protein enriched 
60 
 fraction, was saved for future analysis.  The membrane enriched pellet was then 
suspended in 400 µl lysis buffer plus 5 M urea, incubated on ice for 30 minutes, and 
centrifuged for 30 minutes at ~16,000 x g.  The supernatant was discarded, and the pellet 
was resuspended in 400 µl lysis buffer plus 10% trichloroacetic acid.  A 15 minute 
centrifugation at ~16,000 x g was used to pellet the proteins once again.  The supernatant 
was discarded and 10 µl of 1 M Tris base was mixed with the pellet using a pipette tip.  
40 µl of 2X protein sample buffer was added, and the samples were heated at 37°C for 15 
minutes, cooled to room temperature, and then loaded onto polyacrylamide gels. 
 
2.12  Antibody generation and antibodies used 
 Mouse polyclonal antibodies against human Ubc13 and Mms2 proteins were 
generated as follows.  Five eight-week-old female BALB/c mice were injected with an 
emulsion containing either purified human Ubc13 or Mms2.  The emulsion was made by 
diluting the protein in PBS to 400 µg in a final 1 ml volume.  1.1 ml of Freund’s 
incomplete adjuvant was added to the 1 ml of protein, and the adjuvant and protein were 
emulsified with about 20 strokes of an emulsifier plunger.  2 ml of Tween 80 (1% in 
PBS) was added to the emulsified protein and 0.8 ml (~80 µg protein) of the mixture was 
injected into the intraperitoneal cavity of each mouse using 25 5/8 gauge needles.  Three 
weeks later, a booster was given with the same procedure as before, except that half the 
amount of total protein was injected (~40 µg).  Four weeks later, a second booster was 
given with the same protocol as the first booster.  Five weeks later (a total of 12 weeks 
after the first injection), the mice were orbital bled, followed by cervical dislocation.  
Whole blood was placed on ice for 30 minutes, then centrifuged long enough (~1 minute 
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 at 13000 x g) so the supernatant (serum) could be removed for analysis.  Anti-sera was 
dispensed in 50 µl aliquots and kept frozen at -70°C for long term storage.  Non-injected 
mice were handled in parallel to provide negative control serum.  A good working 
dilution for Western Blots containing ng quantities of protein was found to be 1:2500 and 
1:1000 for the anti-Mms2 and anti-Ubc13 antibodies, respectively. 
Other primary antibodies used in these studies were goat anti-GST (GE Healthcare, 
#27-4577-01), mouse anti-Fur4 (gift in kind from R. Haguenauer-Tsapis), and rabbit anti-
Myc (Upstate, #06-549).  Secondary antibodies used in these studies were alkaline 
phosphatase-conjugated anti-mouse (Calbiochem, #401212), horseradish peroxidase-
conjugated anti-mouse (Upstate, #12-349), and alkaline phosphatase-conjugated anti-goat 
(Calbiochem, #401512).  All antibodies were used at or above the manufacturer’s 
recommended dilutions. 
 
2.13  Ubiquitylation assays 
A 0.5-ml conjugation reaction containing Uba1 (20 nM), 35S-labeled Ub (2.5 
µM), and Ubc13 or Mms2 (250 nM) in an ATP mixture (10 mM HEPES, pH 7.5, 5 mM 
MgCl2, 5mM ATP, and 0.6 unit/ml inorganic phosphatase) was incubated at 30°C for 60 
min. Reactions were terminated by the addition of trichloroacetic acid to a final 
concentration of 10% and processed for SDS-PAGE and subsequent analysis by 
autoradiography. 
 
2.14  Surface plasmon resonance 
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 Surface plasmon resonance (SPR) was performed using a Biacore X instrument.  
To create a chip for protein interaction analysis, a research grade CM5 sensor chip 
(Biacore, #BR-1000-12) was used to immobilize anti-GST antibody by amine coupling, 
according to instructions in the Amine Coupling (Biacore, #BR-1000-50) and GST 
Capture Kits (Biacore, #BR-1002-23).  Approximately 15,000 response units (RU) of 
anti-GST antibody was immobilized to each of the two flow cells (Fc1 and Fc2).  For all 
SPR experiments, GST-fusion or native proteins were purified to >95% homogeneity and 
dialyzed against HBS-P buffer (50 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.005% 
Surfactant P20, pH 7.5).  All reagents were also degassed extensively and filtered 
immediately prior to use.   
For the SPR studies involving GST-Ubc13 and GST-Mms2, a buffer flow rate of 
20 µl per minute and a 2 minute injection of 5 µg/ml protein was used to capture ~1000 
RU of the GST-fusion protein (ligand) in Fc2.  For a control, purified recombinant GST 
(supplied in the GST Capture Kit) was similarly injected into the other flow cell to 
capture ~1000 RU in Fc1.  All data generated were corrected for background in real-time 
(Fc2 – Fc1).  To yield the binding curves, 10 µl of the soluble protein (analyte) at various 
concentrations was then applied to the flow cells at 5 µl per minute for 2 minutes.  
Regeneration of the sensor chip surface was accomplished with a 20 µl per minute 
injection of 10 mM glycine, pH 2.2 for 2 minutes. 
SPR studies of GST-Mms2 and Ub interaction were performed as those described 
above, except that only half (~600 RU) of the GST derivatives were immobilized to the 
sensor chip flow cells.  To account for the slightly different amount of GST-Mms2 
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 immobilized in each assay, the binding response to Ubc13 for each GST-Mms2 protein 
was measured, and the value was used as a factor for standardization. 
For the determination of the Ubc13-Mms2 dissociation constant, Biacore 
BiaEvaluations software was used for fitting binding curves that were generated from 
analyte concentrations ranging from 1 X 10-8 to 5 X 10-8 M for Mms2, and 2.5 X 10-8 to 5 
X 10-7 M for Ubc13.  See Figure 2-2 for an example.  With empirical knowledge 
(McKenna et al., 2001), a 1:1 molecular binding with mass transport was used as the 
interaction parameter in the software.  The Chi2 values were 5.2 and 2.3 for the GST-
Mms2-Ubc13 and GST-Ubc13- Mms2 interactions, respectively.  The data is deemed 
reliable by Biacore standards if Chi2 is below 10.   
Dissociation constants were also determined by manual calculation.  Using plots 
of the response at equilibrium (RUeq) vs. analyte (M), I was able to interpolate the 
maximum response (RUmax) for the interaction.  Double-reciprocal plots of 1/RUeq vs. 
1/analyte (M) were then made and the Kd was calculated using the equation Kd = RUmax · 
Slope.  An example of these plots is shown for the GST-Mms2-Ub interaction in Figure 
2-3. 
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Figure 2-2. Example of binding curves used for computer-generated binding constant 
determination.  Surface plasmon resonance was used to generate binding curves for the interaction 
between GST-Mms2 (ligand) and Ubc13 (analyte).  Binding is depicted in a plot of the response (RU) 
vs. time (s) for various concentrations of analyte.  These curves, along with the specific concentrations 
of protein used, were used in a curve-fitting algorithm provided by Biacore BiaEvaluations software to 
determine the dissociation constant of the GST-Mms2-Ubc13 interaction.
association equilibrium dissociation
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 Figure 2-3. Example of plots used in the manual calculation of dissociation constants.  (A) The 
interaction between GST-Mms2 (ligand) and various concentrations of Ub (analyte) are plotted as 
response at equilibrium (RUeq) vs. analyte (mM).  The maximum response (RUmax) was interpolated 
from the curve as 48.  (B) A double-reciprocal plot of (A) is shown and the slope of the graph is 
determined to be 0.0358. Calculation of the dissociation constant was performed using values from (A) 
and (B), and the equation Kd=RUmax · slope.
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CHAPTER THREE 
FUNCTION OF HUMAN UBC13-UEV COMPLEXES                                                 
IN YEAST DNA DAMAGE TOLERANCE 
 
3.1  Rationale 
The initial goal of this thesis was to establish a reliable experimental system for 
testing the structural and functional relationships of the human Ubc13 and Mms2 
proteins.  The preferred system would allow a quick and simple means to test the effect 
of various mutations on protein function.  Given the extensive genetic characterization of 
UBC13 and MMS2 in S. cerevisiae DNA damage tolerance, it was felt that the most 
straight-forward approach would be to test the human UBC13 and MMS2 genes for 
functional complementation of their yeast counterparts in DDT.  It should be noted here 
that unless otherwise indicated, the gene and protein names given throughout this thesis 
most often refer to the human counterparts, except in Chapter 5. 
As discussed in chapter 1, DDT in S. cerevisiae is a branched pathway that 
includes at least one error-free and one mostly mutagenic component (Broomfield et al., 
2001; Xiao et al., 1999; Figure 1-1).  The RAD6 and RAD18 genes constitute the “stem” 
and are required for both sub-pathways, and their lack of function leads to the most 
severe DNA damage sensitivities of the DDT genes.  It is for this reason that DDT is 
sometimes referred to as the RAD6 DNA repair epistasis group.  As compared with rad6 
or rad18, the mutation of genes involved in the error-free or mutagenic sub-pathways 
67 
 cause a partial sensitivity to DNA damage.  However, the abrogation of both sub-
pathways with an mms2∆ rev3∆ strain, for example, leads to a DNA damage sensitivity 
that is nearly as severe as the rad18 single deletion.  Underscoring the requirement for 
Ub-mediated signaling in DDT, a strong DNA damage sensitive phenotype is also 
observed for point mutations that prevent Ub conjugation to PCNA.  Because DDT is 
initiated by replication-blocking lesions, the genes involved in the pathway are sensitive 
to a wide array of DNA damaging agents.   
Genetically speaking, error-free DDT activity is dependent on UBC13, MMS2, 
and Lys63-linked Ub chains (Hofmann and Pickart, 1999; Pastushok and Xiao, 2004).  
As a result, ubc13, mms2, and ub-K63R mutant strains are similarly sensitive to DNA 
damage.  When this thesis work began, very little was known about the possible 
mechanisms of the Ubc13 and Mms2 proteins.  The only insights came from a genetics-
based inference that Lys63-linked Ub chains generated by Ubc13 and Mms2 were 
required for DDT, and a physical association that was observed between Ubc13 and 
Mms2 (Hofmann and Pickart, 1999).  Soon after, we and our colleagues presented a 
model which outlined how a human Ubc13-Mms2 heterodimer is formed to generate 
Lys63-linked Ub chains (McKenna et al., 2001).  As will be discussed in detail in chapter 
4, the model implies that the function of Ubc13 and Mms2 in DDT is dependent on their 
ability to form a heterodimer and to conjugate Lys63-linked Ub chains.  It was thus 
expected that a reliable system for testing the function of human UBC13 and MMS2 in S. 
cerevisiae would allow correlations to be drawn between heterodimer formation, Lys63-
linked poly-Ub conjugation, and DDT function. 
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 Using yeast DDT as a functional assay for structural studies of human Ubc13 and 
Mms2 has several advantages.  First, S. cerevisiae offers many properties that make it an 
easy organism in which to perform molecular biology experiments, especially when 
compared to human cells.  Those relevant to my studies include efficient plasmid 
transformation, an abundance of genetic markers, ease in creating gene knock-outs 
(cassette-targeted gene disruption), the availability and versatility of plasmid vectors, a 
fast rate of growth, and the relatively short time in which assays can be performed.  
Second, even to this day, the only known cellular function for yeast Ubc13 and Mms2 is 
error-free DDT, and no other phenotypes or growth defects have been observed for ubc13 
or mms2 mutants.  In contrast, the additional cellular roles attributed to mammalian 
Ubc13 and Mms2 as discussed in chapter 1 would likely complicate data interpretation 
and analysis.  Last and most interestingly, the yeast system would be contingent on the 
heterologous function of Ubc13-Mms2 heterodimers.  If the aforementioned mechanistic 
model is correct, the functional complementation in DDT by human UBC13 or MMS2 for 
its corresponding yeast mutant would require the yeast-human Ubc13-Mms2 heterodimer 
pairs to be compatible.  Heterologous functions for Ubc13-Uev pairs have not been 
previously reported. 
The plausibility of using human UBC13 and MMS2 genes in S. cerevisiae is seen 
in several ways.   First, the yeast and human UBC13 and MMS2 genes share 68% and 
47% protein sequence identity, respectively, and almost all of the other DDT genes have 
apparent homologs in higher eukaryotes (Table 3-1).  Furthermore, most, if not all of the 
proteins listed have retained the functional domains or motifs that are seen in S. 
cerevisiae DDT proteins.  The only exception is Rad5, which based upon protein 
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 sequence analysis alone, does not have a true sequence homologue in higher eukaryotes.  
Nevertheless, several potential RAD5 functional homologues are currently under 
investigation.  Second, several genes isolated from higher eukaryotes are found to be 
capable of functionally complementing their corresponding DDT defects in budding yeast 
(Ashley et al., 2002; Koken et al., 1991; Xiao et al., 1998).  Third, in a few limited cases, 
experimental inactivation of mammalian DDT genes in a cell line or in an animal model 
results in phenotypes reminiscent of the corresponding yeast mutants (Li et al., 2002; 
Roest et al., 1996; Tateishi et al., 2000).  Finally, the Lys164 residue in PCNA appears to 
be conserved in all eukaryotic organisms examined so far (Pastushok and Xiao, 2004), 
suggesting that the mechanism of covalent modification of PCNA in DDT has been 
conserved throughout evolution.  Indeed, the Rad18-dependent mono-ubiquitylation of 
mammalian PCNA has been observed (Watanabe et al., 2004) and mono-ubiquitylated 
PCNA signals for the preferential binding of a mammalian TLS polymerase after DNA 
damage (Kannouche et al., 2004; Watanabe et al., 2004). 
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 Table 3-1. Sequence conservation of eukaryotic DDT proteins. 
Protein 
(S. cerevisiae) 
Organism Protein name or 
accession number 
% Identity* 
H. sapiens E2a, E2b 69, 69 
M. musculus Ube2a, Ube2b 69, 68 
A. thaliana Ubc2 65 
D. melanogaster Dhr6 68 
C. elegans Ubc-1 61 
 
 
Rad6 
S. pombe Rhp6 77 
H. sapiens Rad18 14 
M. musculus Rad18 15 
A. thaliana n/a - 
D. melanogaster n/a - 
C. elegans n/a - 
 
 
Rad18 
S. pombe NP_595423 23 
H. sapiens Ubc13 68 
M. musculus Ubc13 68 
A. thaliana Ubc13a, Ubc13b 66, 65 
D. melanogaster Bendless, NP_609715 70, 68 
C. elegans Ubc13 66 
 
 
Ubc13 
S. pombe Ubc13 70 
H. sapiens Mms2, Uev1a 47, 46 
M. musculus Mms2 47 
A. thaliana Uev1a, Uev1b, 
Uev1c, Uev1d 
53, 51, 
53, 52 
D. melanogaster NP_647959 46 
C. elegans Uev1 45 
 
 
Mms2 
S. pombe Mms2 65 
H. sapiens PCNA 35 
M. musculus PCNA 35 
A. thaliana PCNA 39 
D. melanogaster PCNA 35 
C. elegans PCNA 38 
 
 
PCNA 
S. pombe PCNA 45 
* DDT proteins from S. cerevisiae were applied to BLAST analysis and the highest 
scoring homologs from various model organisms were included in the table and shown 
with % amino acid sequence identity.  n/a, not applicable (no sufficient homology found).  
Note: BLAST search with Rad5 failed to identify sufficient sequence homologs from any 
organisms examined in the database to date. 
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 3.2  Results 
3.2.1  Human UBC13 and MMS2 are able to function in S. cerevisiae 
 Early genetic studies on yeast UBC13 and MMS2 demonstrated that both genes 
are indispensable for error-free DDT (Broomfield et al., 1998; Brusky et al., 2000; 
Hofmann and Pickart, 1999).  Therefore, the first functional complementation approach 
was to use double transformations of human UBC13 and MMS2 in ubc13 mms2 double-
deletion yeast strains to test for DDT activity.  The experimental assay used an agar plate 
that is made with an increasing concentration of an alkylating agent, MMS, to induce 
DNA damage.  On these gradient plates, the ubc13∆ mms2∆ strain was unable to grow at 
higher MMS concentrations due to a DNA repair deficiency, and functional 
complementation was observed as a relief of the MMS sensitivity.  Figure 3-1 shows that 
the ubc13∆, mms2∆, and ubc13∆ mms2∆ yeast strains exhibited a roughly equivalent 
sensitivity to MMS.  However, a double transformation containing both human UBC13 
and MMS2 complemented the DNA damage sensitivity of the ubc13∆ mms2∆ strain.  On 
the other hand, the single transformation of human UBC13 or MMS2 did not restore drug 
resistance in the double mutant. 
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 Strain
wild-type
mms2∆
ubc13∆
mms2∆ ubc13∆
control0.025% MMSPlasmid
none
none
none
vector control
hMMS2
hUBC13
hMMS2 + hUBC13
Figure 3-1. Functional complementation of yeast ubc13 mms2 double deletion strains by their 
corresponding human genes. The function of human UBC13 and MMS2 double transformations is 
reflected in the ability to protect the yeast ubc13 mms2 double-deletion strain from killing by MMS.  
Overnight cell cultures were printed on YPD plates containing a gradient of 0.025% MMS, and cells 
with a greater ability  to survive DNA damaging treatment grew further along the gradient. Incubation 
was carried out for 48 hours at 30°C before taking the photograph. The arrow indicates an increasing
MMS concentration. Test plasmids were pGAD-hMMS2 and pGBT-hUBC13.
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3.2.2  Human UBC13 and MMS2 complement their corresponding genes in S. 
cerevisiae 
 With the success of the double transformation approach above, it was desirable to 
see if single transformations of human UBC13 and MMS2 could provide 
complementation for their single-mutant counterparts.  Figure 3-2 shows that 
transformation of the human UBC13 and MMS2 genes is able to provide MMS resistance 
in the ubc13∆ and mms2∆ strains, respectively.  The inability of human UBC13 to 
provide full complementation as compared with the wild-type strain is likely due to the 
nature of the plasmid-based gene fusion and not the actual gene itself.  For example, a 
similar plasmid construct of the yeast MMS2 gene does not provide full DDT 
complementation in the mms2∆ yeast strain (data not shown). 
 Given that MMS gradient plates are an important experimental assay in this 
thesis, a comparison with another method used to evaluate the sensitivity of cells to a 
drug treatment was performed.  In this case, a dilution-plate assay was performed with 
the same strains as the gradient plate shown in Figure 3-2.  In these assays, a plate with a 
single drug concentration is made onto which a 10-fold dilution series of cells is spotted.  
As seen in Figure 3-3, the complementation by human UBC13 and MMS2 in the dilution 
plates is visually comparable to that observed in the gradient plates. 
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 Strain
wild-type
mms2∆
untreated0.025% MMSPlasmid
none
vector control
hMMS2
hUBC13
none
Strain
wild-type
ubc13∆
untreated0.025% MMSPlasmid
none
vector control
none
Figure 3-2. Functional complementation of yeast ubc13 and mms2 single deletions by their 
corresponding human genes. The function of human MMS2 (upper panel) or UBC13 (lower panel) 
is reflected in the ability to protect its corresponding yeast deletion mutant from killing by MMS. 
Overnight cell cultures were printed on YPD plates containing a gradient of 0.025% MMS, and cells 
with a greater ability to survive DNA damaging treatment grew further along the gradient.  Incubation 
was carried out for 48 hours at 30°C before taking the photograph. The arrow indicates an increasing
MMS concentration. Test plasmids were pGAD-hMMS2 and pGBT-hUBC13. The white line indicates 
that the data was taken from a different region on the same plate.
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Plasmid
none
vector control
hMMS2
vector control
hUBC13
untreated0.015% MMS 75 J/m2 UV Strain
wild-type
mms2∆
ubc13∆
dilution series
Figure 3-3. Dilution plate analysis of the functional complementation of yeast ubc13 and mms2 
single deletions by their corresponding human genes. The function of human UBC13 or MMS2 is 
reflected in the ability to protect its corresponding yeast deletion mutant from killing by MMS or UV 
irradiation.  Overnight cell cultures were spotted as serial dilutions on selective minimal media that 
contained either 0.015% MMS or was exposed to 75 J/m2 of UV radiation. 10-fold dilutions increased 
from left to right and cells with a greater ability to survive DNA damaging treatment grew at higher 
dilutions. Incubation was carried out for 72 hours at 30°C before taking the photograph. Test plasmids 
were pGAD-hMMS2 and pGBT-hUBC13.
  MMS is a commonly used alkylating agent that generates DNA damage, but the 
molecular targets that it can affect are not limited to nucleic acids.  This is reflected by 
microarray analysis in yeast which shows that hundreds of genes are responsive to MMS 
treatment in S. cerevisiae, but most of them have no identifiable role in DNA repair 
processes (Jelinsky et al., 2000; Jelinsky and Samson, 1999).  In order to help ensure that 
the complementation observed by human UBC13 and MMS2 is due to DNA repair and 
not an unrelated secondary effect, a parallel experiment to the MMS dilution plate was 
performed but with a very different DNA damaging agent.  In this case, a dilution series 
containing the same strains as in the MMS assay was plated and the cells were 
subsequently treated with ultraviolet (UV) radiation.  The plates were incubated in the 
dark until analysis in order to prevent the direct reversal of DNA damage through 
photoreactivation by DNA repair photolyases.  As with the MMS treatment, the ubc13∆ 
and mms2∆ strains were sensitive to UV irradiation, and the sensitivity was alleviated 
after transformation with human UBC13 and MMS2, respectively (Figure 3-3). 
 
3.2.3  Functional complementation by human MMS2 homologs in S. cerevisiae 
 Although there are no other apparent sequence homologs of MMS2 in yeast, a 
search for MMS2 homologs in human databases reveals the gene UEV1 (also known as 
CROC-1 and CIR1; Xiao et al., 1998).  UEV1 was originally isolated by its ability to 
trans-activate the promoter of the human proto-oncogene, FOS (Rothofsky and Lin, 
1997).  Shortly thereafter, studies by independent groups found that UEV1 is down-
regulated in cells undergoing differentiation (Sancho et al., 1998), but up-regulated in 
cells undergoing immortalization (Ma et al., 1998).  UEV1 resides in the human 
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 chromosomal region 20q13.2 which is frequently amplified in many cancer types 
(Sancho et al., 1998; Savelieva et al., 1997) and UEV1 transcripts are also abundant in 
numerous tumor-derived human cell lines (Ma et al., 1998). 
UEV1 is transcribed as one of two predominant splice variants in human cells, 
termed UEV1A and UEV1B.  The Uev1A and Uev1B proteins are aptly named because 
like Mms2, they contain a Ubc-variant domain.  The Uev domain in each case shares 
greater than 90% amino acid sequence identity with human Mms2.  Beyond this core 
region of homology with Mms2, Uev1A and Uev1B have 33 and 84 residue amino-
terminal extensions, respectively.  Mms2 consists of the Uev domain alone and does not 
have such an extension.  Although the Uev domains of Uev1A and Uev1B are completely 
identical, the amino terminal extensions are encoded by different exons and bear no 
apparent sequence similarity to one another, or to any other peptides in the databases 
used for the Basic Local Alignment Search Tool (BLAST) at the time of writing this 
thesis. 
Given the high degree of similarity between human MMS2 and UEV1, and the 
ability of human MMS2 to complement its yeast counterpart (Figure 3-2 and Xiao et al., 
1998), I was prompted to test whether UEV1A and UEV1B could similarly function in 
yeast DDT.  Figure 3-4 shows that UEV1A is able to provide the mms2∆ strain with a 
resistance to MMS that is equivalent to human MMS2, whereas UEV1B does not.  In fact, 
UEV1B provides no additional MMS resistance whatsoever. 
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 hMMS2
Strain
wild-type
mms2∆
untreated0.025% MMSPlasmid
none
vector control
none
hUEV1A
hUEV1B
Figure 3-4. Heterologous functional complementation of human UEV genes in yeast. The 
function of human MMS2, UEV1A, and UEV1B in place of yeast MMS2 is reflected in the ability 
to protect the mms2 deletion strain from killing by MMS. Overnight cell cultures were printed on 
YPD plates containing a gradient of 0.025% MMS, and cells with a greater ability to survive DNA 
damaging treatment grew further along the gradient.  Incubation was carried out for 36 hours at 
30°C before taking the photograph. The arrow indicates an increasing MMS concentration. Test 
plasmids were pG4BD-hMMS2, pG4BD-hUEV1A, pG4BD-hUEV1B and pGAD-hUBC13.
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 3.2.4  Physical interactions between Ubc13-Uev proteins 
 In order to better understand how human UBC13 and MMS2 are able to function 
in yeast DDT, it was desirable to determine if physical interactions occur between the 
two proteins.  Because Gal4AD and Gal4BD fusion constructs were used in the 
complementation tests, the easiest approach to employ was the yeast two-hybrid assay 
(Fields and Song, 1989).  In addition to making use of the same constructs as for the 
complementation tests, the yeast two-hybrid assay offered other advantages.  The yeast 
two-hybrid assay is an in vivo protein interaction test performed in the same organism 
used in the functional assays.  In addition, while the nuclear localization of test proteins 
in the yeast two-hybrid assay is often undesirable, the Ubc13-Mms2 interaction is 
expected to occur in the nucleus anyway.  Indeed, yeast Ubc13 and Mms2 both localize 
to the nucleus after DNA damage treatment (Ulrich and Jentsch, 2000).  The auxotrophic 
markers in the yeast two-hybrid assay strain also allowed optimization of binding 
sensitivity such that low-affinity (or transient) and high-affinity (stable) interactions 
could be better detected. 
 As seen in Figure 3-5A, a physical interaction between Ubc13 and Mms2 was 
detected.  An interaction between Ubc13 and Uev1A was also seen, even at the most 
stringent assay condition used (growth on medium lacking Ade).  Perhaps with some 
future functional significance, I observed that the Ubc13-Mms2 interaction gave a 
stronger signal than the Ubc13-Uev1A interaction.  On the other hand, a detectible 
interaction was not seen for Ubc13 and Uev1B.  Due to the prevalence of false negatives 
in the yeast two-hybrid assay, I decided to confirm the interaction data in a completely 
different way using in vitro GST pull-downs.  
80 
   
A
Figure 3-5. Ubc13–Uev physical interactions. (A) Yeast two-hybrid analysis of Ubc13–Uev physical 
interactions using the growth assay method. Physical interaction of the hybrid proteins causes the 
expression of the HIS3 and ADE reporters which allows growth on minimal medium lacking His and 
Ade, respectively. Co-transformed plasmids were maintained with Trp and Leu markers and are indicated 
on the left. The plates were incubated at 30°C for 72 hours before taking the photograph. The assay was 
performed in triplicate, but only one representative transformant from each combination is shown. Test 
plasmids were pG4BD-hMMS2, pG4BD-hUEV1A, pG4BD-hUEV1B and pGAD-hUBC13. Cells co-
transformed with pG4BD-hUEV1B + pGAD424 and pG4BD + pGAD-hUBC13 were also negative (not 
depicted).
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 B
Figure 3-5. Ubc13–Uev physical interactions. (B) In vitro GST pull-down assay. Proteins of 
interest in each GST pull-down (Lanes 2 to 4) are indicated at the top. GST-hUev fusion proteins 
were immobilized on glutathione sepharose 4B columns and subsequently incubated with non-fused 
hUbc13. The physical interaction of test proteins allows their co-purification and is visualized by the 
presence of Ubc13 in eluted samples.  A denaturing protein gel stained with Coomassie blue is 
shown. Lanes 5 and 6 were samples of purified hUbc13 and GST, respectively. It is noted that 
repeated handling (i.e. freeze-thawing) of the GST-Mms2 and GST-Uev1B samples caused some 
slight spontaneous cleavage of the fusion protein.
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 In the GST pull-down assays, purified GST fusion proteins were immobilized onto 
Glutathione Sepharose and subsequently incubated with purified human Ubc13 protein.  
After washing away the unbound portion, the bound proteins were eluted, run on a 
denaturing protein gel, and visualized after Coomassie blue staining (Figure 3-5B).  This 
approach enabled the detection of stable protein interactions between Ubc13-Mms2 and 
Ubc13-Uev1A, however, a protein-protein interaction was not observed between Ubc13 
and Uev1B.  The results from the in vitro pull-down were thus in agreement with those of 
the in vivo two-hybrid assay. 
 Based on the human Ubc13-Uev interaction studies in Figure 3-5 and because the 
in vitro ubiquitylation activity of yeast Ubc13 and Mms2 is dependent on their co-
purification (Hofmann and Pickart, 1999), the physical binding of Ubc13-Mms2 is 
expected to be required for their function in DDT.  If this is indeed true, heterologous 
yeast-human Ubc13-Mms2 heterodimers would be expected in the single-gene 
complementation studies above where only a single human UBC13 or MMS2 gene was 
provided.  To help confirm that this is the physiologically relevant situation, the yeast 
two-hybrid assay was used to test for protein interactions between human Ubc13 and 
yeast Mms2, and vice versa.  In Figure 3-6, the human-yeast pairings for Ubc13 and 
Mms2 are seen to physically interact.  Furthermore, the signal generated was apparently 
as strong as the yeast-yeast and human-human protein interactions themselves (Figure 3-
6). 
83 
 hMMS2
Gal4BD Gal4AD
-
- hUBC13
yMMS2 hUBC13
hMMS2 yUBC13
hMMS2 hUBC13
yMMS2 yUBC13
Growth on SD media -Trp -Leu
-His +              
1 mM 3-AT
Figure 3-6. Heterologous Ubc13–Mms2 complex formation. Yeast two-hybrid analysis of 
Ubc13–Mms2 protein interactions by the growth assay method. Physical interaction of the hybrid 
proteins causes the expression of the HIS3 reporter which allows growth on minimal medium 
lacking His.  Co-transformed plasmids were maintained with Trp and Leu markers and are 
indicated on the left. The plates were incubated for 48 hours at 30°C before taking the photograph. 
Two representative transformants from each combination is shown. Cells co-transformed with
Gal4BD- yMMS2 + Gal4AD and Gal4BD + Gal4AD-yUBC13 were also negative (not depicted). Test 
plasmids were pG4BD-hMMS2, pG4BD-yMMS2, pGAD-hUBC13, and pGAD-yUBC13.
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 3.3  Discussion 
 With the overall focus of my thesis work being structure-function studies of 
human Ubc13-Mms2, my initial goal was to develop a reliable assay to provide the basis 
for testing prospective mutant protein function.  Several important factors as discussed in 
the rationale prompted me to test whether the budding yeast S. cerevisiae could be used 
to evaluate human UBC13 and MMS2 function.  In this system, the alkylating agent 
MMS was used to generate DNA damage and plasmid-based copies of UBC13 and 
MMS2 (or the UEV1A and UEV1B homologs) were tested to see if they could function in 
DDT in place of their corresponding yeast mutants.  The data presented in this chapter 
demonstrate that S. cerevisiae DNA damage tolerance is indeed a valid system for testing 
the function of the human UBC13 and MMS2 genes.  Furthermore, the detailed protein 
interaction studies helped to suggest that heterologous Ubc13-Uev complexes are 
functional in DDT. 
 I first demonstrated the ability of simultaneous human UBC13 and MMS2 
transformations to provide DDT function in a ubc13∆ mms2∆ double-deletion yeast 
strain.  Perhaps surprisingly, I observed nearly complete complementation (Figure 3-1).  
The finding suggests that the human proteins are able to effectively retain the DDT 
activities of their yeast counterparts.  A logical extension of this result is that the human 
Ubc13 and Mms2 proteins should be receptive to the upstream events or signals in yeast 
DDT, and are also able to effectively cause or execute the appropriate downstream events 
as well.  The finding is particularly significant with respect to the yeast protein Rad5, 
which is required for Ubc13-Mms2-mediated error-free DDT in S. cerevisiae (Ulrich and 
Jentsch, 2000).  Experimental evidence in S. cerevisiae supports a model whereby Rad5 
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 interacts with Ubc13 and Rad18 (Ulrich and Jentsch, 2000) to provide a physical bridge 
between the E2 complexes Rad6-Rad18 and Ubc13-Mms2, so they can be localized at the 
ubiquitylation target in DDT, PCNA (Hoege et al., 2002).  However, no apparent protein 
sequence homolog for Rad5 exists in higher eukaryotes.  The ability of human Ubc13 and 
Mms2 to function in yeast DDT is suggestive that there is indeed a functional Rad5 
homolog (i.e. analog) in higher eukaryotes.  Another highlight of this first experiment is 
that single transformations of UBC13 or MMS2 were not able to provide DNA damage 
resistance in the ubc13∆ mms2∆ mutant strain.  The finding suggests that the role for 
Mms2 in DDT is dependent on Ubc13, such that a different E2 cannot function in place 
of Ubc13 in DDT.  Reasons for the UBC13 and MMS2 co-dependence and the structural 
basis behind them will be addressed in chapter 4 of this thesis. 
 Similar to the double transformation approach, single gene transformations of 
human UBC13 or MMS2 were able to complement the DDT deficiency of their 
corresponding mutant strains.  With respect to future experimentation, it is notable that 
the extent of complementation by both UBC13 and MMS2 was significant and easily 
noticeable in the assays.  There was a clear and large difference between the 
complemented and non-complemented strains.  It was felt that this would provide a good 
future opportunity to discern between Ubc13 and Mms2 mutants that might only partially 
reduce DDT activity. 
 Because they were used throughout the structure-function studies, two 
experiments were carried out to justify the use of the MMS gradient plate assays.  The 
first showed that the gradient plate assay is as visually effective as the more commonly 
used dilution plate assay.  As can be seen when comparing the single-gene 
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 complementation studies in Figure 3-2 and 3-3, both assay methods allow the same 
conclusions to be drawn.  My preference is for the gradient plate assay because growth on 
dilution plates can be difficult to interpret when cell colony size between strains is 
variable.  The second experiment helped to ensure that the functional complementation 
observed by human UBC13 and MMS2 is attributed to DNA damage tolerance.  As can 
be seen in Figure 3-3, functional complementation was also observed after UV DNA 
damaging treatment.  However, the MMS dilution plate more clearly shows the 
differences between complemented and non-complemented cells.  The result suggests 
that the relief of MMS sensitivity in the ubc13∆ and mms2∆ strains by the human UBC13 
and MMS2 genes is attributed to processes related to DNA repair (i.e. DDT), and not an 
unrelated secondary biological process. 
 With the successful complementation of function by the human MMS2 yeast two-
hybrid construct, the human MMS2 homologs UEV1A and UEV1B were tested to see if 
they could similarly function in yeast DDT.  Indeed, it was found that UEV1A can 
alleviate the MMS sensitivity of the mms2∆ strain to the same extent as MMS2 itself.  On 
the other hand, UEV1B did not provide a detectible relief of DNA damage.  The result is 
somewhat surprising because Uev1A and Uev1B differ only in their amino-termini which 
extend 33 and 84 residues beyond the region of Mms2 homology, respectively.  To better 
understand the possible reasons why human MMS2 and UEV1A complement the mms2∆ 
strain but UEV1B did not, the ability of each protein to physically interact with Ubc13 in 
the yeast two-hybrid assay was tested.  Using the same constructs as in the functional 
complementation tests, physical interactions were detected between Ubc13 and Mms2, 
and Ubc13 and Uev1A.  However, an interaction was not observed between Ubc13 and 
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 Uev1B.  The absence of a detectible interaction because of a false negative in the yeast 
two-hybrid assay can be due to several factors.  A possible reason could be due to the 
production of recombinant protein in S. cerevisiae, such as poor protein expression or 
insolubility.  In addition, the nature of the Gal4 fusion could lead to steric hindrance that 
would not be present in the native protein. Also, it cannot be ruled out that the interaction 
itself is simply below the detectable limits of the assay.  In order to address some of these 
problems, purified proteins were used in in vitro binding experiments testing the same 
interactions as in the yeast two-hybrid assay.  In accordance, the GST pull-down assays 
showed that Ubc13-Mms2 and Ubc13-Uev1A form direct, stable protein interactions, 
whereas Ubc13 and Uev1B do not. 
 The ability of UEV1A to function in place of MMS2 in yeast DDT is a very 
interesting finding.  The high degree of protein sequence similarity between Uev1A and 
yeast Mms2 suggests that they might be orthologs (proteins representing genetic variation 
across species but usually retaining the same biological function).  However, a role for 
UEV1A in DNA repair would be at odds with UEV1 studies to date, which characterize 
UEV1 as a gene involved in the promotion of cell immortalization and tumorigenesis.  
Because genome instability is often at the root of cancer formation, DNA repair proteins 
are generally expected to have a role in preventing tumorigenesis.  These facts are more 
fitting with the suggestion that human Mms2 and Uev1 are paralogs which arose from an 
MMS2 gene duplication sometime during evolution, and have since undertaken divergent 
cellular roles.  Indeed, the studies in this chapter were a part of a recent publication which 
showed that human Mms2 and Uev1A are involved in very different cellular roles 
(Andersen et al., 2005).  Taken together, the ability of Uev1A to function in yeast DDT is 
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 best attributed to an evolutionarily conserved physical interaction with Ubc13 and an 
ability to promote Lys63-linked Ub chain formation, like Mms2. 
 The inability of UEV1B to function in place of MMS2 in yeast DDT was an 
observation initially seen in our laboratory (Xiao et al., 1998).  With this in mind and the 
initial observations that yeast Ubc13 and Mms2 form a complex in vitro, the possibility 
that UEV1B could act as a dominant-negative regulator of UBC13 DDT activity was 
tested.  The premise was that if Uev1B could out-compete Mms2 for binding Ubc13, then 
DDT activity would be correspondingly reduced.  However, through rigorous 
experimentation a dominant-negative effect was not observed (data not shown).  The 
reason came to light through the protein interaction studies above involving Ubc13 and 
the various Uevs.  Ubc13 and Uev1B did not physically interact in either the in vivo yeast 
two-hybrid assay or the in vitro GST pull-down assay and as such, a dominant-negative 
could not be exerted on Ubc13.  Taken together, the data in this chapter provided the first 
clues that an interaction between Ubc13 and its cognate Uev is absolutely required for its 
cellular function.  This idea was more definitively addressed through the detailed Ubc13-
Mms2 mutagenesis studies in chapter 4 of this thesis.  
 To support the idea that a direct Ubc13-Uev physical complex is required for 
DDT function, Ubc13 and Mms2 proteins from yeast and humans were tested for their 
physical interaction with each other.  It was felt that the yeast-human heterologous 
protein interactions would better reflect the actual physiological situation in the single-
gene complementation studies performed above.  Indeed, strong interactions were 
observed between yeast Ubc13 and human Mms2, and between human Ubc13 and yeast 
Mms2.  Furthermore, heterologous complexes were detected as readily as the yeast-yeast 
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 and human-human pairs themselves.  The result suggests an evolutionary conservation of 
the molecular determinants that designate the specificity and affinity of Ubc13 for Mms2.  
The heterologous abilities of Ubc13 and Mms2 as demonstrated in this chapter set a 
precedent for the quick and efficient testing of putative Ubc13 and Uev orthologs 
throughout eukaryotes. 
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 CHAPTER FOUR 
STRUCTURE-FUNCTION CHARACTERIZATION OF UBC13-MMS2 
 
 
4.1  Introduction 
In the chapter one of this thesis, the Ubc13-Mms2/Uev1A heterodimer was 
introduced as a unique E2 complex that generates Lys63-linked Ub chains.  Based on 
various in vitro assays and on structural information, a reasonable model was suggested 
for how the atypical Ub-Lys63 linkages can be made.  In accordance, the phenotypes 
associated with ubc13 and mms2 mutations in yeast DDT seemed to fit well with the 
mechanistic proposal.  However, despite a couple of small exceptions, in vivo functional 
evidence to support the model was lacking.  Therefore, a rational site-directed 
mutagenesis approach was performed to determine how the structure of Ubc13 and 
Mms2 relates to their cellular function.  Using the experimental systems demonstrated in 
chapter 3 of this thesis, I was able to functionally address four integral features of the 
Ubc13-Mms2 structure and mechanistic model.  As indicated in Figure 4-1, they are: 1) 
the Ubc13 active-site, 2) the Ubc13-Mms2 interface, 3) the Mms2-Ub interface and 4) 
the Ubc13-E3 interface.  In each case I was able to create point mutations that led to 
detectable functional consequences, allowing various conclusions regarding structure-
function relationships.  The findings provide evidence in favour of the prevailing 
mechanistic model for Lys63-linked Ub chain formation by Ubc13-Mms2, while also 
further uncovering the structural basis behind the cellular functions of Ubc13 and Mms2. 
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 Figure 4-1. Residues mutated in Ubc13-Mms2 structure-function studies.  A 
molecular structure of the Ubc13 (green) and Mms2 (blue) heterodimer was 
generated using PyMol v0.98 (DeLano, W.L, www.pymol.org).  To determine the 
key regions of the Ubc13-Mms2 heterodimer, point mutations were made at 
residues corresponding to the Ubc13 active-site (violet), the Ubc13-E3 interface 
(orange), the Mms2-Ub interface (yellow), and Ubc13-Mms2 interface (red).
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 4.2  Ubc13 active-site results 
The first structure-function analysis was performed to determine if that the Ub-
conjugating activity of human Ubc13 is required for its function in yeast DDT.  At least a 
few lines of evidence at the time, albeit indirect, indicated that this was the case.  First, 
the study that made the first link between Ubc13, Mms2, and Lys63-linked Ub 
conjugation reported that the ubc13∆, mms2∆, and ub-K63R mutants all shared a similar 
sensitivity to DNA damage (Hofmann and Pickart, 1999).  Second, the genetic 
dependence on MMS2 by UBC13 in DDT (Brusky et al., 2000) is in agreement with the 
role of Mms2 to promote poly-Ub chain formation by Ubc13 in vitro (McKenna et al., 
2001).  Third, based on sequence alignments with other E2s, Ubc13 seems to contain the 
conserved Cys residue (Cys87) required for an E2 active-site (Figure 4-2).  Fourth, 
Ubc13-Cys87 is situated in a cleft that is surrounded by residues that undergo chemical 
shift upon the Ub-Ubc13 interaction in vitro (McKenna et al., 2003a; McKenna et al., 
2003b). 
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 Figure 4-2. Protein sequence alignment of the E2 homologs in S. cerevisiae and 
human Ubc13. An alignment was generated using the CLUSTAL algorithm with 
default parameters.  Only a portion of the entire protein sequences is shown. Residues 
exactly matching the hUbc13 consensus are shaded black. The residues indicated with 
arrows correspond to the human Ubc13 residues mutated in these studies.
C87M64 R70E60F57E55
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 4.2.1  The Ubc13 active-site Cys residue is required for function in DDT 
In order to test if the putative active-site Cys residue of Ubc13 is required for 
DDT, a conservative Ubc13-C87S point mutation was created.  The Cys to Ser mutation 
has been used successfully to abrogate the Ub-conjugating activity of other E2 enzymes 
(Sullivan and Vierstra, 1993; Sung et al., 1991b).  The human UBC13-C87S construct 
was then transformed into a ubc13∆ yeast strain and then analyzed by an MMS gradient 
plate assay.  Figure 4-3A shows that in contrast to wild-type UBC13, the C87S mutant is 
unable to functionally complement the yeast ubc13 deletion after DNA damaging 
treatment.  To help ensure that the Ubc13-C87S protein is actually expressed and folded 
properly, the identical UBC13-C87S construct was tested for physical interactions with 
Mms2 in the yeast two-hybrid assay (Figure 4-3B).   The Ubc13-C87S mutant interacted 
with Mms2 as well as wild-type Ubc13. 
Based on the results, it can be concluded that the Ubc13 active-site Cys residue is 
required for its function in DDT.  Because of a unique property inherent to the particular 
mutation generated, it can be further inferred that DDT requires Ub conjugation by 
Ubc13, and not merely Ubc13-Ub ester formation.  The Cys-Ser mutation enables an E2-
Ub ester to be formed in vitro and in vivo (similar to the Cys thioester), however, the 
intermediate is metabolically stable and does not allow Ub to be conjugated to the target 
(Sullivan and Vierstra, 1993; Sung et al., 1991b).  In this regard, the Ubc13-C87S 
substitution might be useful in future studies involving intermediate steps in Ubc13-
Mms2-mediated Ub-conjugation. 
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Strain
wild-type
ubc13∆
untreated0.025% MMSDNA
none
vector control
UBC13
UBC13-C87S
Figure 4-3. The Ubc13-C87S substitution abrogates its function in yeast DDT but 
not its physical interaction with Mms2. (A) The in vivo function of human UBC13-
C87S is reflected in the ability to protect a ubc13? yeast strain from killing by MMS. 
Overnight cell cultures were printed on YPD plates containing a gradient of 0.025% 
MMS, and cells with a greater ability to survive DNA damaging treatment grew further 
along the gradient. Incubation was carried out for 48 hours at 30°C before taking the 
photograph. The arrow indicates an increasing MMS concentration. (B) Yeast two-hybrid 
analysis of the Ubc13-C87S-Mms2 protein interaction using the β-galactosidase filter-lift 
detection method. Physical interaction of the Gal4 hybrid proteins leads to the expression 
of the β-galactosidase gene which causes blue colour development in the assay. Co-
transformed plasmids were maintained with Trp and Leu markers and are indicated on the 
left. The picture was taken after 4 hours of colour development. Two representative 
transformants from each combination is shown except for the top-most experimental 
controls where a single transformant was used to show a positive (+) and negative (-) 
assay result for Gal4BD-hUbc13 + Gal4AD-hMms2 and Gal4BD + Gal4AD-hMms2, 
respectively. Dotted line indicates data taken from a different part of the same assay filter. 
Test plasmids were pGBT-hUBC13, pGBT-hUBC13-C87S, and pGAD-hMMS2.
Gal4BD Gal4AD
hUbc13-C87S -
+
hUbc13-C87S hMms2
hUbc13 hMms2
controls – see legend + -
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 4.3  Ubc13-E3 interface results 
 As discussed in chapter one, the model for Lys63-linked Ub conjugation identifies 
at least three possible channels for Ub binding and/or transfer.  The third channel is 
generated after the formation of the Ubc13-Mms2 heterodimer, and roughly extends 
outward from the Ubc13 active-site (the site of Lys63-linked Ub conjugation) along the 
β-sheet residues of Ubc13 and the α-1 helix and N-terminus of Mms2 (Figure 1-2 and 1-
3).  The relevance of channel 3 in Ubc13-Mms2 ubiquitylation is suggested by two 
separate crystal structures showing the detailed aspects of E2-E3 physical interactions.   
 One of the structures shows a physical interaction between UbcH7 and a RING 
finger E3, c-Cbl (Zheng et al., 2000).  The binding of the two proteins is predominantly 
mediated through contacts belonging to the RING finger domain of c-Cbl and a surface 
on UbcH7 that corresponds to the region on Ubc13 that is proximal to channel 3.  
Functional relevance for the involvement of this type of E2-E3 interaction in mediating 
ubiquitylation has been demonstrated through mutations that destroy the Zn2+ cross-
bridge of the E3 RING finger.  Such mutants abrogate the ability of E3s to physically 
interact with E2s and as a result, the cellular target is not ubiquitylated (Freemont, 2000; 
Joazeiro and Weissman, 2000; Waterman et al., 1999).  
 The second crystal structure involves a protein from the other predominant class 
of E3s which are marked by the HECT domain.  The HECT domains differ functionally 
from RING finger domains in that it forms thioesters with Ub, whereas the RING finger 
domains do not.  The HECT domain also conforms to a very different 3-dimensional 
structure than the RING finger domain.  It is thus surprising that the manner in which the 
HECT domain E3, E6AP, binds to UbcH7 is strikingly similar to the UbcH7-RING 
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 finger domain interaction (Huang et al., 1999).  Apparently the same UbcH7 surface is 
required for the physical interaction with both the HECT and RING finger domains.  
Although Ubc13-Mms2 (or Ubc13-Uev1A) has not been found to interact with HECT 
domain E3s to date, these findings implicate that channel 3 of Ubc13-Mms2 could be 
used to transfer Ub through HECT and RING finger domain E3s. 
There is no direct experimental evidence to date to support the necessity of 
channel 3 for Ubc13-Mms2 function in DDT.  However, the physical interaction between 
Ubc13 and the RING finger E3 Rad5 (Ulrich and Jentsch, 2000), and the requirement for 
RAD5 in error-free DDT (Xiao et al., 2000) suggest a functional relevance in vivo.  To 
address this problem, a point mutation was created within the Ubc13 surface that is 
typical of general E2-E3 interactions as explained above.  Furthermore, the point 
mutation lies within the aforementioned channel 3.  It was hypothesized that a mutant 
causing the disruption of the Ubc13-E3 interaction would lead to the inability of Ubc13-
Mms2 to pass Lys63-linked Ub chains to the target.  The consequence could be measured 
phenotypically in yeast, for example, by the inability of the UBC13 mutant to 
complement ubc13∆ in DDT. 
 
4.3.1  Design of a Ubc13-M64A mutant  
 In order to determine which residue(s) to mutate, the UbcH7-c-CBL crystal 
structure was used as a 3-dimensional template for human Ubc13.  Given the high degree 
of structural conservation among E2s, I was able to accurately replace the position of 
UbcH7 in the E2-E3 structure with Ubc13.  The result is a hypothetical structure of 
Ubc13 interacting with a RING finger domain (Figure 4-4A).  Using this model, the 
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 visual determination of which Ubc13 residues are likely to come into close contact with 
the RING finger domain of an E3 was possible (space-fill residues in Figure 4-4A).  
These residues were then compared in alignments using the UbcH7 and several Ubc13 
protein sequences.  The analysis revealed that all but one potential E2-RING finger 
interface residue was conserved between UbcH7 and Ubc13.  Furthermore, this residue, 
corresponding to human Ubc13-Met64, is exposed to solvent and completely conserved 
throughout all Ubc13 sequences (Figure 4-4B and personal communication, Janet Hill, 
Plant Biotechnology Institute, Saskatoon, SK).  Given that Ubc13 and UbcH7 do not 
share cellular functions or physical partners, the human Ubc13-Met64 residue (Phe63 in 
UbcH7) was a good candidate for Ubc13-E3 interaction specificity.  This is supported by 
the suggestion that the UbcH7-Phe63 residue is likely important for specifically 
interacting with the E3s c-Cbl (Zheng et al., 2000) and E6-AP (Huang et al., 1999).   
 The Ubc13-M64A point mutation for chosen for several reasons.  First, Ala 
substitutions are typical for “scanning” mutagenesis because alanine has a small non-
polar R-group that is relatively unassuming and unlikely to introduce large structural 
changes.  Second, the Met to Ala substitution is significant enough from a size 
standpoint, and would likely eliminate the Met contacts with the surface of the E3 RING 
finger domain.  Third, a protein sequence alignment of all E2s in yeast reveals that no 
other E2 has a small non-polar residue that corresponds to Ubc13-M64 (Figure 4-2). 
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 Figure 4-4. Identification of a Ubc13 residue of putative importance in 
binding RING finger domains.  (A) Ubc13 surface predicted to interact with a 
RING finger domain. The Ubc13 structure (blue) is oriented in place of UbcH7, 
based on the heterodimer structure of UbcH7-c-Cbl. Only the RING finger portion 
of c-Cbl (green) is shown, with zinc atoms shown in maroon. Ubc13 residues 
shown in space-fill representation are those that fall in proximity to the Ubc13-
RING finger interface.  Residues coloured red are conserved between UbcH7 and 
Ubc13, whereas the yellow residue (Met64) is unique to Ubc13 (correspondingly 
indicated in (B)). (B) Amino acid sequence alignment of Ubc13 from Homo 
sapiens (Hs), Drosophila melanogaster (Dm), Schizosaccharomyces pombe (Sp) 
and Saccharomyces cerevisiae (Sc) against UbcH7.
A
B
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 4.3.2  The UBC13-M64A mutant does not function in DDT 
 The UBC13-M64A mutant was transformed into ubc13∆ yeast strains and tested 
for its ability to function in error-free DDT.  Unlike wild-type UBC13, the UBC13-M64A 
mutant did not relieve the ubc13∆ strain from MMS sensitivity (Figure 4-5A).  UBC13-
M64A demonstrated a phenotype in the functional assay that was indistinguishable from 
the negative control.  The surprisingly strong effect prompted testing to ensure that the 
human Ubc13-M64A protein could be expressed and folded properly in yeast cells.  
Because the Ubc13-Met64 residue lies in a region that is visibly distinct from the Ubc13-
Mms2 interface, I tested the binding of Ubc13-M64A to Mms2 in the yeast two-hybrid 
assay.  Figure 4-5B shows that Ubc13-M64A is indeed proficient in binding to Mms2. 
101 
 Strain
wild-type
ubc13∆
untreated0.025% MMSDNA
none
vector control
UBC13-M64A
UBC13
A
B
Gal4BD Gal4AD
hUbc13-M64A hMms2
Growth on SD media -Trp -Leu
-His +              
1 mM 3-AT
+ -controls - see legend
Figure 4-5. The Ubc13-M64A substitution abrogates its function in yeast DDT but 
not its physical interaction with Mms2. (A) The in vivo function of human UBC13-
M64A is represented in the ability to protect a ubc13∆ yeast strain from killing by MMS.  
Overnight cell cultures were printed on YPD plates containing a gradient of 0.025% 
MMS, and cells with a greater ability to survive DNA damaging treatment grew further 
along the gradient.  Incubation was carried out for 48 hours at 30°C before taking the 
photograph. The arrow indicates an increasing MMS concentration. (B) Yeast two-hybrid 
analysis of the Ubc13-M64A-Mms2 protein interaction using the cell growth method. 
Physical interaction of the Gal4 hybrid proteins leads to the expression of the HIS3 gene 
which allows growth on SD media lacking His. Co-transformed plasmids were 
maintained with Trp and Leu markers and are indicated on the left. Two representative 
transformants are shown except for the experimental controls where a single transformant
was used to show a positive (+) and negative (-) assay result for Gal4BD-hUbc13 + 
Gal4AD-hMms2 and Gal4BD-hUbc13-M64A + Gal4AD, respectively. Cells co-transformed 
with Gal4AD-MMS2 + Gal4BD were also negative in the assay (not depicted). Test 
plasmids were pGBT-hUBC13, pGBT-hUBC13-M64A, and pGAD-hMMS2.
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 4.3.3  Ubc13-M64A disrupts physical interaction with RING finger E3s 
 Due to the requirement of RAD5 in error-free DDT (Ulrich and Jentsch, 2000) and 
its postulated role in acting as a physical bridge between E2 complexes (Hoege et al., 
2002), the inability of UBC13-M64A to provide resistance to DNA damage treatment 
strongly suggested that the mutation impairs a heterologous physical interaction between 
human Ubc13 and yeast Rad5.  The yeast two-hybrid assay was used to test this 
possibility.  Indeed, a detectible physical interaction was observed between human Ubc13 
and yeast Rad5.  However, the interaction was no longer detected when the Ubc13-M64A 
mutant was used (Figure 4-6).  The Ubc13-M64A protein is apparently expressed and 
folded properly in the assay because it was completely able to physically interact with 
Mms2 (Figure 4-5). 
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 Gal4BD Gal4AD
hUbc13
Growth on SD media -Trp -Leu
-His
controls - see legend
yRad5
hUbc13-M64A
yRad5
yRad5
yRad5
yUbc13
Figure 4-6. The Ubc13-M64A substitution abolishes its interaction with Rad5. Yeast 
two-hybrid analysis of the hUbc13-M64A-yRad5 protein interaction using the cell growth 
method. Physical interaction of the Gal4 hybrid proteins leads to the expression of the 
HIS3 gene which allows growth on SD media lacking His. Co-transformed plasmids were 
maintained with Trp and Leu markers and are indicated on the left. Two representative 
transformants are shown except for the experimental controls where a single transformant
was used to show a positive (+) and negative (-) assay result for Gal4BD-hUbc13-M64A + 
Gal4AD-hMms2 and Gal4BD-hUbc13-M64A + Gal4AD, respectively. Plates were incubated 
for 72 hours at 30°C before the picture was taken. Dotted line indicates data taken from a 
different part of the same assay plate. Test plasmids were pGBT-hUBC13, pGBT-
hUBC13-M64A, pGBT-yUBC13 and pGAD-yRAD5.
yUbc13
hUbc13
-
-
-
+ -
104 
  The ability of the Ubc13-M64A mutation to abrogate the interaction with Rad5 
prompted the testing of two other Ubc13-E3 physical interactions.  As discussed in 
chapter 1, Lys63-linked Ub chains generated by Ubc13-Uev are required for TRAF6-
dependent activation of the NF-κB pathway (Deng et al., 2000).  Because TRAF6 is a 
RING finger E3, it was originally expected that a physical interaction might occur 
between Ubc13 and TRAF6.  Using the sensitivity of the yeast two-hybrid assay several 
years later, our laboratory was able to show a physical interaction between mouse TRAF6 
and human UBC13 (Wooff et al., 2004).  It is notable that the human and mouse Ubc13 
amino acid sequences are identical.  As seen in Figure 4-7, human Ubc13 and mouse 
TRAF6 yield a positive signal in the yeast two-hybrid assay.  On the other hand, when 
the human Ubc13-M64A mutant was tested, a physical interaction with TRAF6 was not 
detected even though Ubc13-M64A was still proficient in binding to Mms2 (Figures 4-5 
and 4-7). 
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 Figure 4-7. The Ubc13-M64A substitution abolishes its physical interaction with TRAF6. 
Yeast two-hybrid analysis of the hUbc13-M64A-mTRAF6 protein interaction using the β-
galactosidase filter-lift detection method. Physical interaction of the Gal4 hybrid proteins leads 
to the expression of the β-galactosidase gene which causes blue colour development in the 
assay. Co-transformed plasmids were maintained with Trp and Leu markers and are indicated on 
the left. Two representative colonies from each treatment are shown after a 36 hour incubation at 
30°C. Cells co-transformed with Gal4AD-mTRAF6 + Gal4BD, Gal4AD + Gal4BD-hUbc13-M64A, 
and Gal4AD + Gal4BD-hUbc13 were negative in the assay (not depicted). Test plasmids were 
pGAD-hMMS2, pGAD-mTRAF6, pGBT-hUBC13, and pGBT-hUBC13-M64A.
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  Another putative Ubc13 physical interaction occurs with a novel human mitotic 
checkpoint pathway protein named CHFR (checkpoint with fork-head associated and 
RING finger domains).  CHFR is a RING finger E3 that delays mitosis through an 
unknown mechanism after treatment with microtubule poisons (Scolnick and 
Halazonetis, 2000).   Through various in vitro ubiquitylation assays, it was observed that 
CHFR functions to promote Lys63-linked Ub chain formation by Ubc13-Mms2 (Bothos 
et al., 2003).  Point mutations that destroy the CHFR RING finger domain abolished the 
Ub-conjugation activity attributed to Ubc13-Mms2.  The findings were best explained by 
a RING finger dependent physical interaction between CHFR and Ubc13-Mms2.  In 
order to test this idea directly, a purified GST-CHFR derivative containing the RING 
finger domain was used to perform in vitro GST pull-downs assays with wild-type and 
Ubc13-M64A proteins.  As seen in Figure 4-8, CHFR was able to bind to wild-type 
Ubc13 but not Ubc13-M64A. 
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Ubc13 
M64A
Ubc13 
wt
- Ubc13 
wt
Coomassie Blue Staining
α-Ubc13 Western Blot
Ubc13
Ubc13
Figure 4-8. The Ubc13-M64A substitution abolishes its physical interaction with 
CHFR. A GST pull-down was used to test the in vitro binding of GST-hCHFR to non-
fused wild-type (wt) hUbc13 (Lane 2) and hUbc13-M64A (Lane 3). Physical interaction 
of the test proteins allows their co-purification and subsequent detection in denaturing 
protein gels, as shown above. The binding of GST-CHFR to Ubc13 was not detected in 
the upper panel (the Coomassie blue stained gel). For increased sensitivity, an ?-Ubc13
Western Blot of the same samples is shown in the bottom panel. Lane 1 (protein marker); 
Lane 4, negative control (resin-only) pull-down of Ubc13; Lane 5, Ubc13 protein only. It 
is noted that some degradation of the GST-CHFR fusion occurred during the assay 
(Lanes 2 and 3, upper panel).
GST-CHFR
1 2 3 4 5
2 3 4 5
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 4.3.4  Discussion of the Ubc13-E3 interface 
 Through the above analysis, a structure-based approach was used to generate a 
point mutation (Ubc13-M64A) that was predicted to lie within a putative Ubc13-E3 
interface.  Moreover, the Ubc13-Met64 residue is located near the distal end of a channel 
that has been proposed, based on structural analysis, to provide an outgoing route for 
Lys63-linked Ub conjugated by Ubc13-Mms2.  These ideas present a conceptual link 
between the Ubc13-Mms2 Ub-conjugation event and the subsequent transfer to the E3-
bound target. 
 When testing the functional consequence of the UBC13-M64A mutation in yeast 
DDT, no complementation of the ubc13∆ strain was observed.  However, the Ubc13-
M64A protein was fully capable of binding to human Mms2 in vivo, which indicated that 
the mutation did not affect the overall structure of Ubc13.  The striking phenotypic effect 
of the point mutation was presumably due to the abrogation of a required Ubc13-E3 
interaction (i.e. Ubc13-Rad5 in error-free DDT).  Indeed, a physical interaction between 
the human Ubc13 and yeast Rad5 proteins was detected, and the finding helps to explain 
why the human UBC13 gene is functional in yeast DDT.  The result also suggests that an 
unidentified functional equivalent to RAD5 will be found in higher eukaryotes.  In 
accordance with the lack of complementation by UBC13-M64A, the Ubc13-M64A 
substitution was seen to abolish the physical interaction with Rad5 in the yeast two-
hybrid assay.  The Ubc13-M64A mutation was also shown to have the same effect on 
abolishing the Ubc13-TRAF6 interaction, indicating that the Ubc13-Met64 residue might 
be a general specificity requirement for the physical interaction of Ubc13 with its various 
cognate E3s.  In this light, it might be interesting to determine if the Ubc13-M64A 
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 mutation leads to interactions with other E3s that do not normally physically associate 
with Ubc13. 
Whereas Rad5 and TRAF6 could not be used to demonstrate an in vitro physical 
interaction with Ubc13 (data not shown), the human RING finger E3 protein CHFR was 
used in a GST pull-down experiment with human Ubc13.  A novel protein interaction 
between Ubc13 and CHFR was successfully shown.  Furthermore, the same experiment 
showed that the physical interaction with CHFR was completely disrupted with the 
Ubc13-M64A mutant.  The physical interaction between Ubc13 and CHFR, and the 
abrogation by the Ubc13-M64A mutant has been since confirmed in our laboratory using 
the yeast two-hybrid assay (data not shown). 
 The finding that different E3s interact with Ubc13 through the same residue 
suggests that the conjugation activity of Ubc13 can be exclusively sequestered in 
different cellular pathways.  Moreover, the conservation of the physical interaction 
suggests a conserved biochemical mechanism for the delivery of Lys63-linked Ub to the 
target via “channel 3” of Ubc13-Mms2.  Further structural analysis of Rad5, TRAF6, and 
CHFR, and the identification of additional Ubc13-specific E3s will undoubtedly shed 
more light on this possibility.  It will also be interesting to determine whether Mms2 or 
Uev1A can facilitate the Ubc13-E3 interactions demonstrated above.  While Ubc13 may 
be sufficient, Mms2 and Uev1A might provide additional binding affinity or specificity 
to a particular Ubc13-E3 interaction.  The relatively weak interaction strengths observed 
for Ubc13-Rad5 and Ubc13-TRAF6, and the fact that the Ubc13-M64A mutation reveals 
a separate binding site on Ubc13 for Mms2, suggests that this is a possibility. 
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 4.4  Mms2-Ub interface results 
Based on the studies in this chapter so far, it has been shown that the binding of 
Ubc13 to Ub (at its active-site) and the interaction between Ubc13 with an E3 are both 
important functional aspects of Ubc13-Mms2.  However, two other protein interactions 
are also fundamental to the model for Lys63-linked Ub chain assembly, and they 
provided the opportunity to conduct novel structure-function studies of Ubc13-Mms2.  
One such interaction involves the specific binding of Mms2 to Ubc13.  The important 
determinants of the Ubc13-Mms2 interface and the functional consequences will be 
addressed in detail below.  The other critical interaction is based on NMR chemical-shift 
data which suggest that Mms2 orients Ub to promote linkages through Ub-Lys63.  In 
order to provide functional evidence to support this idea, appropriate mutations in Mms2 
that abolish the interaction with Ub were desired.  If the mechanistic model was to be 
upheld, it was hypothesized that such mutations would abolish Lys63-linked Ub 
conjugation by Ubc13-Mms2, and lead to DNA damage-sensitive phenotypes.  Because 
the Mms2 binding sites for Ub and Ubc13 were proposed to be independent, such 
mutations can potentially act as dominant-negative regulators of Ubc13 Lys63-dependent 
Ub conjugation. 
 
4.4.1  NMR-directed design of Mms2 surface mutations 
 The first probe into the putative Mms2-Ub interaction surface began with 
information taken from detailed NMR analyses of human Mms2 and Ub (S. McKenna, 
University of Alberta, Edmonton, AB, personal communication).  It was discovered that 
certain Mms2 residues undergo changes in chemical environment upon incubation with 
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 Ub in vitro.  These so-called chemical-shifts are indicative of localized changes that can 
be caused by protein-protein interactions.  However, while the sensitivity of the approach 
allows the detection of low-affinity or transient interactions (as was expected for Mms2-
Ub), it also led to an abundance of candidates for Mms2 mutagenesis (Figure 1-3, pink 
residues).  Therefore, only the residues which had undergone the largest chemical 
perturbation shifts and that were also representative of the entire putative interaction 
surface were mutated (S. McKenna, personal communication).  These residues, 
corresponding to Mms2-Glu23, -Lys24, -Ser32, and -Met49, were substituted with Ala 
and are indicated in Figure 4-12. 
 In testing the effects of these mutations, two factors prompted the use of a more 
sensitive variation of the DDT functional complementation approach as performed in 
other parts of this thesis.  One factor was that I expected the affinity of the Mms2-Ub 
interaction to be very weak in order to facilitate the efficient release of acceptor Ub after 
conjugation.  Second, the large number of Mms2 residues that underwent a chemical shift 
upon interacting with Ub suggested that the affinity might be the sum of many small 
contributions from numerous residues.  There was a concern that even the strongest 
phenotypes of individual mutations would go undetected in the typical functional 
complementation assays.   
The more sensitive functional complementation assay variation took advantage of 
the synergistic relationship between mms2 and rev3 in DDT.  The assays were nearly 
identical to those used to demonstrate that human MMS2 functions in yeast DDT, except 
that the strain used in this case was an mms2 rev3 double-deletion strain, instead of the 
mms2∆ single.  With this approach, a very slight MMS-sensitive phenotype (reminiscent 
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 of rev3∆ alone) would be observed in the case of full complementation by an MMS2 
transformation.  On the other hand, a synergistic sensitivity to MMS would be observed 
in MMS2 mutants that have impaired function in error-free DDT.  However, none of the 
mutants caused a DNA damage sensitive phenotype in the assay (data not shown).  In 
order to generate a stronger disruption of the surface, two of the mutations were 
combined to generate MMS2-Q23A/M49A.  However, the double-mutant  functioned as 
well as wild-type MMS2 in the enhanced error-free DDT complementation assay (data 
not shown). 
  
4.4.2  Mutagenesis of a putative Mms2 phosphorylation site 
 In another attempt to identify residues that might be important for Mms2 function 
through binding to Ub, a more directed approach involving the mutation of a putative 
Mms2 phosphorylation site was used.  Initial sequence analysis in 1999 had identified 
that the Mms2 family of Uevs contained a conserved phoshorylation consensus sequence.  
With updated databases, this possibility was re-evaluated and the existence of such a site 
was confirmed.  Most striking is that this consensus sequence (Arg-Ile-Tyr-Ser-Leu) is 
situated on the face of Mms2 that is proposed to interact with Ub.  It was reasoned that a 
functional link between phosphorylation and ubiquitylation was possible.  In accordance, 
preliminary observations indicated that mammalian Mms2 is phosphorylated in vivo (N. 
Syed, University of Saskatchewan, Saskatoon, SK, personal communication). 
 Visualization of the apparent phoshorylation consensus sequence in the human 
Mms2 crystal structure indicated that the hydroxyl group of the Tyr residue is not 
completely solvent-exposed, and is thus unlikely to be accessible for phosphate 
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 modification.  On the other hand, the Ser64 residue was a good candidate because it is 
conserved in Mms2 sequence alignments from yeast and mammals (Figure 4-13) and has 
an R-group that is directed outwards from the Mms2 interior.  When comparing the NMR 
data (McKenna et al., 2003a) for the residues in the consensus sequence, the residues 
immediately flanking Ser64 (Tyr63 and –Leu61) were found to undergo chemical-shift 
upon Mms2-Ub interaction; however, no such change was observed for Mms2-Ser64.  It 
was thus hypothesized that the phosphorylation of Mms2-Ser64 might prevent Ub from 
contacting Mms2-Tyr63 and -Leu61, thus interfering with the Mms2-Ub interaction.  
This was expected to inhibit the Lys63-linked Ub conjugation by Ubc13-Mms2 and lead 
to a measurable reduction in DDT activity.  In this model, the biochemical activity of 
Ubc13-Mms2 could be regulated by a DNA-damage-responsive de-phosphorylation 
event.  The fact that Mms2 proteins expressed in bacteria are proficient in ubiquitylation 
reactions is in accordance with this thought. 
 To address the hypothesis experimentally, two different mutations of the Mms2-
Ser64 residue were created.  Mms2-S64E was the first mutant, and was designed to 
mimic constitutive phosphorylation by the substitution to a larger and negatively charged 
residue.  It was hoped that the mutant would inhibit the Mms2-Ub physical interaction in 
the manner proposed for phosphorylation.  Despite using the aforementioned enhanced 
functional complementation approach, MMS2-S64E behaved like wild-type MMS2 (data 
not shown).  To cover the possibility that the phosphorylation of Mms2-Ser64 plays a 
positive role in Ubc13-Mms2-mediated Ub conjugation, an Mms2-S64A mutation was 
made to prevent phosphorylation.  However, MMS2-S64A had no effect as observed in 
the functional complementation assay (data not shown). 
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4.4.3  Identification of Mms2 surface mutants defective in binding Ub in vitro 
 The inability to detect a phenotypic change for any of the Mms2 mutants in the 
functional assays above could be due to several reasons.  One possibility is that the 
residues chosen for mutagenesis are not as important as the NMR data suggests, or that 
the Ala substitutions were not significant enough to disrupt the Mms2-Ub interactions.  
Another possibility is that the proposed model for Mms2-Ub binding is an in vitro 
phenomenon (or artifact) that does not actually occur inside the cell.  A more favourable 
reason is that the Mms2-Ub interaction occurs with low-affinity over a large surface area 
and cannot be sufficiently abrogated by individual point mutations.  The latter possibility 
is considered to be particularly likely because slight phenotypic differences could have 
been masked by the multi-copy vector and strong promoter used to constitutively express 
the MMS2 derivatives in the assays. 
 The likelihood that the phenotypic changes went undetected became even more 
probable following a publication which used a completely different approach to address 
the putative Mms2-Ub interaction of the yeast proteins (Tsui et al., 2005).  The authors 
began with mutations on the surface of Ub, instead of Mms2, and performed in vitro 
ubiquitylation reactions with purified Ubc13-Mms2 proteins.  Through the analysis it was 
identified that Ub-Ile44 is necessary for the efficient conjugation of Lys63-linked di-Ub.  
However, the result was not particularly surprising because Ub-Ile44 was previously 
shown to be a common feature in protein-protein interactions involving Ub.  
Computerized docking of Ub to the Mms2 surface revealed that the Ub-Ile44 residue 
could potentially interact with Mms2-I57.  Indeed, a yeast Mms2-I57A mutation caused a 
115 
 greater than 10-fold reduction in di-Ub formation and behaved as a weak competitor in 
wild-type yeast Ubc13-Mms2 Ub-conjugation reactions (Tsui et al., 2005).  Furthermore, 
the authors of the yeast protein study were able to demonstrate a partial DNA damage-
sensitive phenotype in vivo for a MMS2-I57A mutant.  It was realized that the success of 
the yeast protein study was likely because a single-copy plasmid employing the native 
yeast MMS2 promoter was used. 
 In order to re-evaluate the Mms2 mutations created in this thesis work, it was felt 
that a protein-protein interaction approach might be more successful.  Possibly due to an 
inherently low binding strength or physical hindrance from the Gal4BD fusion, the yeast 
two-hybrid assay could not be used to detect a physical interaction between Mms2 and 
Ub (data not shown).  As an alternative, surface plasmon resonance (SPR) was used as an 
in vitro approach to detect the Mms2-Ub physical interaction.  SPR technology can be 
used as a sensitive tool for the real-time measurement of protein-protein interactions, and 
the data can often be used to determine kinetic parameters and binding constants (Szabo 
et al., 1995).  In this particular experiment, GST-Mms2 was immobilized to the SPR 
sensor chip, purified Ub was then introduced as the soluble-phase analyte, and the 
binding response for GST-Mms2-Ub was subsequently monitored.  A range of Ub 
concentrations was used in order to generate a series of binding curves for the calculation 
of the Mms2-Ub dissociation constant (Kd).  Using the manual calculation approach as 
described in chapter 2 (Figure 2-3), the Kd of the Mms2-Ub interaction was determined to 
be approximately 200 µM.  The value is in good agreement with the NMR-derived Kd 
from our collaborators who determined it to be approximately 100 µM (McKenna et al., 
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 2003a).  The higher Kd as determined in this thesis may be due to the use of GST-Mms2 
fusion proteins in the experimentation. 
 Given the ability to detect the Mms2-Ub interaction by SPR, all but one of the 
mutant human Mms2 proteins (Mms2-K24A) were purified and expressed.  Preliminary 
analysis by SPR indicated that the Mms2-Q23A/M49A, -S64A, and S64E mutants did 
not affect binding with Ub when compared to wild-type, however, the Mms2-S32A 
mutation caused an appreciable decrease in affinity for Ub (data not shown).  In order to 
put this finding in perspective, a human Mms2-I62A mutation was made which 
corresponds to the yeast Mms2-I57A substitution that was reported to interfere with 
Mms2-Ub binding and function (Tsui et al., 2005).  For further comparison, an Mms2-
S32A/I62A double-mutant was also created to help determine the relationship between 
the Mms2-Ser32 and -Ile62 residues in binding to Ub.  The results in Figure 4-9 show 
that the Mms2-I62A mutation caused a decreased affinity for Ub, but apparently not to 
the extent as Mms2-S32A.  Based on the results of each individual mutant, a reduction in 
Ub-binding by the Mms2-S32A/I62A double-mutant was also expected.  Indeed, the 
ability of Mms2-S32A/I62A to bind Ub was decreased further than either of the single 
mutations alone.  It is worth noting that throughout these experiments, no expression or 
solubility problems with any of the Mms2 derivatives were seen, suggesting that they 
were expressed and folded properly.  In accordance, SPR was used to confirm that each 
of the Mms2 mutants retained an ability to bind purified Ubc13 (data not shown). 
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Figure 4-9. The mutation of the Mms2-Ub interface disrupts its binding with Ub in 
vitro. Surface plasmon resonance was used to measure the binding response of GST-
hMms2 derivatives (indicated at the bottom) with various concentrations of Ub.  It is noted 
that 5 mg/ml Ub yielded a maximum binding response for wild-type (wt) Mms2. Data 
shown is the average of three independent experiments.
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 4.4.4  Functional complementation in DDT is impaired by Mms2-Ub interface 
mutations 
In order to determine the relationship between in vitro Ub binding and DDT 
function, the yeast equivalents of the human Mms2 mutants above causing lowered Ub-
binding were generated.  The yeast MMS2-S27A, -I57A, and –S27A/I57A mutations 
correspond to human MMS2-S32A, -I62A, and –S32A/I62A, respectively.  Each of the 
yeast mutants was created in a single-copy plasmid employing the native yeast MMS2 
promoter.  The ability of each of these constructs to provide functional complementation 
in the mms2∆ rev3∆ yeast strains after DNA damage treatment by MMS was then tested.  
Figure 4-10 shows that MMS2-S27A and MMS2-I57A have comparable deficiencies in 
DDT function.  Strikingly, while the reduction in DDT is moderate in each of the single 
mutants, the MMS2-S27A/I57A mutant displayed a strongly additive decrease in DDT 
function.  The phenomenon is more easily seen when comparing the same strains on 
dilution plates containing MMS.  In fact, the MMS2-S27A/I57A mutant is nearly as 
sensitive to DNA damage as the negative control (Figure 4-11). 
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 Strain
wild-type
mms2∆
untreated0.025% MMSDNA
none
vector control
yMMS2
rev3∆
mms2∆ rev3∆
yMMS2-S27A
yMMS2-I57A
yMMS2-S27A/I57A
Figure 4-10. The mutation of the Mms2-Ub interface disrupts the in vivo function of MMS2.
The in vivo function of yeast MMS2 mutants is reflected in the ability to alleviate an mms2 rev3?
yeast strain from killing by MMS.  Overnight cell cultures were printed on YPD plates containing a 
gradient of 0.025% MMS, and cells with a greater ability to survive DNA damaging treatment 
grew further along the gradient.  Incubation was carried out for 48 hours at 30°C before taking the 
photograph. The arrow indicates an increasing MMS concentration. Test plasmids were YCpL-
yMMS2, YCpL-yMMS2-S27A, YCpL-yMMS2-I57A, YCpL-yMMS2-S27A/I57A.
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vector control
yMMS2
untreated0.01% MMS Strain
mms2∆ rev3∆
dilution series
0.015% MMS
yMMS2-S27A
yMMS2-I57A
yMMS2-S27AI57A
Figure 4-11. The MMS2-S27A/I57A double-mutant causes an additive MMS sensitive 
phenotype. The in vivo function of yeast MMS2 mutants is reflected in the ability to alleviate an 
mms2? rev3? yeast strain from killing by MMS. Overnight cell cultures were spotted as dilutions on 
selective minimal media that contained either 0.01% or 0.015% MMS.  10-fold serial dilutions 
increased from left to right and cells with a greater ability to survive DNA damaging treatment are 
able to grow at higher dilutions.  Incubation was carried out for 48 hours at 30°C before taking the 
photograph. Test plasmids were YCpL-yMMS2, YCpL-yMMS2-S27A, YCpL-yMMS2-I57A, 
YCpL-yMMS2-S27A/I57A.
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 4.4.5  Discussion of the Mms2-Ub interface 
 The mechanistic model of Ubc13-Mms2-mediated ubiquitylation suggests that an 
acceptor Ub is non-covalently bound by Mms2 in a manner that favours the specific 
linkage of Ub molecules through Lys63.  In order to provide functional evidence to 
support the model, a number of site-directed mutations of Mms2 were generated within 
the putative Mms2-Ub interface.  Thus, mutations that disrupt the Mms2-Ub interface 
would be expected to reduce the ability of Mms2-Ubc13 to conjugate Lys63-linked Ub 
chains, leading to a measurable error-free DDT-deficient phenotype. 
 Despite the targeted design of Mms2 mutations based on NMR data and a 
putative phosphorylation consensus sequence within the suspected Mms2-Ub interface, 
phenotypic changes were not observed in initial, albeit extra-sensitive, functional 
complementation assays.  As a result, a potentially more sensitive in vitro method was 
used to evaluate the consequence of the mutations on Mms2-Ub interaction strength.  
Using SPR, a dissociation constant for the wild-type Mms2-Ub interaction was calculated 
to be approximately 200 µM.  Subsequent analysis of the relative binding strength of 
various Mms2 mutants with Ub revealed that an Mms2-S32A mutation was unique in 
causing a decrease in Mms2-Ub interaction strength.  To put the finding in perspective, a 
human Mms2-I62A mutant was generated as the equivalent of a yeast point mutation 
shown by another group to affect Mms2-mediated Ub conjugation in vitro and error-free 
DDT in vivo (Tsui et al., 2005).  In the SPR binding assay, the Mms2-I62A mutation was 
also found to impair the Mms2-Ub interaction but not to the extent of the Mms2-S32A 
mutant.  Interestingly, the generation of both mutants in the same protein (Mms2-
S32A/I62A) caused an additive decrease in affinity for Ub. 
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  In an attempt to correlate Mms2-Ub affinity with in vivo DDT function, the 
human Mms2 mutations that decreased Ub affinity were correspondingly created in yeast 
Mms2.  These yeast mutants were then cloned into single-copy plasmids employing the 
native MMS2 promoter.  Testing them in functional complementation assays, it was 
determined that both the yeast MMS2-S27A and –I57A single mutants caused a slight 
defect in DDT activity.  On the other hand, the yMMS2-S27A/I57A double mutant caused 
a very surprising synergistic defect in error-free DDT.  The finding that each of the single 
mutants is able to function somewhat in DDT provides indirect evidence that the yMms2-
S27A/I57A protein is expressed and folded properly in vivo.  It is also noted that the 
corresponding human Mms2-S32A/I62A mutant was able to efficiently bind Ubc13 in 
the SPR experiments. 
 Taken together, the Mms2 mutations yielded results that were somewhat 
surprising because a strong correlation between in vitro Ub binding and in vivo functional 
complementation was expected; however, some disparity was observed between the in 
vitro and in vivo data.  For example, the yMMS2-S27A single mutation caused a barely 
detectible phenotype in the functional assay, whereas the yMMS2-S27A/I57A double 
mutation caused a phenotype almost indistinguishable from the negative control.  When 
the corresponding hMms2 proteins were tested for their ability to bind Ub in vitro, the 
difference between these single and double mutants was not nearly as pronounced 
(Figures 4-10, 4-11 vs. 4-9). 
A possible explanation for the disparate results is apparent when considering the 
orientation of acceptor and donor Ub molecules in the Ubc13-Mms2 Ub conjugation 
model.  Most notable is the precise placement of the Mms2-bound Ub such that its Lys63 
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 is within 4 Å of the Ubc13 active-site.  The single point mutations can be envisioned to 
cause a slight repositioning of acceptor Ub on the large Mms2-Ub interface.  This slight 
adjustment may be done in such a way that the ε-amino group of Ub-Lys63 is still in 
close enough proximity to the Ubc13 active-site for efficient conjugation.  The 
hypothetical phenotype could be a reduction in Mms2-Ub binding affinity in vitro that is 
overcome by the successful conjugation of Lys63-linked Ub chains in vivo.  On the other 
hand, although the Mms2 double mutation could also retain some affinity to Ub as 
observed in the in vitro assays, the resultant placement of acceptor Ub might not permit 
Lys63-linked Ub conjugation.  The result is a DDT deficient phenotype.  It is noted that 
the hypothesis might be easily addressed through comparisons of the in vitro 
ubiquitylation activity of each of the mutant Mms2 proteins.  The inability to conjugate 
Lys63-linked Ub chains may be expected of the yMms2-S27A/I57A double mutant. 
 The structure-based studies of the Mms2-Ub interface above provided strong 
functional support for the proposed mechanism of Ubc13-Mms2 Lys63-linked Ub 
conjugation.  From another perspective, the results also allowed a more fundamental 
question concerning Mms2 and Ub to be addressed.   
In the simplest sense, Mms2 goes about its mechanistic role with Ubc13 by acting 
as a Ub-binding domain (Ubd).  Ubds are found in Ub-binding proteins (also called Ub 
receptors) and act as autonomous non-covalent Ub-binding modules that are 
indispensable components of the ubiquitylation process (Hicke et al., 2005).  For 
example, the molecular signals generated by the Ub-modification of targets would simply 
go undetected without Ubds.  Nine distinct Ubds have been characterized to date, and 
they are found within hundreds of different proteins throughout eukaryotes.  The length 
124 
 of the Ubd can range in size from about 20 to 150 amino acids, and various crystal 
structures reveal that they generate vastly different structural conformations.  Despite 
these core differences, the specific surface on Ub that they each interact with is 
completely conserved (Hicke et al., 2005).  The critical region for interaction in all cases 
to date surrounds a small hydrophobic patch on Ub that is marked by Ile44.  Another 
notable feature of Ubds is that their affinity for Ub is weak (Kd = 2-500 µM range), but 
binding may be strengthened by the occurrence of multiple Ubds in tandem, which may 
even cause the preferential binding to Ub chains over mono-Ub. 
 The calculation of the Mms2-Ub dissociation contant in these studies to be ~200 
µM helps to confirm that human Mms2 is a bona fide Ubd.  Moreover, the results of the 
Mms2 mutations provide additional insight which suggests that different Uevs may use 
different surfaces to interact with Ub.  A crystal structure of Tsg101 bound to Ub reveals 
that its Uev domain, like the other characterized Ubds, specifically interacts with the 
hydrophobic patch surrounding Ub-Ile44 (Sundquist et al., 2004).  The apparent 
interaction between yeast Mms2-Ile57 and Ub-Ile44 suggests that the Uev-Ub interaction 
is conserved in this regard (Tsui et al., 2005).  However, the identification of a second 
important residue (yMms2-Ser27) for the Mms2-Ub interaction significantly adds to the 
conventional wisdom for how the Mms2 family of Uevs interacts with Ub.  Specifically, 
the spacing of the yMms2-Ser27 and -Ile57 residues helps to map a hypothetical Mms2-
Ub interface, for which a crystal structure has yet to be reported.  As seen in Figure 4-12, 
the surfaces of the Uev domains of Mms2 and Tsg101 that are used to interact with the 
same surface on Ub are apparently distinct.  When the residues that were shown to be 
important for the Mms2-Ub interaction are correspondingly highlighted on Tsg101, it is 
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 revealed that they are localized independent of the Tsg101-Ub interface.  This reasoning 
might provide an additional explanation for the mechanistically distinct functions and 
cellular roles performed by the two predominant Uev families represented by Mms2 and 
Tsg101.  Also, it cannot be ruled out that each Uev domain contains two surfaces capable 
of binding to Ub.  A crystal structure of Mms2 bound to Ub would undoubtedly help to 
clarify these possibilities. 
 Another significant conclusion from the results in this section involves the Mms2-
Ser32 (yeast Mms2-Ser27) residue in particular.  The Mms2-Ser32 residue was found to 
be important for interacting with Ub and enabling Mms2 to function in DDT, in a manner 
that is consistent with the model of Lys63-linked Ub chain synthesis by Ubc13-Mms2.  
The decrease in Ub-binding in the Mms2-S32A mutant is a novel finding that suggests an 
important role for polar contacts in the Mms2-Ub interaction.  This result challenges the 
current understanding of Ubd-Ub interactions in general which claim that the 
predominant interactions are mediated through hydrophobic contacts in and around Ub-
Ile44 (Hicke et al., 2005).  Among all the residues mutated in these studies, including 
Mms2-Ile62 which is speculated to contact Ub-Ile44, the residue corresponding to human 
Mms2-Ser32 is the only one that is absolutely conserved in Mms2 and Uev1 sequence 
alignments (Figure 4-13 and data not shown). 
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 Figure 4-12.  The Uev domains of human Mms2 and Tsg101 use different surfaces to 
physically interact with Ub. The Uev domains of Mms2 (left panel, green) and Tsg101 (right 
panel, green) are orientated similarly and are bound to Ubc13 (blue) and Ub (violet), 
respectively.  The Mms2 residues mutated in the Mms2-Ub physical interaction studies and the 
corresponding Tsg101 residues are shown in yellow. The two residues shown in this study to 
be important for the Mms2-Ub interaction (left panel, white circles) do not visibly correspond 
to the same surface used for the Tsg101-Ub interaction (right panel).  
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 Figure 4-13. Protein sequence alignment of Mms2 proteins from various organisms.
Alignment of Mms2 protein sequences from various model organisms using the CLUSTAL 
method.  Residues identical to the HsMms2 sequence are shaded black and residues 
corresponding to the hMms2-Ub interface that were mutated in this study are indicated with 
arrows.  Hs, Homo sapiens; Sc, S. cerevisiae; Sp, Schizosaccharomyces pombe; Ce, 
Caenorhabditis elegans; Dm, Drosophila melanogaster; At, Arabidopsis thaliana; Mm, Mus
musculus.
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 4.5  Ubc13-Mms2 interface results 
The structure-function studies above have addressed three main features of Ubc13 
and Mms2.  They include the Ubc13 active-site, the Ubc13-E3 interaction, and the 
Mms2-Ub interaction.  The experimental results have helped to draw conclusions 
pertaining to each of these separate yet important features; however, the model of Lys63-
linked Ub conjugation holds that these features are brought together functionally by the 
formation of a unique Ubc13-Mms2 heterodimer.  Therefore, the most intensive and 
meaningful structure-function studies of this thesis were focused upon the Ubc13-Mms2 
interface.  The main goals were to identify important residues for the Ubc13-Mms2 
interaction, to demonstrate a correlation between Ubc13-Mms2 binding and function, and 
to determine why Mms2 forms a specific complex with Ubc13, and not other E2s. 
 
4.5.1  Structure of the Ubc13-Mms2 interface 
The overall structure of the human Ubc13-Mms2 heterodimer is shown in Figure 
4-14A.  Each molecule adopts the characteristic α/β E2 fold and exhibits a very similar 
three-dimensional structure, with the main exception that Mms2 lacks two C-terminal α-
helices as compared with Ubc13.  The highlighting feature is that Mms2 packs against 
Ubc13 to form a unique asymmetrical structure that creates a long channel which buries 
~1500 Å of solvent-accessible surface area (Moraes et al., 2001; VanDemark et al., 
2001).   
Oriented similarly as in Figure 4-14A, a closer look at the Ubc13-Mms2 
heterodimer is shown in Figure 4-14B and reveals the residues in close proximity to the 
interface.  Due to the large number of candidate residues, several factors became 
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 important in determining which amino acids to mutate.  First, initial studies on 
heterodimer formation (McKenna et al., 2001) indicated that the Ubc13-Mms2 complex 
is stable in high salt concentrations, suggesting a large contribution by hydrophobic 
contacts.  Visible inspection reveals that a significant number of these hydrophobic 
contacts likely surround a region that corresponds to a two residue insertion (Mms2-
Asn12 and -Phe13) near the amino-end of the α1 helix of Mms2.  Interestingly, this 
insertion is a distinguishing characteristic of Uev sequences when compared to canonical 
E2s.  Second, a localized change in the orientation of the human Mms2 N-terminus upon 
heterodimer formation with Ubc13 was previously identified (Moraes et al., 2001), 
implicating an importance for the Ubc13 residues in proximity to the Mms2 N-terminus.  
Last, each of the residues mutated are completely conserved or very similar in multiple 
protein sequence alignments of Ubc13 and Mms2 proteins from various model organisms 
(Figure 4-14C). 
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 Figure 4-14. Secondary and tertiary structures of Ubc13 and Mms2. (A) Overall 
structure of the human Ubc13-Mms2 heterodimer. Ubc13 (bottom, green shading) and Mms2 
(top, blue shading). The molecular structure was created using PyMOL version 0.96 by 
DeLano Scientific (http://pymol.sourceforge.net/) and the protein databank file 17JD.
A
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 Figure 4-14. Secondary and tertiary structures of Ubc13 and Mms2. (B) Close-up view of 
residues in proximity to the Ubc13 (green) -Mms2 (blue) interface.  Residues addressed by 
mutagenesis in these studies are indicated in bold and shown in stick (as opposed to line) 
representation.  The complex is oriented as in Figure 4-14A.
B
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 Figure 4-14. Secondary and tertiary structures of Ubc13 and Mms2. (C) Alignment of Mms2 
(upper panel) or Ubc13 (lower panel) protein sequences from various model organisms using the 
CLUSTAL method.  Identical residues are shaded black and residues mutated in this study are 
indicated with a dot.  Hs, Homo sapiens; Sc, S. cerevisiae; Sp, Schizosaccharomyces pombe; Ce, 
Caenorhabditis elegans; Dm, Drosophila melanogaster; At, Arabidopsis thaliana; Mm, Mus
musculus.  Only the regions which span the interface residues are shown.
C
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 4.5.2  Design of Ubc13 mutants and their interaction in the yeast two-hybrid assay 
Because all the evidence to date suggests a specific complex between Mms2 and a 
single E2 (Ubc13), the initial site-directed mutagenesis focused on residues of Ubc13.  It 
was anticipated that this approach would narrow down the search for key residues 
because various E2s, despite often being involved in very different cellular roles, always 
have very conserved core domain sequences.  Therefore, those Ubc13 residues that 
visibly interact with Mms2 in the crystal structure and are not conserved with other E2s 
were seen as good candidates for mutagenesis. 
Before selecting mutants to test in vivo, two readily-available Ala substitutions 
(Ubc13-Y34A and -L83A) were tested for their binding to Mms2 in vitro using GST pull-
down assays.  These residues had been previously suggested (Moraes et al., 2001) to 
contribute hydrophobic contacts at two separate regions of the interface (Figure 4-14B).  
However, neither mutation had a significant effect on binding to Mms2 as determined by 
the GST pull-down assay (data not shown) and isothermal titration calorimetry 
experiments (T. Moraes, personal communication), suggesting that residues presumed to 
contribute hydrophobic contacts would have to be changed more drastically.  With this in 
mind, the Ubc13-Phe57 residue of the putative hydrophobic core was targeted through 
the design of a non-conservative substitution to Glu, which would introduce a charged 
polar group into the region. 
In another attempt to address this same central region of the interface, the role of 
the Ubc13-Glu55 residue was probed.  Crystal structure data implicates a dual role 
whereby the beta and gamma-carbons of Glu55 can provide hydrophobic contacts for 
Mms2-Phe13, while the carboxyl group is used to H-bond with Mms2-Asn12 (Moraes et 
134 
 al., 2001; VanDemark et al., 2001; Figure 4-14B).  The only Ubc13 mutant studied to 
date was the corresponding Glu55 in yeast Ubc13 (VanDemark et al., 2001), for which 
Ala was substituted, resulting only in a small titration-dependent effect on binding and 
function (Ulrich, 2003).  Therefore, a conservative E55Q mutant was created that was 
expected to disrupt the H-bonding with Mms2-Asn12, while maintaining approximate 
size and the putative hydrophobic contacts with Mms2-Phe13. 
The last of the initial Ubc13 mutagenesis focused on Ubc13-Glu60, which is 
situated near the N-terminus of Mms2.  While it is not resolved in the human structure, 
the yeast Ubc13-Mms2 heterodimer shows an H-bond formed between Ubc13-Glu60 and 
Mms2-Ser2.  It was predicted that a conservative Ubc13-E60Q mutation would disrupt 
the bond and address the importance of the Mms2 N-terminus in binding to Ubc13.   
In order to determine the effect of these interface mutations on complex formation 
in the cell, the yeast two-hybrid assay was employed as a qualitative measurement of 
physical interaction strength.  Figure 4-15 shows the effects of these Ubc13 mutations.  
The Ubc13-E60Q mutation did not affect the Ubc13 interaction with Mms2; however, the 
Ubc13-E55Q and Ubc13-F57E mutations resulted in the complete disruption of 
heterodimer formation as visualized in the assay.  The severe consequences of the Ubc13-
Glu55 and -Phe57 mutants prompted the investigation of another residue in this area, 
Ubc13-Arg70. 
The Arg70 residue is absolutely conserved among Ubc13 sequences (Figure 4-
14C).  While it has been suggested that Arg70 can provide hydrophobic contacts in the 
yeast heterodimer structure (VanDemark et al., 2001), another predominant contribution 
to the interface is noted as an H-bond with the carbonyl carbon of Mms2-Met41 (Figure 
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 4-14B).  To address this bond a Ubc13-R70A mutant was generated and its binding to 
Mms2 was tested in the yeast two-hybrid assay.  As seen in Figure 4-15, Ubc13-R70A 
caused an impairment of the Ubc13-Mms2 interaction. 
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 Figure 4-15 In vivo interaction of mutated Ubc13 and Mms2 with wild-type partners 
by a yeast two hybrid assay.  Yeast cells transformed with Gal4AD and Gal4BD fusion 
constructs were used to test the strength of the Ubc13-Mms2 interaction.  Association of 
the Gal4 fusion proteins turns on the GAL1 promoter which transcribes the HIS3 reporter 
gene.  Positive interactions are observed by growth on media without His plus 1 mM 3-AT, 
after 48 hours at 30°C.  Plasmids were maintained in the cell by growth on media without 
Trp and Leu.  At least four colonies from each combination were tested and two 
representative colonies are shown.  It is noted that the left-most colony of the duplicate for 
the Mms2-Ubc13-R70A pairing did not grow well and is not reflective of the other 
replicates for this combination. Test plasmids were pGAD-hMMS2 (and mutant 
derivatives) and pGBT-hUBC13 (and mutant derivatives).
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 4.5.3  Design of Mms2 Mutants and their interaction in the yeast two-hybrid assay 
The finding that all of the substitutions of Ubc13 residues which affect binding lie 
in close proximity prompted the narrowing of the search for key interface residues in 
Mms2.  The Mms2 residues that seemed to most closely correspond to these Ubc13 
residues were Mms2-Asn12 and -Phe13, which correspond to a two amino acid insertion 
unique to Uevs when aligned against E2s (VanDemark et al., 2001). 
Visualization of the Ubc13-Mms2 heterodimer shows an apparent insertion of the 
Mms2-Phe13 residue into a hydrophobic region, created mainly by the Ubc13 residues 
mutated above.  As with Ubc13-F57E, it was decided to exploit this area with an 
aggressive Mms2-F13E substitution to introduce a charged polar group that would likely 
impinge upon the apparent hydrophobic contacts. 
Unlike Phe13, Mms2-Asn12 does not contribute to the hydrophobic core but 
forms H-bonds with the Ubc13 residues Glu55 and Tyr34. However, because only the 
Ubc13-E55Q mutation showed an effect on binding, a possible pairwise interaction 
between with Mms2-Asn12 was tested. Two Asn12 mutations were thus created; one as a 
conservative N12D substitution and a second mutation, N12A, in order to abolish any H-
bonding possibilities with Ubc13-E55Q.  
When testing these Mms2 mutants in the yeast two-hybrid assay, it was found that 
neither Mms2-N12A nor -N12D had a detectable effect on inhibiting complex formation 
as compared to wild-type Mms2 (Figure 4-15).  In contrast, the Mms2-F13E mutation 
seemed to completely disrupt the Ubc13-Mms2 interaction. 
Because the mutagenesis of Ubc13 yielded mutants that resulted in severe 
(Ubc13-E55Q and Ubc13-F57E) and slight (Ubc13-R70A) disruption of the Ubc13-
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 Mms2 physical interaction, it was desired to have a complement of Mms2 mutants with 
similar effects. Because the aggressive introduction of a charged group at Mms2-Phe13 
(F13E) caused a severe effect on interaction, it was hypothesized that a more conservative 
F13Y mutation that simply introduces a small polar hydroxyl group might cause a 
moderate effect. Indeed, the Mms2-F13Y mutant did not interact with Ubc13 as strongly 
as wild-type Mms2, nor did it completely abolish the yeast two-hybrid interaction either 
(Figure 4-15). 
Taken together, the yeast two-hybrid data showed that two mutations (Mms2-
F13Y and Ubc13-R70A) cause weakened interactions between Ubc13 and Mms2, and 
three mutations (Mms2-F13E, Ubc13-E55Q, and Ubc13-F57E) cause the complete 
disruption of the Ubc13-Mms2 interface, as detected in these assays.  
 
4.5.4  The in vivo function of MMS2 and UBC13 interface mutants correlates with 
their in vivo interaction 
Throughout this thesis, the human MMS2 and UBC13 genes were shown to 
functionally complement their yeast counterparts in error-free DDT.  In chapter 3, it was 
experimentally suggested that a Ubc13-Uev physical interaction is necessary for in vivo 
function.  The creation of Ubc13-Mms2 interface mutations that disrupt heterodimer 
formation to different degrees allowed this idea to be tested.  As seen in Figure 4-16, the 
Asn12 mutants of MMS2 that did not reduce the Mms2-Ubc13 interaction in the yeast 
two-hybrid assay appeared to be fully functional in yeast DDT.  On the other hand, the 
mutations at Mms2-Phe13 which address the core hydrophobic region, caused a slight 
(F13Y) and drastic (F13E) decrease in the protection of cells against DNA damaging 
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 treatment by MMS (Figure 4-16).  The partial phenotypes for MMS2-F13Y and -F13E 
were reminiscent of their effects on binding to Ubc13 in yeast two-hybrid assay. 
As in the yeast two-hybrid assay, the UBC13-E60Q mutant behaved no differently 
than the wild-type control in the functional complementation test (Figure 4-16).  
However, each of the Ubc13 mutants in proximity to Mms2-Phe13 led to a decrease in 
DDT activity.  Most strikingly, UBC13-E55Q and UBC13-F57E provided no detectable 
protection against MMS treatment when compared with the negative control.  This 
correlated perfectly with the complete loss of a detectable yeast two-hybrid interaction 
between Mms2 and each of the Ubc13-E55Q and -F57E mutations.  The Ubc13 mutation 
that was designed to destroy H-bonding with the Mms2 backbone, UBC13-R70A, led to 
an incomplete loss in the ability to complement the ubc13∆ deletion.  This was in 
agreement with the yeast two-hybrid assay results, which showed that the Ubc13-R70A 
mutation caused a moderate reduction in binding to Mms2.  
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wild-type
mms2∆
0.025% MMSDNA
none
vector control
MMS2
MMS2-N12A
MMS2-N12D
MMS2-F13Y
MMS2-F13E
Strain
wild-type
ubc13∆
0.025% MMSDNA
none
vector control
UBC13
UBC13-E55Q
UBC13-F57E
UBC13-R70A
UBC13-E60Q
Figure 4-16. Functional complementation of yeast ubc13 and mms2 mutants by 
corresponding human genes and their derivatives .  The function of human Ubc13 or 
Mms2 is reflected in the ability to protect their corresponding yeast deletion mutants 
from killing by MMS.  Cells were printed on YPD plates containing 0.025% MMS and 
cells with a greater ability to  survive DNA damaging treatment grew further along the 
gradient.  Incubation was carried out for 48 hours at 30°C.  All cells grew equally well 
on YPD plates without MMS (data not shown). Test plasmids were pGAD-hMMS2 (and 
mutant derivatives) and pGBT-hUBC13 (and mutant derivatives).
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 4.5.5  Binding ability of interface mutants by in vitro pull-down 
The yeast two-hybrid assay provides a good qualitative indication of binding 
strength but several assay factors already discussed in this thesis can hinder final 
conclusions.  Therefore, to address and confirm the in vivo interaction data, it was 
desirable to quantitatively evaluate the effects of Ubc13 and Mms2 mutations on binding 
in vitro.  Wild-type and mutant proteins were thus expressed and purified as GST fusions 
from bacteria.  When needed, the fusion protein was cleaved and the native, non-fused 
Ubc13 or Mms2 protein was isolated.  The recombinant bacterial expression approach is 
advantageous because prokaryotes do not have ubiquitylation enzymes that can provide 
background interference.  The lack of post-translational modifications during bacterial 
expression was not a concern because in vitro binding and ubiquitylation experiments 
using recombinant protein from bacterial sources have been successful (Hofmann and 
Pickart, 1999; McKenna et al., 2001). 
In addition to the wild-type proteins, two groups of mutants from each of Ubc13 
and Mms2 were purified.  These include those which resulted in reduced binding and 
functional complementation (Mms2-F13Y and Ubc13-R70A) and those that seemed to 
completely abolish the binding and function (Mms2-F13E and Ubc13-F57E).  Despite 
rigorous attempts, GST-Ubc13-E55Q could not be retrieved in soluble form from 
bacteria.  To show that the lack of in vivo binding and function in this mutant was not due 
to insolubility in yeast cells, the ability of Ubc13-E55Q and the other Ubc13 mutants to 
interact with mouse TRAF6 was tested in the yeast two-hybrid assay.  The physical 
interaction between wild-type Ubc13 and TRAF6 was previously shown in Figure 4-7.  
As discussed above and in Woof et al., 2004, the Ubc13-TRAF6 interface is likely 
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 independent of the Ubc13-Uev interface.  Therefore, the Ubc13-E55Q mutation was not 
expected to affect the ability of Ubc13 to bind to TRAF6.  Indeed, all of the Ubc13 
mutants were able to interact with TRAF6 with a binding strength comparable to wild-
type Ubc13 (data not shown). 
As a first approach toward verifying the in vivo interaction data, the purified 
proteins were used in in vitro GST pull-downs.  Wild-type or mutant GST-Ubc13 or 
GST-Mms2 was immobilized and subsequently incubated with non-fused Mms2 or 
Ubc13, respectively.  In order to enhance the sensitivity of the assay, co-purified proteins 
were visualized by Western Blot.  Whereas Ubc13-F57E was unable to interact with 
Mms2, Ubc13-R70A retains an ability to bind Mms2 (Figure 4-17).  Similarly, Mms2-
F13E apparently does not bind Ubc13 in the assay, whereas Mms2-F13Y was able to co-
purify with Ubc13 (Figure 4-17).  The results are in agreement with the in vivo 
interaction data above (Figure 4-15). 
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Figure 4-17. Binding of Ubc13 and Mms2 mutants in vitro. GST pull-downs were 
used to co-purify proteins that form stable interactions. (A) Purified wild-type (wt) or 
mutant GST-Ubc13 protein was immobilized as indicated.  Non-fused Mms2 was 
then added and after washing, the eluted GST-Ubc13 was visualized by Coomassie
Blue staining, and Mms2 was detected by Western blot with antibodies against 
Mms2.  (B) as in (A) but with GST-Mms2 and cleaved Ubc13, and antibodies against 
Ubc13 were used for Western blot.  The right-most lane in each figure contains 
purified proteins as control. Lines indicate that data taken from different parts of the 
same gel or blot.
A
144 
 4.5.6  Binding ability of interface mutants by surface plasmon resonance 
Because in vitro pull-downs lack the quantitative capabilities for measuring 
binding strength, SPR was employed to more clearly show the effects of interface 
mutations on heterodimer formation.  Immobilized anti-GST monoclonal antibodies were 
used to capture the GST fusion protein (ligand), and the non-fused soluble binding 
partner (analyte) was subsequently applied to generate the real-time binding curves. 
Because binding constants for the human Ubc13-Mms2 pair have been previously 
estimated using sedimentation (Moraes et al., 2001) and isothermal titration calorimetry 
(McKenna et al., 2003b) analyses, I first sought to validate the SPR approach by 
determining the Kd for the wild-type Ubc13-Mms2 heterodimer.  Using GST-Ubc13 
fusions as the ligand, a series of curves over varied concentrations of native Mms2 as the 
analyte was generated (for example see Figure 2-2).  These curves were used in 
BiaEvaluations curve-fitting software to determine the dissociation contant (Kd) for the 
interaction.  The same data were also used to make double-reciprocal plots and 
dissociation constants were manually calculated (see Materials and Methods).  The 
manually calculated Kd for GST-Ubc13 and Mms2 was found to be 1.07 X 10-7 M, which 
is in good agreement with the software-determined value of 1.87 X 10-7 M.  To account 
for the possible effect that the N-terminal GST fusion might have on binding strength, a 
reciprocal approach using GST-Mms2 as the ligand and Ubc13 as the analyte was 
performed.  As before, the dissociation constants were very similar between the manually 
determined and computer-generated methods which were 5.14 X 10-8 M and 6.22 X 10-8 
M, respectively.  Taken together, the dissociation constant for the human Ubc13-Mms2 
heterodimer in these experiments was found to be nearly down to 5 X 10-8 M, which is 
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 equal to the lowest value determined for Ubc13-Mms2 by isothermal titration calorimetry 
(McKenna et al., 2003a). 
Perhaps not surprisingly, the calculation of meaningful binding constants for the 
Ubc13 and Mms2 mutant proteins was not possible.  In all cases the binding was too 
weak to generate reliable data at the concentrations required for testing.  Therefore, each 
of the mutations was tested against wild-type for a means of comparison.  While using a 
constant concentration of analyte the peak response during binding at equilibrium (RUeq) 
was recorded (Table 1).  It is notable that in order to better visualize the relative binding 
of mutant proteins, the concentration of analyte that was required was well above that 
which gave a maximum response for the wild-type protein.  The relative binding curves 
for the mutant proteins is shown in Figure 4-18.  From Figure 4-18A and Table 4-1, it is 
seen that the Ubc13-F57E mutation results in barely detectable binding (RUeq = 6) in the 
assay.  On the other hand, the maximum response of the Ubc13-R70A mutation was 
almost 5-fold higher (RUeq = 27). 
It became apparent throughout these studies that the Mms2-Phe13 residue is a 
critical component to the interface.  In order to better resolve the importance of Phe13, a 
third mutation at this position was made, Mms2-F13A.  The F13A mutation corresponds 
to a yeast Mms2-F8A substitution that was created by another group (VanDemark et al., 
2001), who suggested that it eliminates interaction and function with yeast Ubc13.  
Figure 4-18B shows that each of the mutations at Mms2-Phe13 results in considerably 
lower binding strength.  Most strikingly, the introduction of a charged group into the core 
of the interface via Mms2-F13E had the greatest effect on binding (Table 4-1; Figure 4-
18B).  The Mms2-F13E mutation resulted in peak binding that was barely detectable 
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 (RUeq = 1) whereas the interaction utilizing the F13A mutation was appreciably less 
affected (RUeq = 15).  The conservative introduction of small polar hydroxyl group by the 
Mms2-F13Y mutation caused a lesser disruption of the Ubc13 interaction and binds 
approximately two-fold stronger than F13A at equilibrium.  Taken together, the SPR 
results for both the Mms2 and Ubc13 mutants are consistent with the initial observations 
for in vivo binding in the yeast two-hybrid assay. 
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 Figure 4-18. Relative in vitro binding of Ubc13 and Mms2 mutants measured by 
surface plasmon resonance. (A) Relative binding of Ubc13 mutants to GST-Mms2.  a, 
wild-type Ubc13; b, R70A; c, F57E. (B) Relative binding of Mms2 mutants to GST-
Ubc13.  a, wild-type Mms2; b, F13Y; c, F13A; and d, F13E.  Each experiment contains 1 
µM purified Ubc13 or Mms2 as the analyte.  Note that the maximum response for the 
wild-type protein interactions was also achieved when using 0.5 µM protein.
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 Table 4-1. SPR binding data of Ubc13-Mms2 and their mutants. 
Ligand Analyte Kd (M)* RUmax Response (RUeq) 
at 1 µM analyte 
Ubc13 
Ubc13 
Ubc13 
Ubc13 
Mms2 
Mms2 
Mms2 
Mms2 
Mms2-F13A 
Mms2-F13E 
Mms2-F13Y 
Ubc13 
Ubc13-F57E 
Ubc13-R70A 
1.87 X 10-7 (1.07 X 10-7) 
- 
- 
- 
6.22 X 10-8 (5.14 X 10-8) 
- 
- 
262 
- 
- 
- 
160 
- 
- 
            262 
              15 
                1 
              28 
            160 
                6 
              27 
* Calculated from BiaEvaluations curve-fitting software.  Brackets indicate manually 
calculated values. 
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 4.5.7  Catalytic activity of interface mutants in ubiquitylation assays 
Because Lys63-linked Ub chains synthesized by Ubc13-Mms2 are required for 
DNA repair function, the in vivo functional complementation tests in Figure 4-16 are a 
good indicator of Ub chain catalysis.  However, it was wished to provide a more direct 
test of Ub chain formation by the mutant proteins.  Therefore, the in vitro catalytic 
function of purified Ubc13 and Mms2 proteins was monitored in a di-Ub-formation 
assay.  Using the purified proteins from this study, the experiment was performed by 
Trevor Moraes at the University of Alberta.  Figure 4-19 shows that wild-type Ubc13 and 
Mms2 form a strong band representative of di-Ub.  In contrast, each of the mutations had 
a severe effect on di-Ub formation.  In fact, neither Mms2-F13A, -F13E, -F13Y nor 
Ubc13-F57E synthesized detectable Ub conjugates when paired with their wild-type 
partner.  Only Ubc13-R70A led to observable di-Ub formation, which was much less 
than that observed for wild-type Ubc13.  Taken together, the assay data help to show a 
correlation between a deficiency in in vitro Ub conjugation (Figure 4-19) and functional 
impairment in vivo (Figure 4-16).  As previously reported (McKenna et al., 2001), human 
Ubc13 has self-Ub conjugation activity in vitro and it is noted that the interface mutations 
are not compromised in this regard. 
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 Figure 4-19. Catalytic activity of Ubc13 and Mms2 mutants in vitro. Ubiquitylation 
assays were performed by Trevor Moraes (University of Alberta) to monitor di-Ub
formation by the Ubc13-Mms2 complex. The autoradiogram shows radiolabeled Ub
alone or conjugated to Ub2. The autocatalytic activity of Ubc13 is indicated and 
asterisks reveal artifacts of the 35S-labeled Ub (McKenna et al., 2001). Ubc13 + Mms2 
(Lane 1); Ubc13 + Mms2-F13A (Lane2); Ubc13 + Mms2-F13E (Lane 3); Ubc13 + 
Mms2-F13Y (Lane 4); Ubc13-R70A + Mms2 (Lane 5); Ubc13-F57E + Mms2 (Lane 
6).   The Ub2 bands that appeared in Lanes 2, 3 and  6 are attributed to a background 
signal, since it was also seen in the absence of Mms2 (McKenna et al., 2001).
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 4.5.8  Interactions between Ubc13-Arg70 and Mms2-Phe13 
As discussed earlier, it was originally suggested that the Ubc13-Arg70 residue has 
a dual purpose in mediating interactions at the interface.  One is to share hydrophobic 
contacts with Mms2-Phe13 (Phe8 in yeast), while the other is to form polar contacts with 
the Mms2 backbone via its guanidinium group.  To determine the validity of these 
proposals, the combinatorial effect of the Ubc13-R70A mutation with Mms2-F13Y was 
tested.  Based on the crystal structures, it seemed that the Ubc13-R70A mutation would 
not hinder the hydrophobic contacts made with Mms2-Phe13; however, the H-bonds 
would be abolished.  If the two mutations impinge on two different separate sites of the 
interface, it was felt that the combination of the two mutants would cause an additive 
effect on reducing Ubc13-Mms2 binding strength (and function).  In support of this 
hypothesis, the pairing of the Ubc13-R70A and Mms2-F13Y mutations in the yeast two-
hybrid assay did not result in a detectable interaction (Figure 4-20A).  The additive effect 
was also observed in a functional complementation experiment.   An mms2 ubc13 
double-deletion strain co-transformed with UBC13-R70A and MMS2-F13Y was severely 
sensitive to MMS treatment as compared with cells carrying only the single UBC13-
R70A or MMS2-F13Y mutations (Figure 4-20B). 
These results suggested that Ubc13-Arg70 was responsible for a second important 
interface contact point that is independent of the hydrophobic pocket.  In order to better 
address this possibility, a Ubc13-R70L mutant was created that would also abrogate H-
bonding.  However, based on its size and shape, the R70L substitution would be a better 
candidate for retaining hydrophobic contacts with Mms2-Phe13 as compared to R70A.  
As is seen in Figure 4-20C, the combination of the Ubc13-R70A and Mms2-F13Y 
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 mutations once again completely abolished the Ubc13-Mms2 interaction.  In contrast, the 
Ubc13-R70L mutation did not demonstrate the same decrease in binding when coupled 
with Mms2-F13Y.  In fact, the Ubc13-R70L mutation may have partially alleviated the 
effect of Mms2-F13Y.  It is also noted that the Ubc13-R70L mutation was not sensitive 
to MMS treatment like Ubc13-R70A in functional complementation experiments (data 
not shown).  Taken together, these results underscore the importance of Ubc13-Arg70 in 
helping to create a deep Ubc13 hydrophobic pocket for Mms2-Phe13. 
153 
 Figure 4-20. Physical and functional relationships between Ubc13-Arg70 and Mms2-Phe13.  
The Mms2-F13Y and Ubc13-R70A or Ubc13-R70L mutations were co-transformed into yeast 
cells and the double mutant was compared to wild type and single mutants.  (A),(C) Yeast two-
hybrid assay to assess the strength of interaction between Ubc13-R70A and Mms2-F13Y, and 
Ubc13-R70L and Mms2-F13Y, respectively. Association of the Gal4 fusion proteins turns on the 
GAL1 promoter which transcribes the HIS3 reporter gene.  Positive interactions are observed by 
growth on media without His plus 1 mM 3-AT after incubation at 30°C for 60 hours in (A) and 
for 48 hours in (C). Plasmids were maintained in the cell by growth on media without Trp and 
Leu. At least four colonies from each combination were tested and two representative colonies 
are shown. (B) Gradient plate assay to evaluate the heterologous complementation of yeast mms2 
ubc13 double deletion strains. Cells were printed on YPD plates containing 0.025% MMS and 
cells with a greater ability to survive DNA damaging treatment grew further along the gradient.  
Incubation was carried out for 60 hours at 30°C.  All cells grew equally well on YPD plates 
without MMS (data not shown). Test plasmids were pGBT-hUBC13 (and mutant derivatives) 
and pGAD-hMMS2 (and mutant derivatives).
Strain
wild-type
mms2∆ ubc13∆
0.025% MMSDNA
none
vector control
MMS2 + UBC13
MMS2-F13Y + UBC13
MMS2 + UBC13-R70A
MMS2-F13Y + UBC13-R70A
A
B
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 Figure 4-20. Physical and functional relationships between Ubc13-Arg70 and 
Mms2-Phe13.  The Mms2-F13Y and Ubc13-R70A or Ubc13-R70L mutations were co-
transformed into yeast cells and the double mutant was compared to wild type and single 
mutants. (A),(C) Yeast two-hybrid assay to assess the strength of interaction between 
Ubc13-R70A and Mms2-F13Y, and Ubc13-R70L and Mms2-F13Y, respectively. 
Association of the Gal4 fusion proteins turns on the GAL1 promoter which transcribes 
the HIS3 reporter gene.  Positive interactions are observed by growth on media without 
His plus 1 mM 3-AT after incubation at 30°C for 60 hours in (A) and for 48 hours in 
(C). Test plasmids were pGBT-hUBC13 (and mutant derivatives) and pGAD-hMMS2 
(and mutant derivatives).
C
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 4.5.9    Discussion of the Ubc13-Mms2 interface 
The Ubc13-Mms2/Uev1 complex is the only E2 to be clearly shown to create 
atypical poly-Ub chains linked through Lys63 in vivo.  The uniqueness of Ubc13 and 
Mms2 in Ub chain synthesis led to numerous detailed biochemical studies (McKenna et 
al., 2003a; McKenna et al., 2003b; McKenna et al., 2001) and the proposal of a model for 
the generation of Lys63-linked Ub chains.  Although the mechanistic model has been 
widely accepted, it is contingent on a specific Ubc13-Mms2/Uev1 complex that had not 
been sufficiently experimentally addressed.  The studies above were the first to 
systematically mutate Ubc13 and Mms2 in order to specifically address the specifics of 
Ubc13-Mms2 heterodimer formation and function.  In this detailed analysis, several in 
vivo and in vitro methods were employed, including the yeast two-hybrid assay, GST 
pull-downs, and SPR in order to assess Ubc13-Mms2 binding strength.  In addition, an in 
vitro ubiquitylation assay and a heterologous complementation approach were utilized to 
correlate binding ability with biochemical and biological activities.  Overall, an excellent 
correlation between these experimental results was achieved. 
The Ubc13-Mms2 interface is long and narrow, and buries a large solvent-
accessible surface area of ~1500 Å.  The studies above began with the systematic 
mutagenesis of a number of residues along the Loop 1, α1 helix, and the N-terminus of 
Mms2, all of which contain portions which visibly contact Ubc13 in the human (Figure 
4-17, 4-18; Moraes et al., 2001) and yeast (VanDemark et al., 2001) crystal structures.  
The findings led to the identification of a rather unexpected pocket of interactions close 
to the α1 helix of Mms2 that appear to be critical for both complex formation and 
specificity.  The pocket consists of Ubc13-Phe57, -Glu55, and -Arg70, which all reside in 
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 close proximity to the N-terminal end of the Mms2 α1 helix that is now believed to be 
the core of the Ubc13-Mms2 interface.  Accordingly, the Ubc13-F57E and -E55Q 
mutations had extreme effects on disrupting the Ubc13-Mms2 interaction.  Because it 
putatively contributes hydrophobic contacts to the α1 helix of Mms2 (via Mms2-Phe13) 
and an H-bond with the Loop 1 backbone (via Mms2-Met41), Ubc13-Arg70 was 
originally believed to be a bridge between two separate Mms2 contact points.  Through 
the testing of two Ubc13-Arg70 mutations (R70A and R70L), it was resolved that Ubc13-
Arg70 makes its most significant contribution as a component of the hydrophobic pocket 
for Mms2-Phe13.   
Focusing on the Mms2 complement of the core interface region, the Mms2-N12D 
and -N12A mutations were designed to disrupt H-bonding with Ubc13-Glu55.  However, 
unlike Ubc13-E55Q, the Mms2-Asn12 mutations did not disrupt in vivo binding and 
function; arguing against a pair-wise relationship between Mms2-Asn12 and Ubc13-
Glu55.  On the other hand, the mutation of Mms2-Phe13 had profound effects on binding 
and function.  Based on the Ubc13-Mms2 crystal structures, Mms2-Phe13 is seen to 
insert itself deep within a hydrophobic pocket formed by the Ubc13 backbone and several 
side-chain carbons (such as Ubc13-Glu55, -Phe57, -Arg70) in a manner that is similar to 
a key in a keyhole.  To fully explore the significance of this critical interaction, three 
mutations at the Mms2-Phe13 residue were created in order to exploit the possibility that 
the hydrophobic pocket is critical to the Ubc13-Mms2 heterodimer interface.  With 
Mms2-F13E, the aggressive introduction of a charged polar group in the region caused a 
complete loss in detectable binding in each of the in vivo and in vitro assays.  
Underscoring the importance of the deep hydrophobic contacts required for the Mms2 
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 insertion of Phe13 into the Ubc13 pocket, the introduction of a small hydroxyl group 
(Mms2-F13Y) was sufficient to severely disrupt the Ubc13-Mms2 interface.  In 
accordance, Ubc13-Mms2 heterodimer formation is impaired by an Mms2-F13A 
mutation that maintains hydrophobicity but cannot breach the Ubc13 surface in order to 
create the necessary hydrophobic contacts.  These dramatic findings demonstrate that the 
key-like insertion of Phe13 into a Ubc13 hydrophobic pocket is a crucial determinant for 
the strong interaction strength of the Ubc13-Mms2 heterodimer (Figure 4-21).   
 Taken together, these studies have revealed several important Ubc13 interface 
residues; however, Mms2-Phe13 appears to be the only interface residue identified with a 
significant role in binding to Ubc13.   A model based on visual inspection of the crystal 
structures and data found in this section suggests that Mms2-Phe13 is inserted between 
Ubc13-Glu55, -Phe57, and is flanked closely by -Arg70, which together form a critical 
hydrophobic interface pocket.  This model is in agreement with the observations that the 
Ubc13-Mms2 heterodimer is stable in salt concentrations as high as 2.5 M (data not 
shown).  It is thus possible that polar contacts, such as those observed in the crystal 
structures via the Ubc13-Arg70 and Ubc13-Glu55 residues do not significantly contribute 
to binding strength, and might instead play more subtle roles such as aiding Mms2-Ubc13 
recognition. 
Owing to their functional interchangeability, the human (Moraes et al., 2001) and 
yeast (VanDemark et al., 2001) crystal structures of the Ubc13-Mms2 heterodimers are 
very similar (Ashley et al., 2002; Xiao et al., 1998).  In particular, the corresponding 
interface residues that were mutated in the human proteins are conserved and oriented 
identically in yeast.  A slight exception is that the human Ubc13-Phe57 corresponds to 
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 yeast Ubc13-Tyr57; however, the hydroxyl group of Tyr57 is pointed away from the 
critical hydrophobic pocket.  Furthermore, a Ubc13-F57Y mutation behaved identically 
to wild-type Ubc13 in yeast-two hybrid and functional complementation assays (data not 
shown).  The above information allows the use of sequence alignments to determine the 
residues in other yeast Ubc structures that correspond to human Ubc13-Glu55, -Phe57, 
and -Arg70 (Figure 4-22A).  The positions of these corresponding residues for each of 
Ubc2/Rad6 (Worthylake et al., 1998), Ubc4 (Cook et al., 1993), and Ubc7 (Cook et al., 
1997) are physically oriented such that the necessary hydrophobic pocket for Mms2-
Phe13 is not permitted (Figure 4-22C, D, E).  While it appears that Ubc1 could possibly 
allow an Mms2-Phe13 insertion from a spatial standpoint, the stoutness of its Asp and 
Gln residues corresponding to the Ubc13-Glu55 and -Arg70 positions, respectively, 
would not likely allow sufficient hydrophobic contacts from their side-chains.  More 
significantly, Ubc1 contains a Glu residue that would correspond to the Ubc13-F57E 
substitution which caused a complete disruption in Ubc13-Mms2 binding and function.  
It would be of great interest in future studies to see whether these critical Ubc13 residues 
are not only required but also sufficient to interact with Mms2. 
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Figure 4-21. The Mms2-Phe insertion into a Ubc13 hydrophobic pocket is important for 
Ubc13-Mms2 affinity. Shown is a portion of the human Ubc13 (green)-Mms2 (blue) interface 
as resolved in the crystal structure (Moraes et al., 2001). In the top-most panel, Mms2 is seen to 
insert a Phe (hMms2-Phe13) residue into a Ubc13 pocket and the consequences of the mutations 
created in this study at Mms2-Phe13 are depicted. The hypothetical orientation of each Phe13 
mutation was computationally calculated using PyMOL version 0.96 by DeLano Scientific 
(http://pymol.sourceforge.net/) and the relative effect on binding to Ubc13 as determined in these 
studies is indicated by the arrow. This analysis is consistent with a model suggesting that the 
key-like insertion of Mms2-Phe into a Ubc13 pocket is mediated by hydrophobic interactions.
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 Figure 4-22. A hydrophobic pocket is conserved in Ubc13 but not other Ubcs.  (A) Amino 
acid sequence alignment of human Ubc13 with the yeast E2s Ubc13, Ubc1, Ubc2/Rad6, Ubc4, 
and Ubc7. A red dot indicates the residues indicated in (B)-(F). (B)-(F) Crystal structure 
comparison of various Ubcs highlighting residues corresponding to hUbc13-Glu55, -Phe57 and -
Arg70.  (B) Interface of the yeast Ubc13-Mms2 crystal structure. (C)-(F) Other yeast Ubcs are 
presented in the same orientation as Ubc13 in (B). Visible residues are shown with Van der Waals
forces and correspond to those found in this study to reside at critical positions in the human 
Ubc13-Mms2 complex.  Images were generated using RasTop 2.0.3 by Philippe Valadon
(http://www.geneinfinity.org/rastop/).
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CHAPTER FIVE 
A PHYSICAL RELATIONSHIP BETWEEN MMS2 AND RSP5 
 
5.1  Rationale 
 As brought forth in the introduction, two of the most critical questions concerning 
Ubc13-Mms2 are the mechanism of Lys63-linked Ub conjugation and in what cellular 
roles these Lys63-Ub chains function.  The largest body of work in this thesis was 
dedicated to the former, and the studies helped to identify several important structure-
function relationships for Ubc13-Mms2.  Regarding the latter, considerable effort was 
also spent to determine a novel involvement of Ubc13-Mms2 with other proteins.  It was 
presumed that the identification of proteins interacting with Ubc13, Mms2, or both, 
would potentially reveal unidentified E3s or Lys63-linked polyubiquitylation targets.  
While the identification of DDT proteins was expected, the incidence of Lys63-
conjugated Ub chains in other cellular roles suggested that novel physical affiliations 
between Ubc13-Mms2 and other proteins would also be encountered. 
 In order to screen for proteins that interact with human Ubc13 or Mms2, large 
amounts of GST-fused and native protein were purified.  The GST fusion protein was 
used in GST pull-down assays in order to co-purify interacting proteins from human cell 
culture extracts.  Using the native purified protein, I successfully generated specific 
polyclonal antibodies against human Ubc13 and Mms2.  The antibody was then used in 
co-immunoprecipitation experiments that were done in parallel with the GST pull-downs.  
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 Several possible co-purifying proteins were visible in silver-stained protein gels after 
much optimization and refinement.  The protein bands in question were sent for analysis 
by mass spectroscopy but for various reasons, the unknowns were never identified with 
confidence.  In case of some possible future importance I will report here that one of the 
putative interacting proteins has the National Center for Biotechnology Information 
accession number, AAC19150.  AAC19150 is an uncharacterized human protein that is 
seen to contain a phosphotyrosine-binding domain when using the conserved domain 
architecture research tool (Geer et al., 2002).  Around this same time, a large-scale screen 
to identify protein complexes in S. cerevisiae was published (Gavin et al., 2002).  Among 
hundreds of other protein complexes, a novel physical interaction between Mms2 and 
Rsp5 was identified.   
 RSP5 is a multi-functional, essential gene in S. cerevisiae that encodes a protein 
shown to take part in very diverse cellular processes such as chromatin remodeling 
(Harkness et al., 2002), mitochondrial inheritance (Fisk and Yaffe, 1999), cytoskeleton 
dynamics (Kaminska et al., 2002), regulation of RNA transport (Gwizdek et al., 2005; 
Neumann et al., 2003), and membrane permease endocytosis (Horak, 2003; Rotin et al., 
2000).  The inviability of rsp5 mutants is attributed to the transcriptional activation of the 
OLE1 gene required for fatty-acid metabolism (Hoppe et al., 2000). 
 Adding merit to a physical relationship between Rsp5 and Mms2 is that Rsp5 is a 
bona fide E3 enzyme.  Rsp5 contains an approximately 350 amino acid HECT domain 
that is situated at its C-terminus and is both necessary and sufficient for Ub thioester 
formation (Schwarz et al., 1998; Wang et al., 1999).  Rsp5 is able to associate with 
various E2s such as Ubc1, Ubc4, Ubc5, and Ubc7 (Arnason et al., 2005; Dunn and Hicke, 
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 2001b; Rotin et al., 2000) in order to carry out the ubiquitylation of various cellular 
targets.  An association with Ubc13, however, has not been reported.  Ubiquitylation via 
Rsp5 has been found to occur on the large subunit of RNA polymerase (Huibregtse et al., 
1997), various plasma membrane proteins (Rotin et al., 2000), mitochondria (Fisk and 
Yaffe, 1999), and transcription factors (Hoppe et al., 2000).  The list has been further 
expanded by a recent proteomic approach that identified many additional possible 
ubiquitylation targets of Rsp5 (Kus et al., 2005).  An interesting feature of the 
ubiquitylation by Rsp5 is that its targets may be linked by mono- or poly-Ub.  
Furthermore, in at least a few cases, the poly-Ub chains generated via Rsp5 are not linked 
through Lys48.  Given the ability of Rsp5 to associate with different E2s (and potentially 
with Ubc13-Mms2), it is suggested that the nature of the Ub linkage is attributed to a 
specific Rsp5-E2 interaction.   
 In addition to the HECT domain, Rsp5 contains two other characterized protein 
domain types (shown schematically in Figure 5-4B).  A phosphoinositide-interacting C2 
domain (Dunn et al., 2004) is situated at the N-terminus.  The C2 domain is required to 
properly localize Rsp5 to cytosolic membranes in vivo and apparently facilitates the role 
of Rsp5 in endosomal sorting (Dunn et al., 2004; Morvan et al., 2004), but is dispensable 
for most other Rsp5 functions (Dunn and Hicke, 2001a; Wang et al., 1999).  Three WW 
domains are centrally located within the Rsp5 protein sequence.  WW domains are small 
(~40 amino acid) tryptophan-rich modules that mediate protein-protein interactions, with 
affinity for Pro-rich sequences such as the PY motif (Einbond and Sudol, 1996; Wang et 
al., 1999).  They are implicated in binding to the target of ubiquitylation.  The availability 
of three WW domains in Rsp5 permits a high degree of protein interaction variability, 
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 since different combinations of the WW domains seem to be required for functioning in 
specific cellular pathways (Dunn and Hicke, 2001a; Gajewska et al., 2001).  This is likely 
an important feature for enabling Rsp5 to take part in so many different cellular 
pathways.  The arrangement of the C2, WW, and HECT domains of Rsp5 is 
representative of a large family of eukaryotic proteins with a common modular domain 
architecture (Ingham et al., 2004).  The prevalence of these homologs throughout 
eukaryotes suggests that at least some of the functions of Rsp5 are conserved in nature.  
Indeed, like Rsp5, the mammalian homolog Nedd4 is involved in membrane permease 
turnover (Rotin et al., 2000; Staub et al., 2000).  Furthermore, human NEDD4 is able to 
complement some of the rsp5 mutant phenotypes in S. cerevisiae, although it cannot 
restore the viability of rsp5∆ (Gajewska et al., 2003). 
 
5.2  Results 
5.2.1  Stable physical interactions are observed for Mms2 and Rsp5  
 The Mms2-Rsp5 physical interaction was identified in a proteomics-based screen 
for protein complexes in S. cerevisiae (Gavin et al., 2002).  Such large-scale high-
throughput studies are usually performed without sufficient attention to individual data 
points, and are therefore prone to false positives and false negatives.  Furthermore, the 
proteomic study by Gavin et al. failed to follow-up on Mms2 and Rsp5 specifically.  I 
thus sought to independently confirm the reported Mms2-Rsp5 physical interaction.   
 In the first approach, an anti-Myc antibody was used to precipitate Myc-Rsp5 
protein from total yeast cell extracts.  Western blots were then performed using anti-
Mms2 polyclonal antibody to detect whether Mms2 had been co-immunoprecipitated.  
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 However, the Co-IP of Myc-Rsp5 and Mms2 was not observed in these assays (data not 
shown).  In order to enhance the possible Myc-Rsp5-Mms2 interaction, I performed 
subsequent Co-IP experiments by spiking the yeast cell extracts with purified Mms2 
protein.  In these assays, a physical interaction between Rsp5 and Mms2 was implicated 
because the detection of Mms2 in the Co-IP was dependent on cell extracts containing the 
Myc-Rsp5 protein (Figure 5-1A). 
 In another approach, the binding assays were not supplemented with purified 
protein.  Yeast cells co-transformed with plasmids expressing Myc-Rsp5 and GST-Mms2 
were used to make total cell extracts for use in GST pull-down experiments.  After 
affinity purification of the GST-Mms2 fusion, an anti-Myc antibody was then used to 
determine whether Myc-Rsp5 had been co-purified.  As seen in the lower panel of Figure 
5-1B, Myc-Rsp5 was detected in the GST-Mms2 pull-down sample.  On the other hand, 
Myc-Rsp5 was not detected in the same experiment using GST-Ubc13 in place of GST-
Mms2 (Figure 5-1B, lower panel), despite the fact that a slightly greater amount of GST-
Ubc13 was pulled from the extracts as compared with GST-Mms2 (Figure 5-1B, upper 
panel).  The GST pull-down experiments were performed in mms2∆ and ubc13∆ yeast 
strains in order to eliminate competitive interference from endogenous Mms2 and Ubc13, 
respectively. 
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Figure 5-1. An Mms2-Rsp5 physical interaction is detected in vitro. Two separate 
methods were used to demonstrate a stable protein interaction between Mms2 and Rsp5. 
(A) Co-IP of Myc-Rsp5 and yeast Mms2.  Anti-Myc antibody was immobilized onto 
Protein A Sepharose and cell lysates with (Lane1) or without (Lane2) Myc-Rsp5 were 
added for a 4 hour incubation at 4°C.  30 µg of purified yeast Mms2 protein was added in 
the last half of the incubation before the washing steps. Samples were analyzed via SDS-
PAGE and the physical interaction is indicated by the presence of Mms2 in the Western 
Blot (W.B.) against Mms2. Lane 3, Mms2 protein alone. Asterisks indicate background 
bands from the antibody used in the Co-IP. (B) GST pull-down assay.  Crude extracts 
containing Myc-Rsp5 and GST-Mms2 or GST-Ubc13 were incubated with Glutathione 
Sepharose 4B to immobilize GST. After the washing steps, samples were analyzed via 
SDS-PAGE and the physical interaction is indicated by the presence of Myc-Rsp5 in the 
Western Blot against Myc. Lanes 3 and 4, GST pull-down assays using GST-Mms2 and 
GST-Ubc13 respectively.  Upper panel, Western Blot against GST.  Lower panel, Western 
Blot against Myc.  Lanes 1 and 2, samples of the extracts used in the GST-Mms2 and 
GST-Ubc13 pull-downs, respectively, to ensure the presence of Myc-Rsp5. The Myc-
Rsp5 band was not seen in extracts that did not express Myc-Rsp5 (not depicted).
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 5.2.2  A physical interaction is observed for Mms2 and Rsp5 in the yeast two-hybrid 
assay 
 The in vitro binding studies above seemed to confirm the physical interaction 
between Mms2 and Rsp5, but it was felt that the interaction strength was probably weak 
because Western blots were required to detect the proteins of interest in each experiment.  
Weak or transient interactions involving E3 proteins are not surprising.  For example, 
physical interactions between Ubc13-Rad5 and Ubc13-TRAF6 could only be detected in 
the yeast two-hybrid assay (Figure 4-6 and 4-7, respectively).  Therefore, the yeast two-
hybrid assay was used as a completely different and possibly more sensitive approach to 
detect the physical association between Mms2 and Rsp5. 
 RSP5 was cloned into two-hybrid vectors to create Gal4AD- and Gal4BD-Rsp5 
fusion proteins.  As seen in Figure 5-2, the Gal4BD-Rsp5 and Gal4AD-Mms2 pairing 
generated a clear protein interaction signal, whereas the Gal4BD-Rsp5 negative control 
produced no positive signal whatsoever.  It is noted that the Gal4AD-Rsp5 hybrid protein 
itself generated a surprising false-positive result.  It is perhaps possible that Rsp5 contains 
an unidentified cryptic DNA binding domain that is not normally realized due to Rsp5’s 
exclusion from the nucleus.  Further studies are needed to determine if this is truly the 
case.  Nonetheless, the yeast two-hybrid results validated the Mms2-Rsp5 physical 
interaction as detected in the in vitro binding experiments. 
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controls - see legend
yRsp5
yRsp5
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yRsp5
Figure 5-2. An Mms2-Rsp5 physical interaction is detected in the yeast two-
hybrid assay. Yeast two-hybrid analysis of the Mms2-Rsp5 protein interaction 
using the β-galactosidase filter-lift detection method. Physical interaction of the 
Gal4 hybrid proteins leads to the expression of the β-galactosidase gene which 
causes blue colour development in the assay. Co-transformed plasmids were 
maintained with Trp and Leu markers and are indicated on the left. The picture was 
taken after 4 hours of colour development at 30°C. Two representative 
transformants from each combination is shown. Controls were cells co-transformed 
with Gal4AD- yMMS2 + Gal4BD  (on left) and Gal4BD-yMMS2 + Gal4AD-yUBC13 
(on right). Test plasmids were pGAD-yRSP5, pGBT-Rsp5, and pGAD-yMMS2.
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 5.2.3  A physical interaction between Ubc13 and Rsp5 is not observed 
 The GST pull-down results in Figure 5-2B suggested that Rsp5 does not 
physically interact with Ubc13 in vitro.  However, given that the yeast two-hybrid 
approach was more successful in detecting the Mms2-Rsp5 interaction than the GST pull-
downs, the testing of a possible Ubc13-Rsp5 physical interaction in the yeast two-hybrid 
assay was performed. 
 As seen in Figure 5-3, Ubc13 does not appear to physically interact with Rsp5 in 
the yeast two-hybrid assay.  Despite using the same conditions and the equivalent 
constructs as for Rsp5-Mms2 in the filter-lift detection method, the Gal4BD-Rsp5 and 
Gal4AD-Ubc13 pairing did not generate a positive interaction signal.  In an effort to 
provide a greater level of assay sensitivity, a second yeast two-hybrid assay making use 
of a HIS3 reporter gene required for growth of a His auxotroph strain was tried.  In 
personal observations, the yeast two-hybrid growth assay method is seen to be more 
sensitive than measuring colour development in the filter-lift assay.  However, even using 
the most sensitive assay conditions possible with the HIS3 reporter, a physical interaction 
between Rsp5 and Ubc13 was not detected (Figure 5-3).   
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Figure 5-3. A Ubc13-Rsp5 physical interaction is not observed. Yeast two-
hybrid analysis of Ubc13 and Rsp5. Co-transformed plasmids were maintained 
with Trp and Leu markers and are indicated on the left. (A) β-galactosidase filter-
lift assay method. Physical interaction of the Gal4 hybrid proteins leads to the 
expression of the β-galactosidase gene which causes blue colour development in 
the assay. The picture was taken after 12 hours of colour development at 30°C. (B) 
Growth assay method. Physical interaction of the hybrid proteins causes the 
expression of the HIS3 reporter which leads to growth on minimal medium lacking 
His. The plates were incubated for 72 hours before taking the photograph. Two
representative transformants from each combination is shown. Test plasmids were 
pGBT-Rsp5, and pGBT-yMMS2, pGAD-yUBC13.
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 5.2.4  Deletion mapping of the Mms2-Rsp5 physical interaction 
 After demonstrating that Mms2 and Rsp5 do indeed physically interact, it became 
desirable to determine which protein regions or domains are required.  Based on the high 
degree of similarity between Mms2 and E2s, it was expected that the HECT domain of 
Rsp5 would mediate its interaction with Mms2.  E2-E3 interactions have been shown to 
typically occur via the HECT domain (Huang et al., 1999).   
 The yeast two-hybrid assay was used to map the Rsp5-Mms2 interaction because 
it had produced a strong positive signal with the full-length proteins.  To provide the 
greatest insight into the interaction, deletions were created in Rsp5 because of its large 
size and multiple domains.  Mms2 on the other hand has only a small single protein 
domain.  The first series of Rsp5 deletions were generated as N-terminal truncations.  
They were designed to systematically remove the C2 and each of the three WW domains, 
leaving the shortest derivative to contain the HECT domain alone.   As seen in Figure 5-
4, the derivatives containing the HECT domain alone or the HECT domain plus the 
WW3 domain did not interact with Mms2 in the yeast two-hybrid assay.  However, 
deletion of the C2 or the C2 and WW1 domains did not disrupt the Rsp5-Mms2 
interaction.  To ensure that the HECT domain was not required for the interaction with 
Mms2, another series of deletions was generated from the other end of Rsp5.  The 
generation of C-terminal truncations would also help to address false negatives that may 
have arisen due to protein misfolding.  As seen in Figure 5-4B, these C-terminal 
truncations were designed to remove the HECT domain itself, the HECT domain plus the 
WW1 and WW2 domains, or the HECT domain plus all of the WW domains.  Of these 
Rsp5 C-terminal deletions, only the derivative that retained the WW2 and WW3 domains 
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 was able to physically associate with Mms2.  Taken together, the N-terminal and C-
terminal truncations were in agreement with one another.  The deletion mapping 
suggested that the C2, WW1, and HECT domains are not required for the Rsp5-Mms2 
physical interaction.  Put another way, it was deduced that the WW2 and WW3 domains 
were the important determinants for the interaction.  To test whether the WW2 domain 
itself was sufficient for the interaction, a construct containing only the Rsp5 WW2 
domain was generated.  As seen in Figure 5-4, the Rsp5 WW2 domain alone did not 
interact with Mms2 in the yeast two-hybrid assay.  However, a derivative containing only 
the WW2 and WW3 domains was able to restore the Mms2 interaction with Rsp5 (Figure 
5-4). 
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Figure 5-4. Mapping the Mms2-Rsp5 physical interaction. The yeast two-hybrid assay 
was used to test the ability of several Rsp5 deletions to physically interact with Mms2. (A) 
Data from the yeast two-hybrid assay filter-lift detection method. Physical interaction of the 
Gal4 hybrid proteins leads to the expression of the β-galactosidase gene which causes blue 
colour development in the assay. Co-transformed plasmids were maintained with Trp and 
Leu markers and are indicated on the left. The picture was taken after 4 hours of colour
development at 30°C. Two representative transformants from each combination is shown. 
Controls were cells co-transformed with Gal4AD + Gal4BD-RSP5  (on left) and Gal4BD-
yMMS2 + Gal4AD-yUBC13 (on right). Dotted line indicates data taken from a different 
region of the same assay filter. Test plasmids were pGBT-Rsp5 (and derivatives) and pGAD-
yMMS2.
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Figure 5-4. Mapping the Mms2-Rsp5 physical interaction. (B) A schematic of the 
various Rsp5 derivatives used in the yeast two-hybrid assay as performed in (A) is shown. 
The characterized protein domains are coloured for clarity: C2 (red); WW (green); HECT 
(blue). The ability of each derivative to physically interact with full-length Mms2 is 
indicated on the right. 
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 5.2.5  Rsp5 does not likely function in error-free DDT 
 The considerable physical interaction data in this chapter made it apparent that 
Mms2 and Rsp5 are likely to function together in the cell.  The notion that Rsp5 can 
function in error-free DDT seemed plausible given that it is an E3 involved in Ub-Lys63-
mediated polyubiquitylation.  Furthermore, a phenotypic connection between RSP5 and 
error-free DDT was provided in an early S. cerevisiae screen that identified yeast strains 
with elevated spontaneous mutation rates (Gottlieb and von Borstel, 1976; Hastings et al., 
1976).  These so-called mutator strains have elevated mutagenesis rates because DNA 
lesions in these cases are channeled into mutagenic repair pathways (Hastings et al., 
1976).  One of the mutator strains in the screen contained an allele designated mut2, 
which was later mapped to the RSP5 locus (M. Vandenbol, Gembloux Agricultural 
University, Belgium, personal communication).  The mutator phenotype of mut2 was thus 
reminiscent of the phenotype caused by the mms2 mutation.  Mutants of the error-free 
DDT genes are mutators because DNA lesions are channeled into the mutagenic 
translesion DNA synthesis pathway (Broomfield et al., 1998; Broomfield et al., 2001; 
Xiao et al., 1999).  Adding yet another similarity between mut2 and mms2 was the 
observation that mut2 is also sensitive to the DNA damaging agent MMS (Hastings et al., 
1976 and personal observations). 
 A hypothesis to account for the possible role of Rsp5 in error-free DDT was 
made.  Based on the phenotypic similarity of mut2 and mms2, the physical interaction 
between Mms2 and Rsp5, and the reported exclusion of Rsp5 from the nucleus, it was 
felt that Rsp5 could regulate the function of Mms2 by sequestering it outside of the 
nucleus.  Upon DNA damage, Mms2 would then dissociate from Rsp5 in order to enter 
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 the nucleus and perform its function in error-free DDT.  Indeed, the DNA damage 
dependent localization of Mms2 to the nucleus has been reported (Ulrich and Jentsch, 
2000).  Therefore, the mut2 allele of RSP5 could be envisioned to cause the constitutive 
binding to Mms2 in the cytosol, preventing its relocation to the nucleus.  In this case, the 
polyubiquitylation of PCNA would not occur and an increased rate of mutagenesis and 
sensitivity to DNA damage would be observed.  However, preliminary experimentation 
made it apparent that the hypothesis was not likely correct.  When compared with their 
corresponding wild-type strains, it was found that mut2 was less sensitive to MMS than 
mms2 and more significantly, mut2 was not sensitive to UV DNA damage whatsoever 
(data not shown).  Mutants of the error-free DDT genes have the  characteristic 
phenotype of being sensitive to a wide variety of DNA lesions, including those generated 
by UV irradiation (Broomfield et al., 2001).  To definitively exclude the possibility that 
RSP5 functions with MMS2 in error-free DDT, it was desired to show a genetic 
relationship (or lack thereof) between mms2 and rsp5.  Unfortunately, epistatic analysis 
was not easily possible due to the lack of selectable markers in the mut2 strain.  
Furthermore, genetic crosses using the mut2 strain were not successful.  This was not 
particularly surprising because sporulation deficiencies for rsp5 mutant strains had been 
previously reported (Kanda, 1996). 
 
5.2.6  Rsp5 is involved in the Lys63-dependent Ub conjugation of plasma membrane 
permeases  
 Since it seemed that Rsp5 does not function in error-free DDT, it was reasoned 
that the Mms2-Rsp5 physical interaction would be attributed to an unidentified cellular 
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 role for each protein, a cellular role to which Rsp5 had already been described, or both.  
Regarding roles for which Rsp5 had already been described, several factors led to the 
hypothesis that the Mms2-Rsp5 interaction was a part of a plasma membrane protein 
endocytotic pathway. 
 One of the most clearly defined and experimentally studied roles for Rsp5 is in 
regulating the activity of plasma membrane proteins (Horak, 2003).  The Rsp5-dependent 
conjugation of Ub to various permeases and transporters leads to their endocytosis.  The 
physical removal of such proteins from their site of action (i.e. the plasma membrane) is a 
simple and direct method for negative regulation.  The internalization step is followed by 
an endosomal sorting processes that also requires Ub and Rsp5 (Katzmann et al., 2004; 
Morvan et al., 2004; Urbe, 2005).  The trafficking of such proteins through the 
multivesicular sorting pathways through this pathway normally leads to their proteasome-
independent degradation in the vacuole or lysosome.  With this general strategy, Rsp5 is 
implicated in down-regulating over a dozen plasma membrane proteins in yeast, such as 
amino acid permeases and mating-type receptors (Rotin et al., 2000).  The importance of 
this cellular process is underscored by the apparent conservation throughout eukaryotes 
where at least 33 plasma membrane proteins have been identified to be modified in this 
manner (Dupre et al., 2004). 
 The greatest connection between Mms2 and Rsp5 with respect to plasma 
membrane protein endocytosis comes from the type of ubiquitylation that is sometimes 
performed.  The predominant modification via Rsp5 is a single Ub moiety (mono-Ub).  
However, short poly-Ub chains linked through Lys63 have been experimentally 
demonstrated for two yeast membrane proteins.  These proteins, Fur4 and Gap1, function 
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 as the uracil and general amino acid permeases, respectively.  Their Ub-Lys63-dependent 
ubiquitylation was revealed in yeast strains that produced lowered levels of wild-type Ub.  
When these cells were transformed with plasmids overexpressing a ub-K63R mutant (as 
compared to wild-type UB), the level of poly-ubiquitylated Fur4 or Gap1 was noticeably 
decreased (Galan and Haguenauer-Tsapis, 1997; Springael et al., 1999).  These 
observations were supported by experiments using a yeast strain engineered to encode 
Ub-K63R as its sole source of Ub.  In this strain, the Rsp5-dependent Lys63-linked 
ubiquitylation of Fur4 is completely abolished (Galan and Haguenauer-Tsapis, 1997; 
Galan et al., 1996).  While modification by mono-Ub is sufficient for the internalization 
of Fur4 and Gap1, experimental data is consistent with a model whereby the rate of 
internalization is stimulated via Lys63-linked ubiquitylation.  Interestingly, the E2 
responsible for the Lys63-linked Ub conjugation of these membrane permeases was not 
identified (Galan and Haguenauer-Tsapis, 1997), therefore allowing the possibility that 
Mms2 (and Ubc13) may be responsible.  The physical link between Mms2 and Rsp5 
could be envisioned as a bridge between the Lys63-linked Ub conjugating complex 
(Ubc13-Mms2) and the plasma membrane proteins that are apparently modified by such 
poly-Ub chains.   
 
5.2.7  MMS2 is not required for the Lys63-dependent Ub conjugation of the uracil 
permease 
 To address whether the RSP5-dependent Lys63-linked poly-ubiquitylation of 
membrane permeases is dependent on MMS2, Western blots were performed in order to 
directly visualize the ubiquitylation status of Fur4.  However, two factors complicated the 
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 initial analysis.  First, typical soluble-phase yeast cell extracts could not be used to 
harvest the Fur4 protein due to its localization to plasma membranes and endosomes.  
Second, Fur4 is normally expressed at extremely low levels and is not normally detected 
in Western blots (Galan and Haguenauer-Tsapis, 1997).  To overcome these limitations, a 
plasmid over-expressing FUR4 was used in conjunction with an adapted procedure to 
prepare membrane-enriched fractions from yeast cells (Springael et al., 1999).  A similar 
method had been used previously to show that yeast cells with Ub-K63R as their sole 
source of Ub are unable to poly-ubiquitylate Fur4 (Galan and Haguenauer-Tsapis, 1997). 
 As seen in Figure 5-5, a band of increasing molecular weight corresponding to the 
uracil permease is seen in the wild-type cell preparations (Lanes 1 and 3).  These bands 
are completely absent in the fur4∆ strain (Lane 5). Similarly, the Fur4 bands were not 
detected in the yeast strain expressing ub-K63R as its sole source of Ub (Lane 2), 
indicating that the bands observed in Lane 1 correspond to various Lys63-dependent 
ubiquitylation states of the uracil permease.  When the mms2∆ strain was tested (Lane 4), 
there was no apparent effect on the ubiquitylation of Fur4 as compared with the wild-type 
strain (Lane 3).  It is noted that the smearing of bands is typical of proteins modified by 
Ub-chains in vivo, especially those isolated from membrane-enriched fractions (Galan 
and Haguenauer-Tsapis, 1997). 
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Figure 5-5. Mms2 is not required for the polyubiquitylation of the uracil permease.
The polyubiquitylation of Fur4 in various wild-type and mutant S. cerevisiae strains was 
monitored. Membrane-enriched samples were prepared for each strain and then run by 
SDS-PAGE.  A Western blot of these samples using anti-Fur4 antibody is shown. 
Polyubiquitylated Fur4 is indicated (Fur4-Ubn). Strains are: Lanes 1 and 2 represent 
engineered yeast strains expressing single copies of wild-type UB (SUB280) and ub-K63R 
(SUB413), respectively; wild-type (Lane 3); mms2? (Lane 4);  fur4? (Lane 5). All strains 
except fur4? were transformed with a multi-copy plasmid (YEp352fF) expressing Fur4. A 
band cross-reacting with the Fur4 antibody is indicated with an asterisk and is used to 
ensure an approximately equal loading of samples. The smearing of in vivo 
polyubiquitylated proteins such as Fur4 is commonly seen (Galan and Haguenauer-Tsapis, 
1997)
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 5.3  Discussion 
 A large portion of this thesis was dedicated to structure-function studies of 
Ubc13-Mms2, which provided substantial experimental evidence to support a model for 
the precise generation of Lys63-linked Ub chains.  The Ubc13-Uev mechanism of Ub 
conjugation is unique in nature and to my knowledge there is no other reported 
explanation for how Ub can be specifically linked via Lys63.  A paradox thus arises in 
yeast cells because Lys63-linked Ub chains have been identified in various cellular 
pathways but Ubc13 and Mms2 apparently function in error-free DDT only.  The studies 
in this chapter sought to demonstrate novel physical interactions (and functions) for the 
Ubc13-Mms2 complex in order to address this disparity. 
 During my studies, a proteomic screen for protein complexes in yeast identified a 
novel physical interaction between Mms2 and Rsp5 (Gavin et al., 2002).  In order to 
confirm the finding, two different affinity-based approaches were employed in this study.  
Indeed, a physical interaction between Mms2 and Rsp5 in Co-IP and GST pulldown 
experiments was observed.  The Mms2-Rsp5 physical interaction was also detected in the 
yeast two-hybrid assay, which yielded a binding signal that was more readily detectable 
than in the affinity-based experiments.  The clear demonstration of an Mms2-Rsp5 
interaction is particularly significant because it is the first protein interaction found for 
the Mms2 family of Uevs that does not involve Ubc13 or Ub. 
 Given its large size, it was felt that Rsp5 could possibly bind to both Mms2 and 
Ubc13, perhaps leading to a higher-affinity association.  However, a pull-down 
experiment suggested that this might not be the case (Figure 5-1).  In accordance with 
this finding, a yeast two-hybrid assay was also not able to detect a physical interaction 
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 between Ubc13 and Rsp5.  It is noted that the N-terminal Ubc13 fusions may have 
obstructed a physical interaction with Rsp5.  However, this possibility is felt to be 
unlikely because GST and GAL4 fusions to yeast UBC13 are fully proficient in 
functionally complementing ubc13∆ yeast strains (data not shown).   
 The three dimensional structure of the Uev domain is highly super-imposable 
with the Ubc domain and it was thus expected that Mms2 would bind to the HECT 
domain of Rsp5 in the conventional E2-E3 manner as discussed in Chapter 3 of this 
thesis.  In accordance, crystal structure analysis reveals that the Mms2 surface 
corresponding to the E2 surface used to bind HECT domain E3s (Huang et al., 1999) is 
not obstructed by the Mms2-Ub or Mms2-Ubc13 physical interactions.  In order to 
address the hypothesis experimentally, the yeast two-hybrid assay was used to test full-
length Mms2 against a panel of Rsp5 deletions.  Taken together, it was determined that 
the WW2 and WW3 domains are necessary for the Rsp5-Mms2 interaction.  More 
specifically, the WW2 domain itself was found to be required but not sufficient for the 
interaction.  It is noted that the WW2 fragment is small (33 amino acids) and could have 
been obstructed by the relatively large Gal4BD fusion protein.  Contrary to expectations, 
the Rsp5 HECT domain was not required for its interaction with Mms2.  
 The finding that the Rsp5-Mms2 interaction is mediated through WW domains 
was surprising but not without a good explanation.  WW domains are bona fide protein-
protein interaction modules with a binding preference for short Pro-containing sequences, 
such as the PY motif.  Mms2 does not contain an authentic PY motif but was previously 
identified as a Pro-rich protein (Broomfield et al., 1998).  Visual analysis of the Mms2 
amino acid sequences reveals several short regions with multiple Pro residues.   
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  The novel interaction discovered here between a Uev (Mms2) and a HECT 
domain E3 (Rsp5) presents an interesting possibility for coordinating multiple Ub 
conjugation activities.  While binding to Mms2 through its WW domain(s), Rsp5 could 
simultaneously interact with an E2 via its HECT domain.  In this way, Rsp5 could act as 
a physical bridge between Ubc13-Mms2 and another E2 with possibly distinct Ub 
conjugation activities.  The bridging of two different E2s through a single E3 is 
reminiscent of the role for Rad5 in the yeast DDT pathway (Ulrich and Jentsch, 2000).  
Rad5 is proposed to simultaneously bind Rad6-Rad18 and Ubc13-Mms2 to allow the 
mono- and poly-ubiquitylation of PCNA, respectively (Hoege et al., 2002).  This model 
is especially inviting in this case because Rsp5 is involved in the mono- and Lys63-linked 
poly-ubiquitylation of plasma membrane permeases, requiring E2s that have yet to be 
determined. 
 It was initially inviting to speculate that RSP5 is a novel gene involved in error-
free DDT because mut2, an allele of RSP5, was shown to exhibit mutator and MMS-
sensitive phenotypes which are reminiscent of mms2∆.  However, further analysis of 
mut2 suggested that this was not the case.  It was also realized that the mutator and 
MMS-sensitive phenotypes of mut2 may at least be partially explained by currently 
known roles for Rsp5.  For example, Rsp5-dependent ubiquitylation is required for the 
turnover of at least 12 different plasma membrane proteins.  A mutant disrupting this 
activity could lead to an over-abundance of permeases and possibly allow a greater 
amount of MMS into the cell.  Also, an rsp5 allele leads to various mitochondrial-
associated phenotypes (Fisk and Yaffe, 1999) and a mitochondria-mediated nuclear 
mutator phenotype has been identified (Rasmussen et al., 2003).  Nonetheless, it is felt 
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 that future experimentation will be required to completely rule-out the possibility that 
RSP5 is involved in error-free DDT. 
Exploring another possibility, it was felt that the Mms2-Rsp5 physical interaction 
could be attributed to the role of Rsp5 in plasma membrane protein endocytosis.  This 
was thought to be particularly likely because Rsp5 is required for the Lys63-linked Ub 
conjugation of the uracil and general amino acid permeases in a process requiring an 
unidentified E2(s).  To test whether Ub conjugation via Mms2 is required in this role, the 
Lys63-dependent ubiquitylation of the uracil permease (Fur4) was monitored.  When 
samples from the mms2∆ strain were analyzed, it was found that Fur4 was efficiently 
polyubiquitylated, with no discernable difference from the wild-type strain.  It is 
concluded that MMS2 is not required for the Lys63-dependent polyubiquitylation of Fur4.  
In support of this finding, the Lys63-dependent ubiquitylation of Fur4 was also 
unaffected in ubc13∆ yeast strains (R. Haguenauer-Tsapis, personal communication).   
Based on the findings in this chapter, the following possibilities are noted: 
• The Mms2-Rsp5 physical interaction is an experimental artifact. 
• RSP5 is involved in error-free DDT and the mut2 allele will reveal novel 
error-free DDT phenotypes. 
• MMS2 is involved in the RSP5-mediated endocytosis of plasma membrane 
proteins (such as Fur4) but in a manner that is not directly related to their 
Lys63-dependent polyubiquitylation. 
• The Mms2-Rsp5 physical interaction is attributed to a cellular role(s) that 
was not addressed in the experimentation above. 
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 As a final note, the results concerning Fur4 in particular led me to reconsider the 
disparity between Lys63-linked Ub chains found in vivo and the lack of Ubc13-
Mms2/Uev1 involvement.  As will be discussed in chapter six, it is felt that a 
misterpretation may be attributed to some of these cases.  
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CHAPTER SIX - 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1  Conclusions 
The implications and conclusions of the studies presented in this thesis have been 
discussed in detail in their respective chapters.  For the sake of brevity and clarity, the 
major conclusions are summarized as follows: 
 
6.1.1  Major conclusions from chapter three 
• The human UBC13 and MMS2 genes can functionally complement their 
counterparts in S. cerevisiae DDT.  
• Human UEV1A but not UEV1B is able to function in place of MMS2 in S. 
cerevisiae DDT. 
• There is a direct correlation between Ubc13-Uev complex formation and function 
in S. cerevisiae DDT. 
• Heterologous (yeast-human) Ubc13-Uev pairs are functional in S. cerevisiae 
DDT. 
 
6.1.2  Major conclusions from chapter four 
• The functional analysis of site-directed point mutations in Ubc13 and Mms2 
supports the prevailing in vitro mechanistic model of Lys63-linked Ub 
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 conjugation; binding of donor and acceptor Ub by Ubc13 and Mms2, 
respectively, Ubc13-Mms2 heterodimer formation, and the binding of an E3 by 
Ubc13. 
• Yeast Mms2-Ser27 (human Mms2-Ser32) is identified as a novel residue required 
for binding to Ub and suggests for the first time that polar contacts are important 
for the physical interaction. 
• MMS2-S27A/I57A is severely sensitive to DNA damage and may be a potential 
dominant-negative regulator of UBC13 activity. 
• Human Ubc13 can physically interact with the RING finger E3s Rad5, TRAF6, 
and CHFR, but binding is lost in each case with the Ubc13-M64A mutation.  The 
physical interaction with Rad5 is necessary for the function of human UBC13 in 
yeast DDT. 
• There is a direct correlation between the binding strength of Ubc13-Mms2 and 
their ability to alleviate the sensitivity of yeast cells to DNA damage. 
• The binding and specificity of the Ubc13-Mms2 heterodimer relies on the 
insertion of an Mms2 Phe residue into a unique hydrophobic pocket formed by 
residues of Ubc13. 
 
6.1.3  Major conclusions from chapter five 
• Mms2 can make a direct physical interaction with Rsp5. 
• The Mms2-Rsp5 physical interaction maps to the Rsp5 WW2 and WW3 domains. 
• MMS2 is not required for the Ub-Lys63-dependent ubiquitylation of the Fur4 
plasma membrane permease. 
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6.2  Future directions 
A number of future considerations and questions were brought up in previous 
chapters of this thesis.  Three of these of immediate interest are discussed below. 
 
6.2.1  Can an E2 be engineered to create a new physical interaction with Mms2? 
With the detailed mutational analyses in chapter four, an explanation was 
provided for the specificity of Mms2 for Ubc13, but not other E2s.  The model argues 
that the nature and spatial arrangement of residues comprising the necessary hydrophobic 
pocket for the hMms2-Phe13 (yMms2-Phe8) insertion is unique to Ubc13.  However, it 
was noted in the visual comparison with Ubc13 that Ubc1 would be the most likely of the 
E2s to spatially accommodate a physical interaction with Mms2.  In this context it is 
important to recall that the PheÆGlu mutation of the Ubc13-Phe57 residue caused a 
complete loss in binding to Mms2.  Sequence alignments reveal that Ubc1 contains a Glu 
at this corresponding position (Figure 4-28).  It is interesting to speculate that this Ubc1-
Glu59 residue is under selective pressure because phylogenetic analysis reveals that Ubc1 
is the closest evolutionary ancestor to Ubc13 (data not shown). 
Future studies are proposed to first ensure that Mms2 does not physically interact 
with Ubc1 and then to systematically engineer the Ubc13 “pocket” onto Ubc1, beginning 
with a Ubc1-E59F mutation.  The creation of a Ubc1-Mms2 physical interaction in this 
manner would be the best test of the Mms2-Ubc13 interaction model proposed in chapter 
four. 
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 6.2.2  What is the mechanism of Lys63-linked Ub conjugation in vivo? 
The functional data presented in this thesis has authenticated the prevailing 
mechanism of Lys63-linked Ub conjugation by Ubc13-Mms2.  However, the model was 
created from in vitro observations and is not without its limitations.  For instance, while 
the conjugation of Ub molecules through Lys63 is clear, a mechanism for how the di-Ub 
conjugate is delivered to the target (possibly via an E3) has not been explained.  To 
accommodate this conceptual gap, I propose a simplified mechanism for Ubc13-Mms2 
whereby the conjugation and target-delivery steps are performed concurrently in vivo. 
A model for Lys63-linked Ub conjugation in vivo is diagrammed in Figure 6-1B.  
I propose that the Ub to be bound by Mms2 is not free, but already conjugated to the 
target (or E3 if applicable).  In this case the Ubc13-Mms2 heterodimer containing a 
Ubc13-Ub thiloester is directed at a pre-ubiquitylated target.  The physical interaction 
between Mms2 and the Ub leads to the proper orientation to facilitate Lys63-linked Ub 
conjugation, and the Ubc13-Mms2 complex can be subsequently released.  The 
simplicity of the model does not require a separate mechanism for the delivery of the 
Lys63-linked Ub conjugate. 
At least two lines of evidence strongly support this proposed in vivo mechanism.  
First, the Lys63-linked ubiquitylation of PCNA by Ubc13-Mms2 is dependent on the 
mono-ubiquitylation of PCNA by Rad6-Rad18 at the same Lys residue (Hoege et al., 
2002).  Second, Ub molecules are activated in a mechanism that involves the direct 
transfer of the Ub C-terminus from an E1 to an E2 thioester.  The Ub bound by Mms2 in 
the mechanism shown in Figure 6-1A is therefore unlikely to be activated and would not 
be competent for conjugation to a target Lys.  The pre-conjugation model shown in 
Figure 6-1B eliminates the problem of activation for the Mms2 acceptor Ub. 
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 Figure 6-1. Proposed mechanisms for the Lys63-linked Ub conjugation of a target in vivo .  (A) A two-step model showing the 
conjugation of di-Ub by Ubc13-Mms2 and the subsequent transfer of Ub2 to the target by an unknown mechanism. (B) A single-step 
model showing that the conjugation of di-Ub by Ubc13-Mms2  occurs directly on a pre-ubiquitylated target.  Coloured items in the 
figure correspond to Ubc13 (violet), Mms2 (green), Ub (white circles), Ub-C-terminus (black), Ub-Lys48 (red), Ub-Lys63 (blue), 
Ubc13 active-site (yellow).
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 6.2.3  Possible misinterpretation of Lys63-dependent Ub conjugation in vivo 
Regarding Lys63-linked Ub chains, there appears to be a disparity between the 
enzyme shown to specifically generate them (i.e. Ubc13-Uev) and their apparent 
involvement in various cellular roles.  For example, in S. cerevisiae there are several 
reported instances of Lys63-linked Ub chains in vivo that do not require Ubc13-Mms2 for 
their synthesis.  This phenomenon was demonstrated in chapter five of this thesis with 
Mms2 and the Fur4 permease.  The apparent paradox can be most easily explained by the 
existence an additional undiscovered mechanism of Lys63-linked Ub conjugation that 
does not involve Ubc13-Uev.  Another possibility may involve misinterpreted 
conclusions regarding Ub chain experimentation. 
The experiments that clearly show the dependence of Ub-Lys63 in vivo make use 
of the ub-K63R mutation to demonstrate a certain phenotype.  In many cases the apparent 
interpretation is that Lys63-linked Ub chains (linked via Lys63 only) are responsible for 
the observation.  However, the conclusion may not be correct in all cases.  An illustration 
of this point involving steric hindrance is shown in Figure 6-2.  I propose that in some 
cases the first Ub molecule is linked to the target (or E3) in a manner that obstructs a 
particular Lys residue.  In the hypothetical model in Figure 6-2A, the Ub-Lys48 residue is 
available for all conjugations.  In another example, the Lys48 of the Ub conjugated to the 
target is physically obstructed (Figure 6-2B, upper panel).  This latter case may lead to a 
chain that initially requires a Ub-Lys63 linkage but is otherwise linked via Ub-Lys48.  In 
cells that express Ub-K63R alone, a target that would normally bear such chains would 
be indistinguishable from a target that was to be modified with Ub-Lys63 linkages only 
(Figure 6-2B, C, lower panel).  Poly-ubiquitylation of the target would be prevented in 
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 both cases, regardless of the particular chain that was to be made.  Because of this 
ambiguity, I prefer the term “Lys63-dependent Ub chains” in place of “Lys63-linked Ub 
chains”, except when it is clear that all linkages are made via Ub-Lys63. 
The use of Ub-Lys63 as the best initially-available Lys is particularly reasonable 
because it is situated approximately 180° from the Ub C-terminus, and is likely to be 
accessible to the conjugation machinery (shown schematically in Figure 6-2).  On the 
other hand, the Ub-Lys48 residue is approximately 90° from the Ub C-terminus and can 
be envisioned to be more easily obstructed by steric hindrance.  It is notable that this 
hypothetical scenario would likely argue against the “freeing” of Lys48 by Ub backbone 
rotation because the conjugating enzymes involved are likely to be conformationally 
restricted via physical interactions, such as between the E3 and target. 
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 Figure 6-2. Possibilities for Ub4 chain formation involving Ub-Lys48 and -Lys63. A diagram showing the consequence that the Ub-K63R 
mutation would have on three different poly-Ub chains. (A) A poly-Ub chain with linkages via Ub-Lys48 (and the Ub-C-terminus) only. (B) A 
poly-Ub chain similar to (A) but using a single linkage via Ub-Lys63. (C) A poly-Ub chain with linkages via Ub-Lys63 (and the Ub C-terminus) 
only. Coloured items in the figure correspond to Ub (white circles), Ub-C-terminus (black), Ub-Lys48 (red), Ub-Lys63 (blue), target/E3 (gray).
BA C
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